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ABSTRACT 
 Tirapazamine (3-amino-1,2,4-benzotriazine 1,4-dioxide, TPZ) is a heterocyclic 
di-N-oxide that can be selectively reduced enzymatically in oxygen-poor (hypoxic) cells 
commonly associated with solid tumors.  This reduction yields a non-toxic mono-N-oxide 
metabolite resulting from deoxygenation that we were interested in functionalizing.  We 
prepared various structural TPZ analogs to expand the library of benzotriazine containing 
compounds in hopes of finding structural changes promising for use clinically. We 
looked at changing the structure of TPZ and its 1-oxide metabolite at various positions of 
the benzotriazine core.  We found interesting fluorescence properties of TPZ and its 1-
oxide metabolite that could be exploited for use as a hypoxia selective fluorescence 
probe.  We also report how metabolic deoxygenation of tirapazamine would result in 
electronic changes useful for activation of various DNA-alkylating substituents.  We 
designed TPZ analogs containing nitrogen mustards or quinone methide derivatives that 
would be selectively activated upon reduction in hypoxic cells.  We examined rates of 
reactivity and physical properties of these new compounds to test their viability as 
hypoxia selective DNA alkylating agents.  The results provided evidence that the 1,2,4-
benzotiazine 1,4-dioxide unit can serve as an oxygen-sensing prodrug platform for the 
selective activation of external substituents in hypoxic cells. 
 We observed that DNA alkylating agents like N-mustards, designed to form DNA 
cross-links at 5`-GNC sequences, also form cross-links not previously associated with the 
class of compounds.  These new cross-links are described to result from depurination of 
deoxyguanine residues to form an abasic site (Ap).  We have previously reported the 
ability of Ap-sites to cross-link with an opposing deoxyadenine residue.  Ap-sites are 
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commonly generated by DNA alkylating agents, and are one of the most common DNA 
lesions that occur in cells.  This intriguing result is directly related to the other work 
presented in this document, involving the reaction between an Ap-site in DNA and 
various nucleobases on the opposing strand of the DNA double helix.  Here we 
summarize the work included in our previous reports of Ap-site cross-links formed with 
deoxyguanine or deoxyadenine residues, along with new and unpublished experiments. 
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Chapter 1.  Tirapazamine as a Fluorescent Probe for Cellular 
Hypoxia 
 
 
1.1 Introduction 
 Cellular hypoxia may enable selective treatment of tumor cells.1-2  Several pro-
drugs currently in clinical trials have been designed to take advantage of this 
phenomenon in order to selectively treat tumors.3 These drugs contain structures such as 
nitro groups, quinones, and N-oxides,4-6 and undergo 1e- enzymatic reduction to yield an 
O2-sensitive radical.  The initial 1-e- reduction is reversed in healthy-normoxic cells by a 
process known as "redox cycling."7 Alternatively, under low oxygen concentration 
(hypoxia), the radical species can fragment or undergo further reduction.3 This oxygen 
sensitivity provides the selectivity towards hypoxic cells.  It should be noted that some 
pro-drugs are metabolized by 2e- reductases through a non-oxygen sensitive process.  
And while 2e- reduction may not be inhibited by molecular oxygen, it can still be useful 
against tumors over-expressing these enzymes.3   
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Scheme 1 
 
 Our group has been particularly interested in tirapazamine (TPZ, 1), one of the 
first pro-drugs used as a treatment against hypoxic tumor cells.  Its IUPAC name is 3-
amino-1,2,4-benzotriazine 1,4-dioxide.  This drug showed promising anti-tumor 
selectivity and even advanced to Phase III clinical trials.6 TPZ is metabolized through an 
oxygen sensitive 1e- reduction to generate free radical 2.  This then fragments to form a 
DNA-damaging radical.  Two mechanisms have been proposed for this process (Scheme 
1).  One involves formation of a triazinyl radical 3 that causes DNA damage,8 although 
evidence leading to hydroxyl radical (!OH) generation instead has been described.9 After 
fragmentation, the unreactive benzotriazine 1-N-oxide metabolite 4 is left as a byproduct.  
While TPZ (1) has shown to have high reactivity towards DNA after 1 e- reduction, it 
showed only limited effectiveness in clinical trials. In fact it was often used in 
combination with other treatments.6, 10 And while TPZ has high selectivity toward 
"moderate" hypoxia (KO2 ≈ 1uM = inhibition by oxygen, Ki),3, 11 its limited efficacy is 
theorized to be partly due to its low tissue penetration of hypoxic tumors12 as well as 
failure to stratify patients based upon the hypoxic character of their tumors.13 Some other 
pro-drugs require more extreme hypoxic conditions than TPZ (KO2 ~0.1uM), 
consequently these compounds require higher tissue penetration to be reduced 
enzymatically.3 While TPZ has not earned approval by the FDA, it has sparked interest in 
N
N+N
NH2
21, TPZ
O–
1e–, H+
4
(enzymatic)
+
NH2
+N N
O–
.
N
OH
•OH
O2
NH2
+N N
O–
+N
O–
N
N+N
NH2
O–
3
+ H2O
O2•–
 
Tirapazamine as a Fluorescent Probe for Cellular Hypoxia                                Chapter 1 
	   3	  
many researchers to develop new benzotriazine 1,4-dioxide analogues for enhanced 
tumor cell killing properties.14-16 
 Synthesis of TPZ analogs will be required for second-generation drugs in this 
family, or for use as molecular tools to detect hypoxia and bioreductive enzymes in 
biological samples.  While there have been successful efforts to synthesize analogues of 
improved cellular permeability,13, 15 our lab focused on a different goal.  TPZ (1) has 
fluorescent properties which could be exploited for use as a probe for hypoxia or 
enzymes involved in drug activation.  When TPZ (1) is reduced to its 1-oxide metabolite 
(4), a bright green fluorescence (513 nm in pH 7 buffered water, 478 nM in acetonitrile) 
can be observed upon excitation.17-18 The parent drug TPZ is not fluorescent under the 
same conditions.  This significant change in fluorescent properties sparked our interest 
towards using TPZ for detecting hypoxia in cell samples and as a fluorescent substrate for 
bioreductive enzymes.  While typically fluorescent probes for bio-imaging typically emit 
at higher wavelengths (650-800 nm),19 probes which fluoresce at lower wavelengths 
(500-550 nm) have been useful for cellular imaging.20-23 Additionally, probes with 
quantum yields much higher than the mono-N-oxide metabolite of TPZ (compound 4, 
~0.12 in acetonitrile) typically are used.18  Our goal in this study is to test a variety of 
structurally diverse benzotriazine analogues to see if particular structural changes would 
lead to promising compounds of higher quantum yield for use as fluorescent probes for 
detecting hypoxia and bioreductive enzymes in cell samples.   
 
 
 
 
Tirapazamine as a Fluorescent Probe for Cellular Hypoxia                                Chapter 1 
	   4	  
 
Figure 1 
 
Figure 1.  3-Amino-1,2,4-benzotriazine 1,4-di-N-oxide map. 
 
1.2 Preparation of Various Substituted Benzotriazine Analogs 
 Chapter 1 primarily focuses on the preparation of benzotriazine analogues with 
substituents in different locations on the ring system (Scheme 2).  Not only did we 
synthesize analogs with the goal of finding compounds with improved fluorescence 
properties, but we also prepared analogs that could be functionalized for other purposes 
as well (Chapter 2).  The first analogs prepared involved various Pd-catalyzed reactions, 
particularly C-C bond forming Suzuki-Miyaura couplings and C-N bond forming 
Buchwald-Hartwig couplings.  To our knowledge there has been no previous report of 
using Pd-catalyzed reactions to couple amines or aryl boronic acids to a halide-containing 
benzotriazine core (Scheme 2).  We chose to synthesize various substituted 
benzotriazines at the 3-position (Figure 1).  Literature reports of 3-chlorobenzotriazine 
(5) has been previously described,24 and this would be useful for Pd-coupling reactions to 
achieve a wide variety of products. 
 
 
 
7
6 5
8
N4
3
N2
N1
O–
NH2
O–
Figure 1
 
Tirapazamine as a Fluorescent Probe for Cellular Hypoxia                                Chapter 1 
	   5	  
 
Scheme 2 
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 Starting with compound 4, prepared using a method adapted from Fuchs et al,25 
compound 5 was synthesized as in Boyd et al (Scheme 3).24  First, hydroxylation of the -
NH2 group in 4 via diazaonium ion intermediate was done with sodium nitrite in 
trifluoroacetic acid followed by hydrolysis.  The dried precipitate was then chlorinated 
with Vilsmeier reagent in neat POCl3 with a catalytic amount of DMF.  In a similar 
reaction, POBr3 is used to prepare the 3-bromo derivative (6) for use in Pd coupling 
reactions.  Aryl halides in hand, various amines were coupled with compounds 5 and 6 
(3-Cl and 3-Br) to yield products 7-15 (Table 1).  The reactions were done in toluene 
under reflux conditions with a catalytic amount of Pd(OAc)2 and SPhos ligand with 
K3PO4 (4 equiv.) for 24 h.  The products were purified by column chromatography and 
the resulting yields are summarized in Table 1.  The Buchwald coupling yields seemed to 
be influenced by sterics and nucleophilicity.  Not all the reactions shown were complete 
within the 24 h reaction time.  Several reactions could potentially provide higher yields if 
allowed to react further.   
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Table 1.  Comparison of Buchwald-Hartwig Coupling vs Substitution 
Reactions of 3-Amino-Substituted-1,2,4-Benzotriazine 1-Oxides 
 
N
N+N
O–
N
H
N
N+N
O–
N
H
N
N+N
N
H
O–
N
N+N
O–
N
N
N+N
O–
N
N
N+N
O–
N
N
N+N
O–
N
H
OH
N
N+N
O–
N
H
N
N+N
O–
N
H
H2N
NH2
H2N
HN
HN
HN
H2N OH
H2N
NH2
N
N+N
O–
Br
Amine (1.4 eq)
Pd(OAc)2 (5%)
ligand (10%)
K3PO4, toluene
reflux, 24 hrs N
N+N
O–
N
N+N
O–
Amine (10 eq)
EtOH, 24 hrs
6
R R
 
Tirapazamine as a Fluorescent Probe for Cellular Hypoxia                                Chapter 1 
	   8	  
 We wanted to show that the halide-substituted benzotriazines are indeed viable 
substrates for Pd coupling reactions.  We synthesized compounds 7 and 8 under Pd-
coupling conditions at varying temperature, both with and without the Pd-catalyst (Table 
2, structures provided in Table 1).  The results show that in the presence of catalyst, 
product yield was significantly higher (Table 2).  Higher temperatures gave marginally 
higher yields in both reactions as well.  Stoichiometric amounts of benzylamine yielded 
product in the absence of catalyst, suggesting that the 3-position is highly electrophilic 
toward nucleophilic aromatic substitution.  We prepared compounds 7-15 via 
nucleophilic aromatic substitution as well and compared these results to the Pd-coupling 
reactions (Table 1). 
Table 2.  Presence of Pd-Catalyst Increased Reaction Yield for Benzotriazine 
Pd-Coupilng Reactions  
 
 Nucleophilic aromatic substitution reactions at the 3-position under mild 
conditions using excess amine have already been reported.26 All Pd-catalyzed products 
(7-15) were additionally synthesized by a nucleophilic aromatic substitution reaction in 
ethanol with excess amine at room temperature to see if similar trends in product yields 
were obtained (Table 1).  The results show that reaction yields again varied depending on 
the amine nucleophilicity, but not all products were obtained with this method 
(compound 8).  While nucleophilic aromatic substitution would provide selective product 
Table 2. Confirmation of Pd Catalysis
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generation, Pd coupling reactions could still be a powerful tool for preparing certain 3-
amino-substituted benzotriazines.  Products requiring less nucleophilic amines, use of 
stoichiometric equivalents because of low supply, or removal of excess starting materials 
during workup make a Pd catalyzed reaction more desirable.  Overall our results support 
a mixed mechanism of Pd-coupling and nucleophilic aromatic substitution occurring in 
our reactions. 
 We felt it useful to explore other Pd-coupling reactions for use in generating other 
TPZ analogs.  In addition to C-N bond coupling reactions, C-C bond coupling reactions 
were explored (Table 3).  Using Suzuki conditions, analogs 16-18 were prepared where 
we coupled aryl boronic acids to 3-halide containing 5 or 6.  Both electron rich and 
electron poor boronic acids were utilized, each requiring differing reaction times. Under 
Suzuki conditions with a toluene/water solvent system, C-C coupling was inefficient in 
presence of an unprotected -NH2 substitutent.  Reaction of p-aminophenyl boronic acid 
gave compound 7 as the major product.  This means that either the Buchwald coupling or 
competing nucleophilic aromatic substitution reactions (or some combination) must have 
been favored over C-C coupling, resulting in C-N bond formation followed by 
protodeboronation to yield the 3-N-substituted 7.27 Using an N-Boc-protected amine as in 
as in compound 16 was required to prevent unwanted C-N coupling reactions from 
occurring.  p-Cyanophenyl boronic acid provided compound 17 in relatively low yield.  
Lower product yield can be attributed to the cyano substituent generating an electron 
poor carbon resulting in a slower coupling reaction, though slightly different reaction 
conditions were used as well (see Experimental).  Performing these Suzuki coupling 
reactions in round bottom flasks under reflux in N2 generally seemed to provide non-
 
Tirapazamine as a Fluorescent Probe for Cellular Hypoxia                                Chapter 1 
	   10	  
quantitative yields (presented in Ujjal Sarkar's Thesis17 and unpublished observations), 
independent of the reaction time.  This must be due to oxidation of the palladium catalyst 
or phosphine ligand during the reaction, resulting from inadequate reaction setup leading 
to contamination by O2.  We observed similar results for the synthesis of compound 18, 
but performing the coupling reaction in a sealed tube for a longer period of time (96 h) 
substantially increased the reaction yield of this product (93%) when compared to 
previous methods (31%). 
Table 3.  Preparation of 1,2,4-benzotriazine 1-Oxide 
Analogs by Suzuki Coupling Reactions 
 
 The Stille coupling reaction has been utilized for installation of an ethyl group 
onto the 3-position of the benzotriazine system in the presence of various substituents at 
the 6- and 7-position (Figure 1).28 Pchalek et al reported the synthesis for a TPZ analogue 
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currently in clinical trials as a hypoxia selective tumor drug with improved cellular 
resilience for increased tumor cytotoxicity.  A series of papers concluded that analogues 
containing 3-aminoalkylamino substituents are prone to faster unwanted metabolism 
rates, and that electron-donating substituents in the 6-position helped counteract this 
increased rate of metabolism of the benzotriazine di-N-oxide system.13, 15 Therefore, 
synthesizing analogues with varying substituents on the benzo ring (Figure 1) could be a 
useful tactic.   
 We set out to synthesize various diethanolamine (DEA) substituted TPZ 
analogues initially using the 6-fluoro-3-ethyl benzotriazine (21) as a scaffold for 
incorporating this diol-containing amine.  Oxidation of 21 with m-CPBA followed by 
nucleophilic aromatic substitution with diethanolamine in acetonitrile gave 23 with room 
temperature (Scheme 4).  The resulting compound gave a benzotriazine of increased 
polarity (and water solubility), and resembled an aromatic nitrogen-mustard (see Chapter 
2).   
Scheme 4 
 
 We prepared other analogues containing this polar dialkylamino substituent.  
Using conditions listed before, we prepared compound 25 (Scheme 5A) containing the 
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diethanolamine substituent at the 3-position instead.  Diethanolamine was easily 
substituted onto compound 5 to give 24, but isolation of 25 after N-oxidation was 
unsuccessful.  This observation has been described before by earlier group members, 
where N-oxidation of the benzotriazine system containing a 3-dialkylamine deaminated 
yielding the 3-OH containing 26 (Scheme 5B).17  Additionally, benzotriazine N-oxidation 
of 5 does not proceed easily (Scheme 5).29 Thus we did not pursue preparation of 25 any 
further. 
Scheme 5 
 
 We continued functionalizing the benzo ring with amine substituents, specifically 
at the 6- and 7- positions (Figure 1, Scheme 6).  Using fluorine-containing benzotriazines 
(19 and 31), we synthesized 27 and 32 by radical deamination with tert-butyl nitrite in 
DMF both in 50% yield as reported by from Boyd et al.24 Removing the -NH2 group 
from the benzotriazine core (Figure 1, 3-position) results in a more electron deficient ring 
system, allowing for easy nucleophilic aromatic substitution of the fluorine atoms on the 
benzotriazine ring.  Nucleophilic aromatic substitution of 27 with diethanolamine at room 
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temperature in acetonitrile at room temperature provided 28 in 81% yield.  The reaction 
of 7-fluoro benzotriazine 32 with diethanolamine in acetonitrile gave an isolated yield of 
66%, but heat was required to get the reaction to proceed in a comparable amount of time 
as with 6-fluoro 28.  The observed reaction conditions requiring higher temperatures 
indicates that the 6-position is much more electrophilic than the 7-position on the 1,2,4-
benzotriazine 1-oxide ring system (Scheme 6).   
Scheme 6 
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Scheme 7 
 
 Using the same reaction conditions for the 3-amine containing 6-fluoro or 7-
fluoro benzotriazines 19 and 31, respectively, did not yield 36 and 39 efficiently.  The 
reactions would not go to completion, even in the presence of heat.  We found it 
necessary to use a much more polar solvent than previously required in addition to heat to 
facilitate these reactions.  N-methylpyrrolidinone (NMP) was selected and upon heating 
(100 °C) of 19 with excess diethanolamine (DEA), the reaction afforded 36 in high yield 
as a suspension isolated by filtration (Scheme 7). 
 Utilizing these same vigorous reaction conditions was not suitable for preparation 
of compound 39.  The reaction did not go to completion and poor solubility of both 
starting material and product prevented the isolation of 39 (Scheme 8).  It seems that the 
6-position is a significantly more electrophilic site than at the 7-position, as seen by the 
difference in reaction conditions to obtain complete substitution at each position (Scheme 
6).  In fact, experimental evidence shows that the presence of the di-N-oxide selectively 
assists in the nucleophilic substitution of 6-fluoro over 7-fluoro benzotriazines.30 These 
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observations would be explained by a less electrophilic carbon at position 7 of the 
benzotriazine system, similar to the relationship between para- and meta-positions on a 
substituted benzene ring.   
Scheme 8 
 
 Adapting previously reported methods, fluoro-containing di-N-oxides 29, 34, 37, 
and 40 were prepared via oxidation of the 1-oxide benzotriazine precursors (19,27,31, 
and 32) with trifluoroperacetic acid generated in situ.28, 30 Using similar reaction 
conditions listed before (Scheme 6), diethanolamine was substituted onto the benzoring 
(displacing fluorine) to yield products 30 and 38 cleanly as 1,4-di-N-oxide counterparts to 
compounds 28 and 36 (Schemes 6 and 7).  Neither NMP nor heat was required to prepare 
38, as supported by literature30 suggesting that the 6-position (Figure 1) of the 
benzotriazine core is more electrophilic upon oxidation to the 4-N-oxide.  This 
relationship was not seen for substitution at the 7-position, as nucleophilic substitution of 
34 and 40 with diethanolamine did not yield 35 or 41 cleanly, thus were not isolated nor 
characterized (Scheme 6 and 8).  (The implications of these observations are discussed in 
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occuring during the attempted synthesis of 35 (Scheme 8 and 9).  It has been shown that 
N-oxides can be deoxygenated when heated in the presence of alcohols under basic 
conditions (Scheme 9).31 
Scheme 9 
 
 
1.3  Fluorescence Properties of Substituted Benzotriazine Analogues 
 We were interested in comparing absorbance and emission wavelengths of all 
new compounds with that of the parent mono-N-oxide compound 4.  We additionally 
performed calculations for molar absorptivity (ε), quantum yield (Φ) of fluorescence, and 
brightness (ε x Φ).  With molecules in hand, selected benzotriazine analogues were tested 
for fluorescence and Table 4 summarizes the results.  Absorbance and fluorescence 
measurements were taken in acetonitrile (20 uM) because the quantum yield of 
compound 4 (0.12) has previously been determined (in acetonitrile).18.  Additionally, 
aqueous environments commonly quench fluorescence measurements.   
 
 Molar absorptivity coefficients were calculated using Beer's law (Equation 1).  
Fluorescence quantum yields were estimated using Equation 2.  Using compound 4 as a 
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given excitation wavelength and the integration of the fluorescent peak (I) resulting from 
emission can provide a quantum yield useful for comparison.32  The refractive index (n) 
is only needed when using different solvents for comparison.  This equation was used to 
estimate measurements for quantum yield (Φ) and brightness (ε x Φ) of select compounds 
that showed promising fluorescence properties (Table 4). 
 For the 3-substituted analogs, only compound 9 and 11 displayed any significant 
fluorescent properties.  Both produced weak fluorescence in acetonitrile, but interestingly 
compound 9 was fluorescent in the low polarity solvent dichloromethane (Φ = 0.070).  
We are unsure why such weak fluorescent properties are seen for analogs containing 
groups at the exocyclic -NH2 group.  It is possible that intramolecular quenching is 
occuring,33-34 as seen by compound 9 when in polar solvents (unpublished observations). 
 
 The 7-substituted compounds (33 and 31) showed promising fluorescence.  The 
addition of the exocyclic secondary amine at the 6- or 7- position resulted in a significant 
change in absorbance and fluorescence properties, particularly the 7-position (33).  In 
addition to a longer fluorescence wavelength (565 nm) compared to the compound 4 (478 
nm), compound 33 is a stronger chromophore resulting in "brighter" fluorescence as well.  
Compound 31 containing the 7-fluoro atom produced the brightest fluorescence listed in 
Table 4.  The emission wavelength of 31 (485 nm) was similar to that of the parent 
compound 4 but its quantum yielding (Φ) was estimated to be almost twice as large 
(0.21).  These results indicate that substituents (EDG and EWG) placed at the 7-position 
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of the benzotriazine core would be useful for producing interesting fluorescent properties 
for these compounds. 
Table 4.  Spectroscopic Data for Substituted Benzotriazine Analogs 
 
 
 Previous work in our group has shown that compound 42, containing an electron 
donating -OMe group at the 7-position produces bright fluorescence with approximately 
50% increase in quantum yield (0.18) when compared to 4 (0.12), the major TPZ 
metabolite.17-18 Fluorophores generally require a "push-pull" system for brilliant 
fluorescence.  The electron withdrawing 1-N-oxide moiety is in conjugation with the 7-
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OMe substituent, similar to 33, and possibly acts as an electron withdrawing "group" for 
charge transfer.  Excitation of TPZ (1) was reported to result in formation of an 
oxaziridinium intermediate (Scheme 10) by the 4-N-oxide.18 This cyclization was 
hypothesized to be the cause of fluorescence quenching in TPZ.18 Cyclization of the 1-N-
oxide was reported to be much less favorable, preventing any rapid quenching in 
compound 4 resulting in longer fluorescence lifetime than the 1,4-dioxide.18  
Scheme 10 
 
 To see if using a different electron-donating substituent would have a similar 
effect, a morpholine substituent was attached to the 7-position (43).  It was discussed 
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obtained in low yield, as multiple products were obtained during the Pd-coupling 
reaction.  All starting material (45) underwent a single- or double-Boc-deprotection 
during the reaction under these conditions.  The mono-deprotected, morpholino coupled 
product (43A) was used for final isolation of product 43 after acid deprotection.  
Additionally, 43B was isolated from the reaction mixture as well.  The fluorescence 
properties of these compounds are discussed below. 
Scheme 11 
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compounds were synthesized using cyanamide condensation conditions as before with 
the respective amino-nitronaphthalenes (Scheme 12).  2-amino-3-nitronaphthalene was 
commercially available whereas 2-aminonitronaphthalene and 1-amino-2-
nitronaphthalene were prepared as previously reported.35-36 All naphthotriazines were 
synthesized in low yields, attributed to lower solubility in aqueous acid and base.  Early 
attempts to synthesize 46 proved difficult, as utilizing a previously reported synthesis 
forming 49 followed by unselective oxidation did not yield the 1-oxide product of interest 
(Scheme 12, 50).37 A crystal structure was obtained to confirm that N-oxidation occurred 
at the position 2 endocyclic nitrogen of the triazine ring (Figure 2), thus this route was 
not pursued further.   
Scheme 12 
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Figure 2 
 
Figure 2.  X-ray crystal structure of compound 50. 
 
 We also prepared molecules designed with a goal of changing conjugation in the 
ring by using different substituents on the benzotriazine core (Scheme 13).  Compound 
51 was prepared by acid deprotection of 16 (see below).  This molecule was predicted to 
extend the conjugation of the exocyclic -NH2 group with the triazine ring system by 
addition of a phenyl group.  Compound 53 was prepared to see if putting an electron 
withdrawing group in the 7-position would create a new push-pull system.  Placing an 
ester in the 7-position allows one to draw a resonance structure and delocalize the lone 
pair of the -NH2 group onto the carbonyl oxygen (Scheme 13).  We predicted this would 
implement a new conjugated system, potentially altering the fluorescence properties of 
the benzotriazine ring system.  Compound 53 was synthesized in two steps.  The first 
reaction involved nucleophilic aromatic substitution of free guanidine base with 3-fluoro-
4-nitrobenzoic acid followed by ring closure using potassium tert-butoxide to provide 52.  
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The second reaction involved esterification of the resulting carboxylic acid containing 
benzotriazine yielded 53 cleanly. 
Scheme 13 
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morpholino group, was estimated to have almost two-fold increase in quantum yield 
(0.21) when compared to 4 (0.12), similar to the bright green fluorescent 7-OMe analog 
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(598 nm) as well, suggesting this could be a good candidate for development of a hypoxia 
selective fluorescent probe.   
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47 showed fluorescence of longer wavelength (603 nm), but it also gave lower quantum 
yield (0.026).  Compound 46 produced no measureable fluorescence, though its 2-N-
oxide isomer 51 surprisingly produced blue fluorescence (468 nm), meaning lower 
wavelength with respect to 4. 
 Compound 51 containing the phenyl "bridge" between the exocyclic -NH2 and the 
triazine core resulted in the expected longer wavelength fluorescence, though with a 
significant loss in quantum yield.  Compound 53 on the other hand, only observed a 
minor increase in fluorescence wavelength (495 nm) with about a 50% increase in 
quantum yield.  Similar observations have been seen for 6- and 7-fluoro compounds 19 
and 31, suggesting the "through-conjugation" effect may not be a contributor of the 
fluorescence for this compound. 
 
1.4  Chapter 1 Summary 
 Here we presented the synthesis of a variety of 1,2,4-benzotriazine N-oxide 
precursors potentially for use as fluorescent probes to detect hypoxia and bioreductive 
enzymes in biological samples.  The synthetic techniques combined here will be useful to 
generate many more TPZ analogs with different structural characteristics.  We utilized 
Pd-coupling reactions to attach substituents at various positions on the benzotriazine core.  
Yields varied widely, but we feel this would still be a useful technique for preparation of 
benzotriazine analogs.  Nucleophilic aromatic substitution reactions expanded the 
possibilities for utilizing the different positions on the benzotriazine ring system. 
 We explored how fluorescence properties of compound 4 (Scheme 1) changed 
when making substitutions at various positions of the benzotriazine core.  While the 1-
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oxide metabolite 4 of TPZ (1) is fluorescent, longer fluorescence wavelengths and 
quantum yields are needed for biological imaging.19 Extending conjugation did indeed 
produce longer fluorescence wavelengths, though typically the quantum yield decreased 
as well (47 and 51).  Similar to earlier experiments in the lab, substitution of a 
morpholine group onto the 7-position produced a fluorophore with superior quantum 
yield or brightness (43 and 33).  We were surprised to observe a significant red-shift in 
fluorescence associated with compound 43, along with the increased brightness.  While 
substitutions at the 6-position provided red-shifted fluorescence as well, they were not as 
bright (36 and 28).   
 These results will guide future work towards the first report of using the 
benzotriazine core as a useful tool to detect hypoxia and bioreductive enzymes in cell 
samples.  We will calculate quantitative data of fluorescent properties for all potential 1-
N-oxide candidates, and their corresponding 1,4-dioxides to check for switchable 
fluorescence. 
 
1.5 Experimental 
Synthesis of 3-amino-1,2,4-benzotriazine 1-oxide (4): Compound 4 was prepared as in 
Ujjal Sarkar's thesis.17  2-nitroaniline (4.8 g, 35 mmol) and cyanamide (3 g, 70 mmol) 
were heated together at 100 °C for 10 minutes until a melt is achieved.  The mixture was 
cooled slightly and HCl (25mL, conc.) was added dropwise while stirring over a 30-
minute period.  (CAUTION: A violent exothermic reaction may occur during or after 
HCl addition).  After addition of acid was complete the mixture was heated to 100°C for 
20 min and then cooled to room temperature with continued stirring.  NaOH (12 mL, 16 
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M) was added and the mixture stirred vigorously at 100°C for 2 h.  The orange precipitate 
was collected by vacuum filtration, washed thoroughly with 25% hexane in ethyl acetate 
and dried in the oven overnight.  The bright yellow powder was obtained in 93% yield: 
1H NMR (300 MHz, DMSO-d6) δ 8.12 (ddd, J = 8.6, 1.2, 0.27 Hz, 1 H), 7.75 (ddd, J = 
8.4, 6.9, 1.4 Hz, 1 H), 7.53 (dd, J = 8.5, 0.7 Hz, 1 H), 7.36-7.31 (comp, 3 H); 13C NMR 
(75 MHz, DMSO-d6) δ 160.3, 148.8, 135.7, 129.9, 125.9, 124.7, 119.9. 
 
Synthesis of 3-amino-1,2,4-benzotriazine 1,4-dioxide (1):  Compound 4 (411 mg, 2.5 
mmol) was dissolved in trifluoroacetic acid (7.7 mL) with stirring while H2O2 (6.1 mL of 
70% solution) was added dropwise.  The reaction was allowed to stir for 10 min and 
heated to 50 °C overnight protected from light.  The reaction was cooled to room 
temperature and poured into H2O (100 mL).  The resulting yellow solution was 
neutralized by slow addition of solid NaHCO3 with vigorous stirring.  The solution 
became deep red and a red powder precipitated.  The precipitate was collected by vacuum 
filtration, washed thoroughly with water and diethyl ether, and dried in a dessicator to 
give 1 in 40% yield: 1H NMR (500 MHz, DMSO-d6) δ 8.20 (d, J = 8.7 Hz, 1 H), 8.13 (d, 
J = 8.6 Hz, 1 H), 8.02 (bs, 2 H), 7.93 (appt, J = 8.1, 7.5 Hz, 1 H), 7.53 (appt, J = 8.1, 7.6 
Hz, 1 H); 13C NMR (125 MHz, DMSO-d6) δ 151.9, 138.8, 135.7, 130.9, 127.1, 121.5, 
117.4. 
 
Synthesis of 3-chloro-1,2,4-benzotriazine 1-oxide (5):  A procedure from Boyd et al 
was followed for preparation of compound 5.24  Compound 4 (1.3 g, 7.2 mmol) was 
dissolved in trifluoroacetic acid (8 mL) and then cooled to 0 °C.  Sodium nitrite (1 g, 2 
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equiv) was added slowly, keeping the temperature of the solution <5 °C.  The resulting 
solution was stirred at room temperature for 2 h before being poured into an ice/water 
slurry (80 mL) and stirred for 30 min.  The resulting precipitate was collected by vacuum 
filtration, washed with cold water (20 mL), and dired in the oven overnight.  In a N2-
purged 2-neck roundbottom flask with reflux condenser, the dried solid (1.12 g, 7 mmol), 
phosphorus (V) oxychloride (5 mL, 12-13 equiv), and dimethylformamide (60 µL) were 
added.  The mixture was heated at 105 °C under an N2 atmosphere for 1 h.  The reaction 
was immediately poured onto crushed ice (100 mL) and stirred for 30 min.  The resulting 
suspension was extracted with CH2Cl2 (100 mL) and organic fraction separated, dried 
with anhydrous Na2SO4 and solvent removed by rotary evaporation.  Purification by 
column chromatography with silica gel with CH2Cl2 afforded 5 as a colorless solid in 
88% overall yield after 2 steps.  Characterization by NMR (in DMSO-d6) compared with 
lit. reports confirmed identity: 1H NMR (500 MHz, CDCl3) δ 8.41 (d, J = 8. 6 Hz, 1 H), 
8.00-7.99 (m, 2 H), 7.77 (ddd, J = 8.6, 7.1, 1.4 Hz, 1 H).13C NMR (125 MHz, CDCl3) δ 
157.1, 147.4, 136.9, 133.9, 131.1, 128.6, 120.4. 
 
Synthesis of 3-bromo-1,2,4-benzotriazine 1-oxide (6):  Compound 6 was prepared 
using a method similar to 5.  Compound 4 (1.3 g, 7.2 mmol) was dissolved in 
trifluoroacetic acid (8 mL) and then cooled to 0 °C.  Sodium nitrite (1 g, 2 equiv) was 
added slowly, keeping the temperature of the solution <5 °C.  The resulting solution was 
stirred at room temperature for 2 h before being poured into an ice/water slurry (80 mL) 
and stirred for 30 min.  The resulting precipitate was collected by vacuum filtration, 
washed with cold water (20 mL), and dired in the oven overnight.  In a N2-purged 2-neck 
 
Tirapazamine as a Fluorescent Probe for Cellular Hypoxia                                Chapter 1 
	   28	  
roundbottom flask with reflux condenser, the dried solid (423 mg, 2.6 mmol) and solid 
phosphorus (V) oxybromide (5 mL, 12-13 equiv) were added.  The mixture was heated at 
105 °C under an N2 atmosphere for 30 min.  The reaction was immediately poured into 
an ice-water slurry (25 mL) and stirred for 30 min.  The resulting suspension was 
extracted with CH2Cl2 (4x 15 mL).  The combined organic fractions were washed with 
saturated sodium bicarbonate, saturated brine, and dried with anhydrous Na2SO4.  The 
solvent was then removed by rotary evaporation.  Purification by column 
chromatography with silica gel with CH2Cl2 afforded 6 as a colorless solid in 43% overall 
yield after 2 steps: 1H NMR (300 MHz, CDCl3) δ 8.41 (d, J = 8.7 Hz, 1 H), 8.01-7.99 
(comp, 2 H), 7.78 (ddd, J = 8.5, 4.8, 3.6 Hz, 1 H); 13C NMR (75 MHz, CDCl3) δ 147.9, 
147.4, 136.7, 131.0, 128.4, 120.3; HRMS (ESI) m/z calc for C7H4N3ONaBr (M+Na+) 
247.9435, found 247.9439. 
 
Representative Procedure for Coupling of 3-Halo-1,2,4-benzotriazine 1-Oxides with 
Amines: 3-N-phenylamino-1,2,4-benzotriazine 1-oxide (7).  Toluene (4 mL) was 
degassed by bubbling nitrogen through the solvent for 10 min in a round bottom flask.  
To this container compound 6 (28.5mg, 0.16 mmol), K3PO4 (150 mg, 4 eq), Pd(OAc)2 (5 
mol%), SPhos ligand (10%), and Anilne (13 µL, 1.4 eq) were added and the mixture was 
stirred at 55 °C for 24 hours.  The reaction was cooled to room temperature, water added 
(10 mL), and extracted 3 times with dichloromethane (10 mL).  The organic layers were 
collected, combined, and dried with anhydrous Na2SO4.  The solvent was evaporated and 
the crude product was purified by column chromatography on silica gel with CH2Cl2 to 
obtain a yield of 27% of an orange solid.  Using the same conditions at 20 °C gave a 21% 
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yield.  Without palladium catalyst yields were 0% at 20 °C and 5% at 55°C: 1H NMR 1H 
NMR (300 MHz, DMSO-d6) δ 10.245 (1H, s), 8.225 (1H, dd, 8.5 Hz, 1.0 Hz), 7.906-
7.855 (3H, m), 7.746 (1H, dd, 8.4 Hz, 0.8 Hz), 7.472 (1H, t, 7.8 Hz), 7.36 (2H, t, 7.9Hz), 
7.054 (1H, t, 7.4 Hz); 13C NMR (300 MHz, DMSO-d6) δ 156.83, 148.04, 139.76, 131.43, 
129.12, 127.07, 126.41, 123.05, 120.29, 119.85; HRMS (ESI) m/z calculated for 
C13H10N4O (M+H+) 239.0927, found 239.0915 
 
Representative Procedure for Coupling of 3-Halo-1,2,4-benzotriazine 1-Oxides with 
Amines: 3-N-benzylamino-1,2,4-benzotriazine 1-oxide (9).  Toluene (4 mL) was 
degassed by bubbling nitrogen through the solvent for 10 min in a round bottom flask.  
To this container 3compound 5 (58.3mg, 0.33 mmol), K3PO4 (300 mg, 4 eq), Pd(OAc)2 
(5 mg, 5% eq), SPhos ligand (15 mg, 10%), and benzylamine (50uL, 1.4 eq) were added 
and the mixture was stirred at 50 °C for 24 hours.  The reaction was cooled to room 
temperature, water added (10 mL), and extracted 3 times with dichloromethane (10 mL).  
The organic layers were collected, combined, and dried with anhydrous Na2SO4.  The 
solvent was evaporated and the crude product was purified by column chromatography 
on silica gel with CH2Cl2 to obtain compound 9 as a yellow solid in 87%.  Using the 
same conditions at 20 °C gave a 74% yield.  Without the palladium catalyst yields of 
34% at 20 °C and 67% at 55°C were obtained: 1H NMR (500 MHz, DMSO-d6) δ 8.442 
(1H, s), 8.138 (1H, d, 8.6 Hz), 7.770 (1H, t, 7.7 Hz), 7.559 (1H, t, 8.4 Hz), 7.386-7.304 
(6H, m), 7.233 (1H, t, 7.3 Hz), 4.592 (2H, d, 5.5) ; 13C NMR (500 MHz, DMSO-d6) δ 
159.36, 139.54, 136.15, 130.61, 128.78, 128.65, 127.56, 127.18, 126.48, 125.09, 120.29, 
44.16; HRMS (ESI) m/z calculated for C14H12N4O (M+H+) 253.1084, found 253.1097. 
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General Buchwald Coupling at 3 position (Method A): 
Toluene (4 mL) was degassed by bubbling nitrogen through the solvent for 10 min in a 
round bottom flask attached to a reflux condenser with N2.  To this container compound 6 
(0.3 mmol), K3PO4 (150 mg, 4 eq), Pd(PPh3)4 (5 mol%) and the amine (1.4 eq) were 
added and the mixture was stirred at 100 °C for 24 hours.  The reaction was cooled to 
room temperature, water added (10 mL), and extracted 3 times with dichloromethane (10 
mL).  The organic layers were collected, combined, and dried with anhydrous Na2SO4.  
The solvent was evaporated and the crude product was purified by column 
chromatography on silica gel with CH2Cl2.  
 
General Nucleophilic Aromatic Substitution at 3-position (Method B):  
To a solution of compound 6 (0.16 mmol) in EtOH (2 mL), the amine (1.4 eq) is added 
and the mixture was stirred at room temperature for 24 hours.  The resulting mixture was 
dissolved in CH2Cl2 (10 mL) and water added (10 mL).  The organic layer was collected, 
and dried with anhydrous Na2SO4.  The solvent was evaporated and the crude product 
was purified by column chromatography on silica gel with CH2Cl2 
 
Synthesis of 3-N-phenylamino-1,2,4-benzotriazine 1-oxide (7): Method A gave 
compound 7 as an orange solid in 87% yield and method B in 67% yield.  
 
Synthesis of 3-N-phenylamino-1,2,4-benzotriazine 1-oxide (9): Method A gave 
compound 9 as an orange solid in 65% yield and method B in 82% yield.  
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Synthesis of 3-(2,6-dimethylphenylamino)-1,2,4-benzotriazine 1-oxide (8): 
Method A gave compound 8 as a yellow solid in 27% yield and method B afforded no 
product: 1H NMR (500 MHz, CDCl3) δ 8.292 (1H, d, 8.7 Hz), 7.688 (1H, t, 7.6 Hz), 
7.575 (1H, d, 8.0 Hz), 7.337 (1H, t, 7.8), 7.207-7.148 (3H, m), 7.207-7.148 (1H, s), 2.294 
(6H, s); 13C NMR (500 MHz, CDCl3) δ 149.23, 136.66, 135.98, 134.32, 131.69,128.81, 
127.94, 125.93, 120.79, 106.06, 19.07; HRMS (ESI) m/z calculated for C15H14N4O 
(M+H) 267.1240, found 267.1231 
 
Synthesis of 3-(diethylamino)-1,2,4-benzotriazine 1-oxide (10): 
Method A gave compound 10 as an orange solid in 92% yield and method B in 90% 
yield: 1H NMR (500 MHz, CDCl3) δ 8.120 (1H, d, 8.6 Hz), 7.769 (1H, t, 7.3 Hz), 7.571 
(1H, d, 8.5 Hz), 7.321 (1H, t, 7.7 Hz), 3.620 (4H, q, 9.8 Hz), 1.178 (6H, t, 7.0 Hz); 13C 
NMR (500 MHz, CDCl3) δ 157.70, 149.01, 136.15, 129.51, 126.52, 124.96, 120.24; 
HRMS (ESI) m/z calculated for C11H14N4O (M+H) 219.1240, found 219.1236 
 
Synthesis of 3-dipropylamino-1,2,4-benzotriazine 1-oxide (11): 
Method A gave compound 11 as a thick orange oil in 50% yield and method B in 99% 
yield: 1H NMR (500 MHz, CDCl3) δ 8.150 (1H, d, 8.6 Hz), 7.552 (1H, t, 7.7 Hz), 7.463 
(1H, d, 8.5 Hz), 7.123 (1H, t, 7.7 Hz), 3.511 (4H, t, 7.6 Hz), 1.659-1.584 (4H, m), 0.897 
(6H, t, 7.5 Hz); 13C NMR (500 MHz, CDCl3) δ 158.49, 149.46, 135.24, 129.77, 126.63, 
124.18, 120.54, 49.74, 20.98, 11.45; HRMS (ESI) m/z calculated for C10H18N4O (M+H) 
247.155,0 found 247.1550 
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Synthesis of 3-(3`-hydroxypropylamino)-1,2,4-benzotriazine 1-oxide (13): Method A 
gave the compoundn 13 as a bright yellow solid in 97% yield and method B in 96% 
yield: 1H NMR (500 MHz, DMSO-d6) δ 8.127 (1H, d, 8.6 Hz), 7.874 (1H, bs), 7.772 (1H, 
t, 7.7 Hz), 7.566 (1H, d, 8.3 Hz), 7.323 (1H, t, 7.8 Hz), 4.494 (1H, t, 5.2 Hz), 3.500 (2H, 
m), 3.394 (2H, bm), 1.739 (2H, m) ; 13C NMR (500 MHz, DMSO-d6) δ 158.96, 135.72, 
130.03, 126.02, 124.43, 119.94, 58.51, 38.02, 31.78; HRMS (ESI) m/z calculated for 
C10H12N4O2 (M+H) 221.1033, found 221.1042 
 
Synthesis of 3-(2`-naphthylamino)-1,2,4-benzotriazine 1-oxide (14): 
Method A gave compound 14 as a red solid in 50% yield and method B in 71 % yield. 1H 
NMR (500 MHz, DMSO-d6) δ 10.492 (1H, s), 8.647 (1H, s), 8.260 (1H, d, 8.5 Hz), 
7.944-7.808 (6H, m), 7.505 (2H, m), 7.405 (1H, t, 7.5 Hz); 13C NMR (500 MHz, DMSO-
d6) δ 156.77, 147.96, 137.37, 136.40, 133.95, 131.50, 129.79, 128.62, 127.83, 127.65, 
127.21, 126.78, 126.55, 124.73, 120.93, 120.25, 115.23; HRMS (ESI) m/z calculated for 
C17H12N4O (M+H) 289.1084, found 289.1093 
 
Synthesis of 3-(1`-naphthylamino)-1,2,4-benzotriazine 1-oxide (15): 
Method A gave compound 15 as a red solid in 41 % yield and method B in 25 % yield: 
1H NMR (500 MHz, DMSO-d6) δ 10.087 (1H, s), 8.209 (1H, d, 8.7 Hz), 8.106 (1H, d, 7.8 
Hz), 7.979 (1H, d, 8.0 Hz), 7.849 (1H, d, 8.3 Hz), 7.819-7.764 (2H, m), 7.586-7.502 (4H, 
m), 7.429 (1H, t, 7.8 Hz); 13C NMR (500 MHz, DMSO-d6) δ 158.56, 148.14, 135.94, 
133.98, 133.96, 130.86, 129.06, 128.13, 126.44, 126.14, 126.00, 125.84, 125.73125.69, 
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123.24, 122.81, 119.92; HRMS (ESI) m/z calculated for C17H12N4O (M+H) 289.1084, 
found 289.1093 
 
Synthesis of 3-(4`-N-Boc-aminophenyl)-1,2,4-benzotriazine 1-oxide (16):  Toluene (7 
mL) and water (2.5 mL) were degassed by bubbling nitrogen through the solvents for 10 
min in a round bottom flask.  To this container 3-chloro-1,2,4-benzotriazine 1-oxide (5, 
109.2mg, 0.6 mmol), K3PO4 (150 mg, 4 eq), Pd(OAc)2 (5 mol%), SPhos ligand (10%), 
and 4`-aminophenyl boronic acid (185 mg, 1.4 eq) were added and the mixture was 
stirred at 100 °C for 18 hours.  The reaction was cooled to room temperature, water added 
(10 mL), and extracted with dichloromethane (3x10 mL).  The organic layers were 
collected, combined, and dried with anhydrous Na2SO4.  The solvent was evaporated and 
the crude product was purified by column chromatography on silica gel with 0-0.5% 
MeOH in CH2Cl2 to obtain compound 16 as a pale yellow solid with a yield of 61%.  1H 
NMR (500 MHz, DMSO-d6) δ 9.779 (1H, s), 8.389 (1H d, 8.6 Hz), 8.299 (2H, d, 8.8 Hz), 
8.104-8.055 (2H, m), 7.806 (1H, t, 7.3 Hz), 7.681 (2H, d, 8.8 Hz); 13C NMR (500 MHz, 
DMSO-d6) δ 159.62, 152.94, 147.57, 143.53, 136.61, 133.37, 130.72, 129.14, 127.60, 
120.20, 118.27, 80.01, 28.43; HRMS (ESI) m/z calculated for C18H18N4O3 (M+H+) 
339.1452, found 339.1465. 
 
Synthesis of 3-(4`-cyanophenyl)-1,2,4-benzotriazine 1-oxide (17):  Acetonitrile (1.5 
mL), aqueous Na2CO3 (1.5 mL, 0.4 M), 3-bromo-1,2,4-benzotriazine 1-oxide (6, 69 mg, 
0.3 mmol), and 4-cyanophenylboronic acid (48 mg, 1.1 equiv) were added to a 
roundbottom flask and degassed by bubbling nitrogen through the solvent for 10 min.  To 
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this container Pd(PPh)4 (17 mg, 5 mol%) was added and the mixture was stirred at 95 °C 
for 43 hours.  The reaction was cooled to room temperature, water added (10 mL), and 
extracted with dichloromethane (3x10 mL).  The organic layers were collected, 
combined, and dried with anhydrous Na2SO4.  The solvent was evaporated and the crude 
product was purified by column chromatography on silica gel with CH2Cl2 to obtain 
compound 17 as a pale yellow solid in 20% yield. Crude NMR's supplied were compared 
with previously characterized product showing the reaction was successful: NMR (300 
MHz, CDCl3) δ 8.65 (m, J = 8.7, 1.9 Hz, 2 H), 8.52 (d, J = 8.7, 0.9 Hz, 1 H), 8.13 (dd, J 
= 8.5, 0.8 Hz, 1 H), 8.01 (ddd, J = 8.4, 7.0, 1.4 Hz, 1 H), 7.84 (m, J = 8.7, 1.9 Hz, 2 H), 
7.78 (ddd, J = 8.7, 7.0, 1.3 Hz, 1 H); 13C NMR (75 MHz, CDCl3) δ 147.4, 136.0, 132.5, 
131.0, 129.5, 128.9, 120.3, 114.2; HRMS (ESI) m/z calc for C14H9N4O (M+Na+) 
271.0596, found 271.0604. 
 
Synthesis of 3-(4`-nitrophenyl)-1,2,4-benzotriazine 1-oxide (18):  Toluene (10 mL), 
water (2.5 mL), 3-bromo-1,2,4-benzotriazine 1-oxide (6, 504 mg, 2.5 mmol), 4-
cyanophenylboronic acid (504 mg, 1.4 equiv), K3PO4 (500 mg, 1.2 equiv), Pd(OAc)2 (25 
mg, 5% equiv), and SPhos (100 mg, 10% equiv) were added to a seal tube and degassed 
by bubbling nitrogen through the solution for 15 minutes.  Then the reaction was sealed 
and was stirred at 105 °C for 96 h.  The reaction was cooled to room temperature, water 
added (50 mL), and extracted with dichloromethane (3x50 mL).  The organic layers were 
collected, combined, and dried with anhydrous Na2SO4.  The solvent was evaporated and 
the crude product was purified by column chromatography on silica gel with 75% CH2Cl2 
in hexane to obtain a pale yellow solid in 93% yield: 1H NMR (500 MHz, DMSO-d6) δ 
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8.73 (d, J = 8.9 Hz, 2 H), 8.53 (d, J = 8.5, 1 H), 8.39 (d, J = 8.9 Hz, 2 H), 8.16 (d, J = 8.5, 
1 H), 8.02 (appt, J = 7.2, 7.1 Hz, 1 H), 7.80 (appt, J = 7.4, 7.3 Hz,  1 H); 13C NMR (125 
MHz, DMSO-d6) δ 158.5, 149.8, 147.4, 139.7, 136.0, 131.1, 129.5, 129.3, 123.8, 120.3; 
HRMS (ESI) m/z calc for C13H9N4O3 (M+H+) 269.0675, found 269.0671. 
 
Synthesis of 3-amino-6-fluoro-1,2,4-benzotriazine 1-oxide (19):  Compound 19 was 
prepared using a procedure adopted from Hay, M.P. et al.)30  5-fluoro-2-nitroaniline (5 g, 
32 mmol) and cyanamide (10 g, 240 mmol) were heated together at 100 °C for 15 
minutes to combine the solids.  The mixture was cooled slightly and HCl (25 mL, conc.) 
was added drop wise while stirring over 30-min.  (CAUTION: A violent exothermic 
reaction may occur during or after HCl addition).  After addition of acid was complete 
stirring was continued for an additional 10 min, adding more cyanamide to help stir if 
needed.  The mixture was heated to 100 °C for 2 h and cooled to room temperature with 
continued stirring.  NaOH (50 mL, 7.5 M) was added and the mixture stirred vigorously 
at 100 °C for 30 min.  The orange suspension was cooled to room temperature, poured 
into 500 mL H2O, and filtered under vacuum.  The precipitate was washed thoroughly 
with water and diethyl ether and then dried in the oven at 70 °C overnight.  Compound 19 
was obtained in 70% yield as a bright yellow powder.  1H NMR (500 MHz, DMSO-d6) δ 
8.21 (dd, J = 10, 6 Hz, 1H), 7.50 (bs 2H), 7.30 (dd, J = 10, 2.6 Hz, 1H), 7.21 (m, 1H); 13C 
NMR (125 MHz, DMSO-d6) δ 166.1 (d, J = 254 Hz), 160.8, 150.7 (d, J = 16 Hz), 127.5, 
123.4 (d, J = 12 Hz), 114.2 (d, J = 26 Hz), 109.6 (d, J = 23 Hz); HRMS (ESI) m/z 
calculated for C7H5FN4O (M+H+) 181.0520, found 181.0521. 
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Synthesis of 3-chloro-6-fluoro-1,2,4-benzotriazine 1-oxide (20):  Compound 19 (1.3 g, 
7.2 mmol) was dissolved in trifluoroacetic acid (8 mL) and then cooled to 0 °C.  Sodium 
nitrite (1 g, 2 equiv) was added slowly, keeping the temperature of the solution <5 °C.  
The resulting solution was stirred at room temperature for 2 h before being poured into an 
ice/water slurry (80 mL) and stirred for 30 min.  The resulting precipitate was collected 
by vacuum filtration, washed with cold water (20 mL), and dried in an oven at 70 °C 
overnight.  In a N2-purged 2-neck roundbottom flask with reflux condenser, the dried 
solid (730 mg, 4 mmol), phosphorus (V) oxychloride (5 mL, 12-13 equiv), and 
dimethylformamide (60 µL) were added.  The mixture was heated at 105 °C under an N2 
atmosphere for 1 h.  The reaction was immediately poured onto crushed ice (100 mL) and 
stirred for 30 min.  The resulting suspension was extracted with CH2Cl2 (100 mL) and 
organic fraction separated, dried with anhydrous Na2SO4 and solvent removed by rotary 
evaporation.  Purification by column chromatography with silica gel with CH2Cl2 
afforded 20 as a colorless solid in 55% overall yield after 2 steps: 1H NMR (500 MHz, 
DMSO-d6) δ 8.50 (dd, J = 9.5, 5.5 Hz, 1 H), 7.98 (dd, J = 9.1, 2.6 Hz, 2 H), 7.81 (ddd, J 
= 9.3, 8.5, 2.7 Hz, 1 H); 13C NMR (125 MHz, DMSO-d6) δ 166.8 (d, J = 258 Hz), 156.9, 
149.4 (d, J = 16 Hz), 132.0, 123.9 (d, J = 11 Hz), 121.7 (d, J = 27 Hz), 112.8 (d, J = 24 
Hz); HRMS (ESI) m/z calculated for C7H3ClFN3O 198.9949, found 198.9950. 
 
Synthesis of 3-ethyl-6-fluoro-1,2,4-benzotriazine 1-oxide (21):  To a N2 purged 2-neck 
round-bottom flask with reflux condenser, compound 20 (555 mg, 2.8 mmol), 
tetraethyltin (667 µL, 1.2 equiv), and dimethoxyethane (10 mL) were added.  The mixture 
was degassed by bubbling nitrogen through the solution and then Pd(PPh3)4 (162 mg, 5% 
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equiv) was added.  The solution was refluxed for 24 h.  The solvent was evaporated and 
dark solid taken up in CH2Cl2 (15 mL) and sat'd KF (aq, 10 mL) and the mixture was 
stirred vigorously for 30 min.  THe biphasic mixture was passed through a pad of celite.  
The filtrate was washed with CH2Cl2 and organic phase collected.  Purification by 
column chromatography with silica gel with CH2Cl2 to give 21 in 28% yield with 55% 
recovery of 20: 1H NMR (500 MHz, DMSO-d6) δ 8.46 (dd, J = 9.5, 5.6 Hz, 1 H), 7.90 
(dd, J = 9.3, 2.7 Hz, 1 H), 7.73 (ddd, J = 9.4, 8.5, 2.7 Hz, 1 H), 2.96 (q, J = 7.56 Hz, 4 H), 
1.34 (t, J = 7.6 Hz, 3 H); 13C NMR (125 MHz, DMSO-d6) δ 168.3, 165.8 (d, J = 256 Hz), 
149.0 (d, J = 15 Hz), 130.5, 123.3 (d, J = 11 Hz), 120.4 (d, J = 27 Hz), 112.5 (d, J = 23 
Hz), 29.9, 11.7; HRMS (ESI) m/z calculated for C9H9FN3O (M+H+) 194.0724, found 
194.0729. 
 
Synthesis of 3-ethyl-6-fluoro-1,2,4-benzotriazine 1,4-dioxide (22):  Compound 22 (490 
mg, 2.5 mmol) was dissolved in CH2Cl2 (10 mL) and MCPBA (1.3 g, 2.3 equiv) was 
added.  The mixture was stirred at room temperature for 24 h before an additional portion 
of MCPBA was added and the solution stirred an additional 3 days.  Water (100 mL) was 
then added and stirred with NaHCO3 (1.5 g) overnight.  The organic layer was separated, 
dried with anhydrous Na2SO4, and then purified by column chromatography on silica gel 
with 0-0.5% MeOH in CH2Cl2. Compound 22 was obtained in 16% yield as a yellow 
solid: 1H NMR (500 MHz, CDCl3) δ 8.53 (dd, J = 9.5, 4.9 Hz, 1 H), 8.17 (dd, J = 8.2, 2.6 
Hz, 2 H), 7.57 (ddd, J = 9.5, 7.5, 2.7 Hz, 1 H), 3.21 (q, J = 7.5 Hz, 2 H), 1.44 (t, J = 7.5 
Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 166.10 (d, J = 253.90 Hz), 160.83, 150.72 (d, J 
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= 15.55 Hz), 127.45, 123.35 (d, J = 11.69 Hz), 114.20 (d, J = 26.61 Hz), 109.6 (d, J = 
22.63 Hz). 
 
Synthesis of 6-diethanolamino-3-ethyl-1,2,4-benzotriazine 1,4-dioxide (23):  
Compound 22 (86 mg, 0.4 mmol), and Diethanolamine (102 mg, 2 equiv) were dissovled 
in acetonitrile (10 mL) and water (0.5 mL) and the reaction was stirred for 3 days or until 
completed.  The solvent was removed by rotary evaporation and purification by column 
chromatography on silica gel with 0-5% MeOH in CH2Cl2.  Compound 23 was obtained 
as an orange solid in 70% yield: mp 210-212 °C dec; 1H NMR (500 MHz, DMSO-d6) δ 
8.08 (d, J = 9.8 Hz, 1 H), 7.52 (dd, J = 9.9, 2.8 Hz, 1 H), 7.19 (d, J = 2.8 Hz, 1 H), 4.94 
(t, J = 5.0 Hz, 2 H), 3.66 (comp, 8 H), 2.98 (q, J = 7.4, 2 H), 1.25 (t, J = 7.5 Hz, 3 H); 13C 
NMR (125 MHz, DMSO-d6) δ 155.2, 153.4, 140.7, 125.9, 122.3, 120.2, 92.8, 57.8, 53.3, 
23.44, 9.2; HRMS (ESI) m/z calculated for C13H19N4O4 (M+H+) 295.1401, found 
295.1404. 
 
Synthesis of 3-diethanolamino-1,2,4-benzotriazine 1-oxide (24):  Compound 5 (102 
mg, 0.5 mmol) was dissolved in ethanol (2 mL) and diethanolamine (580 mg, 10 equiv) 
was added.  The mixture was stirred at room temperature for 48 h.  The solution was 
diluted with water (10 mL) and extracted with CH2Cl2 (6x 10 mL).  The combined 
organic fractions were washed with brine, dried with anhydrous Na2SO4, and solvent 
removed by rotary evaporation.  Purification by column chromatography on silica gel 
with 0-1% MeOH in CH2Cl2 gave compound 24 as a bright orange solid in 85% yield: 
mp 205-210 °C dec; 1H NMR (500 MHz, DMSO-d6) δ 8.36 (d, J = 7.9 Hz, 1 H), 7.79 
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(ddd, J = 8.4, 7.0, 1.3 Hz, 2 H), 7.58 (d, J = 8.5 Hz, 1 H), 7.45 (ddd, J = 8.4, 6.9, 1.1, 1 
H), 4.81 (t, J = 5.4 Hz, 2 H), 3.72 (bs, 4 H), 3.65 (bs, 4 H); 13C NMR (125 MHz, DMSO-
d6) δ 158.4, 148.8, 136.3, 129.6, 126.5, 125.2, 120.2, 58.7, 51.2; HRMS (ESI) m/z 
calculated for C11H15N4O3 (M+H+) 251.1139, found 251.1142. 
 
Synthesis of 6-fluoro-1,2,4-benzotriazine 1-oxide (27).  Using the general procedure of 
Boyd et al.24 19 (930 mg, 5 mmol) was dissolved in anhydrous DMF (50 mL) and the 
mixture degassed by bubbling argon through the solution for 30 min.  To this mixture t-
butyl nitrite (3.5 mL, 5 equiv, 90%) was added by syringe and the mixture heated in a 60 
°C oil bath for 2 h under an atmosphere of argon gas.  The reaction was cooled and the 
solvent removed under vacuum.  The resulting dark residue was taken up in ethyl acetate 
(300 mL) and mixed with brine (150 mL) and stirred vigorously.  The phases were 
allowed to separate and the organic layer was washed with brine (2 x 150 mL), dried over 
anhydrous sodium sulfate, and solvent removed by rotary evaporation.  Column 
chromatography on silica gel eluted with a gradient of 0-10% ethyl acetate in CH2Cl2 
gave 27 in 50% yield: mp 127-129 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.19 (s, 1 H), 
8.50 (dd, J = 9.6, 5.52 Hz, 1 H), 7.99 (dd, J = 9.1, 2.7 Hz, 1 H), 7.82 (m, 1 H); 13C NMR 
(125 MHz, DMSO-d6) δ 166.1 (d, J = 257), 155.5, 149.3 (d, J = 15 Hz), 133.1, 123.8 (d, 
J = 11 Hz), 121.8 (d, J = 27 Hz), 113.3 (d, J = 23 Hz); HRMS (ESI) m/z calculated for 
C7H4FN3O (M+H+) 166.0411, found 166.0417. 
 
Synthesis of 6-diethanolamino-1,2,4-benzotriazine 1-oxide (28):  Compound 20 (361 
mg, 2.2 mmol) and diethanolamine (500 mg, 2.5 equiv) were dissolved in acetonitrile (7 
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mL) and the mixture heated in an 80 °C oil bath overnight.  The reaction mixture was 
cooled and solvent removed under reduced pressure by rotary evaptoration.  The resulting 
solid was suspended in ethanol (10 mL) and briefly heated to 80 °C with stirring then 
cooled to 0 °C and the resulting precipitate collected by vacuum filtration.  The orange 
solid was washed with cold ethanol and diethyl ether and dried in an oven overnight at 70 
˚C.    Compound 28 was obtained in 81% yield: 1H NMR (500 MHz, DMSO-d6) δ 8.77 
(s, 1 H), 8.11 (d, J = 9.8, 1 H), 7.50 (dd, J = 9.8, 2.7 Hz, 1 H), 6.89 (d, J = 2.7, 1 H), 4.89 
(t, J = 4.9 Hz, 2 H), 3.64 (bs, 8 H); 13C NMR (500 MHz, DMSO-d6) δ 154.9, 154.0, 
149.6, 127.0, 121.0, 120.9, 102.3, 58.3, 53.5; HRMS (ESI) m/z calculated for 
C11H14N4O3 (M+H+) 251.2612, found 251.1138.   
 
Synthesis of 6-fluoro-1,2,4-benzotriainze 1,4-dioxide (29):  A procedure adapted from 
Pchalek and Hay was followed.28  Trifluoroacetic anhydride (600 µL) and CH2Cl2 (3 mL) 
were mixed with stirring in an ice bath and 70% H2O2 (210 µL) was added dropwise.  
The mixture was stirred for 10 min and then allowed to warm to room temperature.  This 
solution was cooled in an ice bath and and slowly added to an ice cold solution of 27 (71 
mg, 0.43 mmol) in CH2Cl2 (3 mL).  The reaction was stirred in an ice bath for 4 h before 
being diluted with cold NH4OH (4 mL, 1M), shaken well, and the organic layer was 
separated.  The aqueous layer was washed 2x CH2Cl2. The combined organic fractions 
were dried over anhydrous sodium sulfate and column chromatography on silica gel 
eluted with 1% MeOH in CH2Cl2 gave 29 in 71% yield: 1H NMR (500 MHz, DMSO-d6) 
δ 9.36 (s, 1 H), 8.48 (dd, J = 9.5, 5.0 Hz, 1 H), 8.13 (dd, J = 8.5, 2.7 Hz, 2 H), 7.92 (ddd, 
J = 9.5, 8.2, 2.8 Hz, 1 H); 13C NMR (125 MHz, DMSO-d6) δ 165.8 (d, J = 258 Hz), 
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143.2, 141.7 (d, J = 12 Hz), 133.2, 125.6 (d, J = 11 Hz), 122.8 (d, J = 26 Hz), 105.0 (d, J 
= 18 Hz); HRMS (ESI) m/z calculated for C7H5FN3O2 (M+H+) 182.0360, found 
182.0364. 
 
Synthesis 6-diethanolamino-1,2,4-benzotriazine 1,4-dioxide (30):  Compound 27 (47 
mg mg, 0.26 mmol) was dissolved in a mixture acetonitrile (4 mL), water (1 mL), and 
diethanolamine (65 g, 2.4 equiv).  The suspension was stirred at 75 °C overnight 
protected from light.  The solvent was removed by rotary evaporation, the orange residue 
resuspended in ethanol, briefly heated with stirring and slowly cooled to 0 °C.  The 
resulting precipitate was collected by vacuum filtration and dried under vacuum to give 
30 as a dark-red powder in 73% yield: 1H NMR (500 MHz, DMSO-d6) δ 9.05 (s, 1 H), 
8.09 (d, J = 9.8 Hz, 1 H), 7.58 (dd, J = 9.8, 2.6 Hz, 1 H), 7.16 (d, J = 2.6 Hz, 1 H), 4.94 
(t, J = 4.9 Hz, 1 H), 3.66 (comp, 8 H); 13C NMR (125 MHz, DMSO-d6) δ 153.3, 142.0, 
140.8, 126.5, 122.4, 121.0, 93.0, 57.7, 53.3; HRMS (ESI) m/z calculated for C11H15N4O4 
(M+H+) 267.1088, found 267.1088. 
 
Synthesis of 3-amino-7-fluoro-1,2,4-benzotriazine 1-oxide (31):    (adopted from Hay, 
M.P. et al.)  4-fluoro-2-nitroaniline (5 g, 32 mmol) and cyanamide (11 g, 26 mmol) were 
heated together at 100°C for 15 minutes until a melt is achieved.  The mixture was cooled 
slightly and HCl (20 mL, conc.) was added dropwise while stirring over a 30-minute 
period.  (CAUTION: A violent exothermic reaction may occur during or after HCl 
addition).  After addition of acid was complete stirring was continued for an additional 10 
minutes.  The mixture was heated to 100°C for 3 hours and cooled to room temperature 
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with continued stirring.  NaOH (80 mL, 4 M) was added and the mixture stirred 
vigorously at 100°C for 2 h.  The orange suspension was cooled to room temperature, 
poured into water (500 mL) and vacuum filtered.  The precipitate was washed thoroughly 
with H2O and Et2O and dried in the oven overnight.  The yellow powder was obtained in 
91% yield.  1H NMR (500 MHz, DMSO-d6) δ 7.89 (dd, J = 8.6, 2.9 Hz, 1H), 7.75 (m, 
1H), 7.62 (dd, J = 9.3, 5.2 Hz, 1H), 7.35 (bs, 2H); 13C NMR (125 MHz, DMSO-d6) δ 
160.5, 158.4 (d, J = 246 Hz), 146.6, 129.8 (d, J = 11 Hz), 128.8 (d, J = 9 Hz), 126.1 (d, J 
= 26 Hz), 105.0 (d, J = 27 Hz); HRMS (ESI) m/z calculated for C7H5FN4O (M+H+) 
181.1465, found 181.0521. 
 
Synthesis of 7-fluoro-1,2,4-benzotriazine 1-oxide (32).  Using the general procedure of 
Boyd et al.24 31 (930 mg, 5 mmol) was dissolved in anhydrous DMF (50 mL) and the 
mixture degassed by bubbling argon through the solution for 30 min.  To this mixture t-
butyl nitrite (3.5 mL, 5 equiv, 90%) was added by syringe and the mixture heated in a 60 
°C oil bath for 2 h under an atmosphere of argon gas.  The reaction was cooled and the 
solvent removed under vacuum.  The resulting dark residue was taken up in ethyl acetate 
(300 mL) and mixed with brine (150 mL) and stirred vigorously.  The phases were 
allowed to separate and the organic layer was washed with brine (2 x 150 mL), dried over 
anhydrous sodium sulfate, and solvent removed by rotary evaporation.  Column 
chromatography on silica gel eluted with a gradient of 0-10% ethyl acetate in CH2Cl2 
gave 32 in 50% yield: mp 160-162 °C; 1H NMR (500 MHz, DMSO-d6) δ 9.20 (s, 1 H), 
8.24 (dd, J = 9.3, 5.3 Hz, 1 H), 8.202 (dd, J = 8.4, 2.8 Hz, 1 H), 8.083 (m, 1 H); 13C NMR 
(125 MHz, DMSO-d6) δ 162.6 (d, J = 254 Hz), 154.0 (d, J = 3 Hz), 144.9, 136.0, 132.5 
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(d, J = 9 Hz), 126.7  (d, J = 26 Hz), 105.2 (d, J = 29 Hz); HRMS (ESI) m/z calculated for 
C7H4FN3O (M+H+) 166.0411, found 166.0419.   
 
Synthesis of 7-diethanolamino-1,2,4-benzotriazine 1-oxide (33):  Compound 20 (361 
mg, 2.2 mmol) and diethanolamine (500 mg, 2.5 equiv) were dissolved in acetonitrile (7 
mL) and the mixture heated in an 80 °C oil for 4 days.  The reaction mixture was cooled 
and solvent removed under reduced pressure by rotary evaptoration.  The resulting solid 
was suspended in ethanol (10 mL) and briefly heated to 80 °C with stirring then cooled to 
0 °C and the resulting precipitate collected by vacuum filtration.  The orange solid was 
washed with cold ethanol and diethyl ether and dried in an oven overnight at 70 ˚C.    
Compound 32 was obtained in 66% yield.  1H NMR (500 MHz, DMSO-d6) δ 8.77 (s, 1 
H), 7.86 (d, J = 9.5, 1 H), 7.79 (dd, J = 9.5, 2.9 Hz, 1 H), 7.22 (d, J = 2.8, 1 H), 4.89 (t, J 
= 4.7 Hz, 2 H), 3.63 (bs, 8 H); 13C NMR (125 MHz, DMSO-d6) δ 150.4, 149.1, 140.2, 
136.0, 129.3, 125.3, 93.1, 57.8, 53.1; HRMS (ESI) m/z calculated for C11H14N4O3 
(M+H+) 251.2612, found 251.1144. 
 
Synthesis of 7-fluoro-1,2,4-benzotriazine 1,4-dioxide (34):  A procedure adapted from 
Pchalek and Hay was followed.28  Trifluoroacetic anhydride (600 µL) and CH2Cl2 (3 mL) 
were mixed with stirring in an ice bath and 70% H2O2 (210 µL) was added dropwise.  
The mixture was stirred for 10 min and then allowed to warm to room temperature.  This 
solution was cooled in an ice bath and and slowly added to an ice cold solution of 32 (75 
mg, 0.43 mmol) in CH2Cl2 (3 mL).  The reaction was stirred in an ice bath for 4 h before 
being diluted with cold NH4OH (4 mL, 1M), shaken well, and the organic layer was 
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separated.  The aqueous layer was washed 2x CH2Cl2. The combined organic fractions 
were dried over anhydrous sodium sulfate and column chromatography on silica gel 
eluted with 1% MeOH in CH2Cl2 gave 34 in 61% yield: 1H NMR (500 MHz, DMSO-d6) 
δ 9.33 (s, 1 H), 8.43 (dd, J = 9.5, 5.1 Hz, 1 H), 8.20 (dd, J = 8.5, 2.6 Hz, 2 H), 8.06 (ddd, 
J = 9.4, 8.2, 2.7 Hz, 1 H); 13C NMR (125 MHz, DMSO-d6) δ 163.2 (d, J = 255 Hz), 
142.0, 137.3, 136.3 (d, J = 11 Hz), 125.1(d, J = 26 Hz), 122.6 (d, J = 10 Hz), 106.5 (d, J 
= 28 Hz); HRMS (ESI) m/z calculated for C7H5FN3O2 (M+H+) 182.0360, found 
182.0363. 
 
Synthesis of 3-amino-6-(bis(2-hydroxyethyl)amino)-1,2,4-benzotriazine 1-oxide (36):  
Compound 19 (1.97 g, 11 mmol) and diethanolamine (5.75 g, 5 eq.) were suspended in 1-
methyl-2-pyrrolidinone (18 mL) and heated at 100 °C for 18 h.  The resulting orange 
suspension was cooled to room temperature, triturated with cold ethanol (40 mL) and 
collected by vacuum filtration.  The solid was washed with dichloromethane and dried in 
an oven overnight at 70 ˚C to give 36 as an orange powder in 94% yield.  For further 
purification the solid was suspended in ethanol, briefly heated with stirring, cooled, and 
collected by vacuum filtration.  1H NMR (500 MHz, DMSO-d6) δ 7.88 (d, J = 9.7 Hz, 1 
H), 6.99 (dd, J = 9.7, 2.4 Hz, 2 H), 6.83 (bs, 2 H), 6.41 (d, J = 2.3, 1 H), 4.85 (t, J = 5.2 
Hz, 2 H), 3.60-3.56 (m, 8 H); 13C NMR (125 MHz, DMSO-d6) δ 160.6, 153.3, 150.8, 
122.0, 120.9, 114.4, 99.7, 58.0, 53.2; HRMS (ESI) m/z calculated for C11H15N5O3 
(M+H+) 266.1248, found 266.1252. 
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Preparation of 3-amino-6-fluoro-1,2,4-benzotriazine 1,4-oxide (37):  Compound 19 
(0.59 g, 3.3 mmol) was dissolved in trifluoroacetic acid (10 mL) with stirring while H2O2 
(8 mL of 70% solution) was added dropwise.  The reaction was allowed to stir for 10 min 
and heated to 50 °C for 7 d protected from light.  The reaction was cooled to room 
temperature and poured into H2O (100 mL).  The resulting yellow solution was 
neutralized by slow addition of solid NaHCO3 with vigorous stirring.  The solution 
became deep red and a red powder precipitated.  The precipitate was collected by vacuum 
filtration, washed thoroughly with water and diethyl ether, and dried in a dessicator to 
give 37 in 43% yield.  1H NMR (500 MHz, DMSO-d6) δ 8.29 (dd, J = 9.6, 5.2 Hz, 1 H), 
8.20 (bs, 2 H), 7.83 (dd, J = 9.2, 2.7 Hz, 1 H), 7.45 (m, 1 H); 13C NMR (125 MHz, 
DMSO-d6) δ 165.9 (d, J = 256), 151.9, 139.9 (d, J = 13), 128.2, 125.2 (d, J = 11), 116.5 
(d, J = 27), 102.0 (d, J = 129); HRMS (ESI) m/z calculated for C7H5FN4O2 (M+H+) 
197.0469, found 197.0477. 
 
Synthesis of 3-amino-6-(bis(2-hydroxyethyl)amino)-1,2,4-benzotriazine 1,4-oxide 
(38).  Compound 37 (240 mg, 1.3 mmol) was suspended in a mixture acetonitrile (35 
mL), water (1 mL), and diethanolamine (1.4 g, 10 eq).  The suspension was stirred at 
room temperature for 2 d protected from light.  The solvent was removed by rotary 
evaporation, the orange residue resuspended in cold ethanol, and the solid collected by 
vacuum filtration.  The solid was washed with cold ethanol followed by diethyl ether and 
dried in an oven overnight at 70 ˚C to give 38 as an orange powder in 73% yield.  1H 
NMR (500 MHz, DMSO-d6) δ 7.94 (d, J = 9.8 Hz, 1 H), 7.71 (bs, 2 H), 7.20 (dd, J = 9.9, 
2.7 Hz, 1 H), 6.96 (d, J = 2.7, 1 H), 4.93 (t, J = 5.1 Hz, 2 H), 3.64 (bs, 8 H); 13C NMR 
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(125 MHz, DMSO-d6) δ 153.7, 151.8, 140.1, 123.0, 122.8, 116.5, 91.2, 58.2, 53.7; 
HRMS (ESI) m/z calculated for C11H15N5O4 (M+H+) 282.1197, found 282.1201. 
 
Synthesis 3-amino-7-fluoro-1,2,4-benzotriazine 1,4-dioxide (40):  Compound 31 (500 
mg, 2.8 mmol) was dissolved in trifluoroacetic acid (6 mL) with stirring while H2O2 (4 
mL of 70% solution) was added dropwise.  The reaction was allowed to stir for 10 min 
and heated to 50 °C for 7 d protected from light.  The reaction was cooled to room 
temperature and poured into H2O (100 mL).  The resulting yellow solution was 
neutralized by slow addition of solid NaHCO3 with vigorous stirring.  The solution 
became deep red and a red powder precipitated.  The precipitate was collected by vacuum 
filtration, washed thoroughly with water and diethyl ether, and dried in a dessicator to 
give 40 in 47% yield as a yellow solid.  1H NMR (500 MHz, DMSO-d6) δ 8.20 (dd, J = 
9.5, 5.1 Hz, 1 H), 8.03 (bs 2 H), 7.98 (dd, J = 8.7, 2.6 Hz, 1 H), 7.88 (ddd, J = 9.3, 8.3, 
2.7 Hz, 1 H); 13C NMR (125 MHz, DMSO-d6) δ 160.0 (d, J = 249), 151.7, 136.5, 131.2 
(d, J = 11), 125.6 (d, J = 27), 120.6 (d, J = 9), 106.3 (d, J = 28); HRMS (ESI) m/z 
calculated for C7H5FN4O2 (M+H+) 197.1459, found 197.0472. 
 
Synthesis 7-chloro-1,2,4-benzotriazine 1-oxide (44):  Compound 44 was prepared 
using a procedure adopted from Hay, M.P. et al.)30  4-chloro-2-nitroaniline (5.6 g, 33 
mmol) and cyanamide (15 g, 360 mmol) were heated together at 100 °C for 15 minutes to 
combine the solids.  The mixture was cooled slightly and HCl (20 mL, conc.) was added 
drop wise while stirring over 30-min.  (CAUTION: A violent exothermic reaction may 
occur during or after HCl addition).  After addition of acid was complete stirring was 
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continued for an additional 10 min, adding more cyanamide to help stir if needed.  The 
mixture was heated to 100 °C for 3 h and cooled to room temperature with continued 
stirring.  NaOH (100 mL, 8 M) was added and the mixture stirred vigorously at 100 °C 
for 2 h.  The orange suspension was cooled to room temperature, poured into 400 mL 
water, and filtered under vacuum.  The precipitate was washed thoroughly with water and 
diethyl ether and then dried in the oven at 70 °C overnight.  Compound 44 was obtained 
in 73% yield as a yellow powder: 1H NMR (500 MHz, DMSO-d6) δ 8.13 (d, J = 2.3 Hz, 1 
H), 7.80 (dd, J = 9.0, 2.4 1 H), 7.55 (d, J = 9.0 Hz, 1 H), 7.48 (bs, 2 H); 13C NMR (125 
MHz, DMSO-d6) δ 160.4, 147.7, 136.0, 130.0, 128.3, 128.0, 118.9; HRMS (ESI) m/z 
calculated for C7H6ClN4O (M+H+) 197.0225, found 197.0232. 
 
Synthesis 7-chloro-3-N,N-Bis(Boc-amino)-1,2,4-benzotriazine 1-oxide (45):  
Compound 44 (679 mg, 3.5 mmol) and 4-dimethylaminopyridine (21 mg, 5% equiv) 
were suspended in N-methylpyrrolidone (3.5 mL) and di-tert-butyl dicarbonate (1.67 g 
(2.2 equiv) was added.  The mixture was stirred under an atmosphere of nitrogen at room 
temperature for 4 h.  The resulting solution was diluted with tetrahydrofuran (20 mL) and 
precipitated by slow addition of water (200 mL).  The precipitate was collected by 
vacuum filtration, washed with water, and dried under vacuum.  Compound 45 was 
collected as a colorless solid in 96% yield: 1H NMR (500 MHz, CDCl3) δ 8.47 (d, J = 2.2 
Hz, 1 H), 8.0 (d, J = 8.9 Hz, 1 H), , 7.91 (dd, J = 9.0, 2.2 Hz, 1 H), 1.46 (s, 1 H); 13C 
NMR (125 MHz, CDCl3) δ 155.4, 149.9, 146.0, 137.5, 137.3, 130.6, 119.8, 84.7, 28.0; 
HRMS (ESI) m/z calculated for C17H22ClN4O5 (M+H+) 397.1273, found 397.1278. 
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Synthesis 3-amino-7-morpholino-1,2,4-benzotriazine 1-oxide (43):  Compound 45 
(120 mg, 0.3 mmol), tert-butanol (10 mL), sodium tert-butoxide (87 mg, 2.5 equiv), 
Pd(OAc)2 (3.4 mg, 5% equiv), and SPhos (12.3 mg, 10% equiv) were degassed inside a 
seal tube by bubbling N2 through the mixture for 20 min.  Morpholine (65 µL, 2.5 equiv) 
was added and the reaction vessel sealed.  The reaction was heated to 100 °C for 18 h 
before an additional portion of morpholine, Pd(OAc)2, and SPhos were added and the 
reaction continued heating at 100 °C for 24 h.  Water (30 mL) was added and the reaction 
was extracted with ethylacetate (3x 30 mL), organic fractions combined and dried over 
anhydrous Na2SO4.  (significant amount of product lost in aqueous layer).  Purification 
by column chromatography on silica gel with 0-2% MeOH in CH2Cl2 yielded two 
products, 43A and 43B in 9% and 16% yield respectively.  Compound 43A (6.8 mg) was 
dissolved in CH2Cl2 (2 mL) and then trifluoroacetic acid (200 µL) was added.  The 
mixture was stirred at room temperature for 1.5 h and then neutralized by slowly addition 
of saturated sodium bicarbonate solution (6 mL). The mixture was vacuum filtered and 
dark red solid collected and dried under vacuum to yield 43 in 65% yield (6% yield after 
two steps): 1H NMR (500 MHz, DMSO-d6) δ 7.75 (dd, J = 9.0, 2.8 Hz, 1 H), 7.47 (d, J = 
9.4 Hz, 1 H), 7.29 (d, J = 2.7 Hz, 1 H), 6.97 (bs, 2 H), 3.76 (t, J = 4.7 Hz, 4 H), 3.12, (t, J 
= 4.8 Hz, 4 H); 13C NMR (125 MHz, DMSO-d6) δ 159.2, 148.3, 144.1, 130.1, 128.0, 
126.6, 99.4, 65.9, 48.1; HRMS (ESI) m/z calculated for C11H14N5O2 (M+H+) 248.1142, 
found 248.1146. 
 
Synthesis of 3-aminonaphtho[2,1-e][1,2,4]triazine 1-oxide (46):  Compound 46 was 
synthesized from 1-nitro-2-naphthylamine prepared as in Hodgson and Kilner.35 1-nitro-
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2-naphthylamine (356 mg, 1.9 mmol) and cyanamide (1 g, 24 mmol) were mixed 
together by heating to 100 °C with stirring for 15 min.  The mixture was cooled to room 
temperature and then HCl (2.5 mL, conc) was added and the reaction was stirred at 100 
°C for 2 h.  The reaction was cooled to room temperature and then NaOH (10 mL, 16 M) 
was added.  The reaction was heated again at 100 °C for 3 h before being cooled to room 
temperature and diluted with water (25 mL).  The precipitate was collected by vacuum 
filtration and washed thoroughly with water and 25% ethyl acetate in hexane.  After 
drying in an dessicator overnight, compound 46 was obtained as a yellow solid in 20% 
yield: 1H NMR (500 MHz, DMSO-d6) δ 9.70 (d, J = 8.5, 1 H), 8.21, (d, J = 9.1, 1 H), 
8.204 (d, J = 7.7 Hz, 1 H), 7.80 (appt, J = 8.3, 7.3, 2 H), 7.70 (appt, J = 7.5, 7.3 Hz, 1 H), 
7.48 (d, J = 9.0, 1 H), 7.40 (bs, 2 H); 13C NMR (125 MHz, DMSO-d6) δ 161.5, 153.4, 
138.4, 130.9, 130.1, 129.7, 128.0, 125.2, 125.1, 125.1, 124.9; HRMS (ESI) m/z 
calculated for C11H9N4O (M+H+) 213.0771, found 213.0776. 
 
Synthesis 3-aminonaphtho[2,3-e][1,2,4]triazine 1-oxide  (47):  3-nitro-2-
naphthylamine (3.5 mg, 0.5 mmol) and cyanamide (240 mg, 2.1 mmol) was added to a 
round bottom flask and heated to 100 °C with stirring to melt together.  The reaction was 
cooled to room temperature and then HCl (520 µL, conc) was added and then the mixture 
was heated to 100 °C for 30 min.  The reaction was cooled to room temperature and then 
NaOH (1 mL, 8 M) was added.  The reaction was stirred at 100 °C for 2 h, then cooled to 
room temperature and water (8 mL) added.  The resulting suspended solid was collected 
by centrifugation and washed with water and 25% ethyl acetate in hexane then dried 
under vacuum.  Compound 47 was collected as a dark purple solid in 23 % yield: 1H 
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NMR (500 MHz, DMSO-d6) δ 8.91 (s, 1 H), 8.15 (d, J = 8.4 Hz, 1H), 8.06 (s, 1 H), 7.99, 
(d, J = 8.5 Hz, 1 H), 7.60 (appt, J = 7.3, 6.9 Hz, 1 H), 7.48 (appt, J = 7.2, 6.9 Hz, 1H), 
7.38 (bs 2 H); 13C NMR (125 MHz, DMSO-d6) δ 158.3, 143.1, 137.2, 129.6, 129.4, 
129.3, 129.2, 127.1, 125.8, 121.8, 120.0; HRMS (ESI) m/z calculated for C11H9N4O 
(M+H+) 213.0771, found 213.0771. 
 
Synthesis 3-aminonaphtho[1,2-e][1,2,4]triazine 1-oxide  (48):  Compound 48 was 
synthesized from 2-nitronaphthylamine prepared as in Katritzky and Laurenzo.36 2-
nitronaphthylamine (812 mg, 4.3 mmol) and cyanamide (2 g, 48 mmol) were mixed 
together by stirring at 100 °C  for 15 minutes.  The mixture was cooled to room 
temperature and HCl (5 ml, conc) was added.  The reaction was heated to 100 °C  with 
stirring for 2 h.  After cooling to room temperature, NaOH (50 mL, 7.5 M) was added 
and the reaction stirred at 100 °C  for 2 h.  When complete the mixture was diluted with 
water (100 mL) and vacuum filtered.  The precipitate was washed thoroughly with water 
and diethyl ether.  Purification was done by column chromatography on silica gel with 
10% acetone in CH2Cl2 to give compound 48 as a yellow solid in 8% yield: 1H NMR 
(500 MHz, DMSO-d6) δ 8.83 (d, J = 8.2 Hz, 1 H), 8.02, (d, J = 3.4 Hz, 1 H), 8.00 (s, 1H), 
7.84 (appt, J = 8.0 Hz, 2 H), 7.76 (appt, J = 7.2, 0.9 Hz, 1 H), 7.71 (d, J = 9.4 Hz, 1 H), 
7.52 (bs, 2 H); 13C NMR (125 MHz, DMSO-d6) δ 161.2, 149.4, 135.3, 131.1, 128.4, 
128.0, 127.6, 126.6, 124.4, 124.7, 116.0; HRMS (ESI) m/z calculated for C11H9N4O 
(M+H+) 213.0771, found 213.0776. 
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Synthesis 3-aminonaphtho[2,1-e][1,2,4]triazine 2-oxide  (50):  Compound 50 was 
synthesized via oxidation of 49 (prepared as reported in Suzuki and Kawakami.37) with 
dimethyldioxirane (prepared as in Murray and Singh)38 Compound 49 (20 mg, 0.1 mmol) 
was dissolved in acetone (6 mL) and dimethyldioxirane (4x 1 mL) was added over 2 d 
until most of the starting material has reacted.  The solvent was removed by rotary 
evaporation and purification by column chromatography on silica gel with 4% acetone in 
CH2Cl2 gave compound 50 in 73% yield: 1H NMR (500 MHz, DMSO-d6) δ 8.63 (d, J = 
8.2 Hz, 1 H), 8.26 (bs 2 H), 8.07 (d, J = 9.0 Hz, 1 H), 8.02 (d, J = 7.9 Hz, 1 H), 7.75 
(appt, J = 7.9, 7.3 Hz, 1 H), 7.68 (appt, J = 7.8, 7.1 Hz, 1 H), 7.54 (d, J = 9.0 Hz, 1 H); 
13C NMR (125 MHz, DMSO-d6) δ 150.4, 133.9, 132.6, 132.1, 131.2, 128.8, 128.5, 127.8, 
127.2, 123.5, 121.8; An crystal structure was obtained by vapor diffusion with ethyl 
acetate and hexane and analyzed by Xray Diffraction (Figure 2).  
 
Synthesis 3-(4`-aminophenyl)-1,2,4-benzotriazine 1-oxide (51):  Compound 16 (118 
mg, 0.3 mmol) was dissolved in toluene (5 mL) and H3PO4 (0.25 mL, 85%, 5 equiv) was 
added.  The mixture was stirred vigorously at room temperature for 24 h.  At the end of 
the reaction water (10 mL) was added and the mixture was extracted with ethyl acetate 
(5x 10 mL).  The organic fractions were combined, dried with Na2SO4 and solvent 
removed by rotary evaporation.  Purification by column chromatography with 10-50% 
ethyl acetate in hexane afforded 51 in 57% yield as a red solid: 1H NMR (500 MHz, 
DMSO-d6) δ 8.32 (d, J = 8.56 Hz, 1 H), 8.10 (d, J = 8.7 Hz, 2 H), 8.02-7.97 (comp, 2 H), 
7.70 (ddd, J = 8.4, 6.5, 1.7 Hz, 1 H), 6.69 (d, J = 8.7 Hz, 2 H), 5.98 (s, 2 H); 13C NMR 
(125 MHz, DMSO-d6) δ 160.4, 153.2, 147.8, 136.4, 132.8, 130.0, 129.6, 128.8, 120.6, 
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120.2, 113.8; HRMS (ESI) m/z calculated for C13H13N4O (M+H+) 239.0927, found 
239.0933. 
 
Synthesis of 3-amino-7-carboxy-1,2,4-benzotriazine 1-oxide (52):  Compound 52 was 
prepared using a modified method of Suzuki and Kawakami.39	  NaOH (508 mg,  equiv) 
was dissolved in hot ethanol (30 mL), guanidine hydrochloride (1.2 g, 10 equiv) added, 
and the resulting mixture stirred for 20 min.  The reaction was cooled to room 
temperature and filtered to remove the white precipitate.  To the filtrate THF (20 mL) and 
4-fluoro-3-nitrobenzoic acid (226 mg, 1.2 mmol) were added and the resulting 
heterogeneous mixture refluxed for 4 h.  Potassium tert-butoxide (153 mg, 10 equiv) 
were added and the mixture stirred at reflux for an additional 2 h.  After the reaction was 
complete, the THF was decanted off and water (60 mL) added with vigorous stirring.  
Acidification with HCl (1 M) resulted in precipitation of a yellow solid that was collected 
by vacuum filtration and washed with dilute HCl, followed by minimal amounts of water 
and diethyl ether.  The solid was then dried in an oven overnight at 70 ˚C to give 52 in 
93% yield: 1H NMR (500 MHz, DMSO-d6) δ 13.33 (bs, 1 H), 8.62 (d, J = 1.7 Hz, 1 H), 
8.17 (dd, J = 8.8, 1.7 Hz, 1 H), 7.69 (s, 2 H), and 7.56 (d, J = 8.8 Hz, 1 H); 13C NMR 
(125 MHz, DMSO-d6) δ 165.9, 161.1, 151.1, 134.8, 129.5, 126.2, 126.0, 122.1; HRMS 
(ESI) m/z calculated for C8H6N4O3 (M+H+) 207.0513, found 207.0518. 
 
Synthesis 3-amino-7-ethylester-1,2,4-benzotriazine 1-oxide (53):  Compound 52 was 
suspended in ethanol (5 mL) and H2SO4 (0.5 mL, conc) and the mixture was refluxed for 
6 h.  After completion, the reaction was diluted with ethyl acetate (50 mL) and washed 
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with water (3x 50 mL), saturated sodium bicarbonate (3x 50 mL), and brine (50 mL).  
The organic fraction was dried over anhydrous Na2SO4 and solvent removed by rotary 
evaporation.  Compound 53 was obtained as a dark red solid in 67% yield: 1H NMR (500 
MHz, DMSO-d6) δ 8.62 (d, J = 1.8 Hz, 1H), 8.17 (dd, J = 8.8, 2.0 Hz, 1 H), 7.74 (bs, 
2H), 7.57 (d,  J = 8.9 Hz, 1 H), 4.35 (q, J = 7.1 Hz, 2 H), 1.35 (t, J = 7.1 Hz, 3 H) ; 13C 
NMR (125 MHz, DMSO-d6) δ 164.4, 161.1, 151.3, 124.4, 129.5, 126.4, 124.9, 122.0, 
61.3, 14.1; HRMS (ESI) m/z calculated for C10H10N4O3 (M+H+) 235.0826, found 
235.0828. 
 
Crystal Structure 1 
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Crystallographic Data Crystal Structure 1 
Emperical formula C11 H8 N4 O1 
Formula weight 212.21 
Temperature, (K) 173(2) 
W. length, (Å) 0.71073 
Crystal system Triclinic 
Space group P -1 
a, (Å) 6.943(6) 
b, (Å) 7.699(7) 
c, (Å) 9.097(8) 
α, (deg) 72.560 (11) 
β, (deg) 87.991 (11) 
γ, (deg) 87.212 (11) 
Volume, (Å3) 463.2(7) 
Z/calculated density (Mg/m3) 2/1.522 
Absorption coefficient (mm-1) 0.105 
Crystal size (mm) 0.25 x 0.15 x 0.05 
Reflections collected/unique 5306 / 2065 [R(int) = 0.0434] 
Data/restraints/parameters 2065 / 0 / 145 
GOF 0.981 
R indices (all data) R1 = 0.0582, wR2 = 0.1476 
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1.6  NMR Spectra for Compound Characterization 
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Chapter 2. Hypoxia Selective DNA Alkylating Analogs of 
Tirapazamine 
 
 
2.1 Introduction 
 As previously described, TPZ is a hypoxia selective prodrug with interesting anti-
tumor properties.1-2 It contains a triazine ring system with two N-oxide species.  This 
triazine di-N-oxide core is a complex structure that undergoes redox cycling during drug 
metabolism.3 TPZ is enzymatically reduced to form a protonated radical anion species (2, 
Chapter 1, Scheme 1) thought to fragment producing a hydroxyl radical (!OH) and the 
reduced benzotriazine 1-oxide 3 (Chapter 1, Scheme 1).2  The !OH species is the active 
drug metabolite that is thought to cause DNA damage via single- and double-strand 
breaks.2,4-5 These are deleterious types of DNA damage that result in cell death.   
 In the presence of aerobic amounts of oxygen (>10 µM), the protonated radical 
anion is back-oxidized to give TPZ, producing superoxide (!O2-) in the process.3,6 As 
termed earlier, this "Redox Cycling" is the basis for all hypoxia selective and 
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bioreductively activated prodrugs.7-8 Nitro and N-oxide containing compounds can be 
bioreductively metabolized in the absence of oxygen (<1 µM) by cytochrome P450 
reductase.6-7,9-12 This oxygen sensitivity is what gives TPZ and other similar prodrugs 
their selective hypoxic cytotoxicity.  The oxygen concentrations in normal healthy cells 
inhibit the bioreduction by oxidizing any radicals that form.  Under low oxygen 
concentrations, as seen in tumor tissue, the oxygen concentration is not high enough to 
sufficiently block radical generation, allowing fragmentation and !OH generation to 
occur.  This process also produces 4 as unreactive, wasted material.  This oxygen 
sensitive process results in a huge loss of mass with respect to the reactive metabolite, 
!OH. We hope to develop analogues that make use of the unreactive benzotriazine 1-
oxide core (4) in order to increase the overall effective cytotoxicity of the pro-drug.  We 
synthesized molecules potentially activated after 1e- reduction under hypoxic conditions 
by grafting nitrogen mustard substituents on the benzo-ring (Scheme 2).   
Scheme 1 
 
 Many pro-drugs that incorporate N-mustards possess increased hypoxia-selective 
cell killing properties.  They are notorious for causing DNA interstrand cross-links by 
alkylating dG in 5`-GNC sequences,13-14 and have been repeatedly used for designing 
new anticancer agents (54, 55, 56, and 57).10,15-20 Nitrogen mustards alkylate at the N-7 
position of deoxyguanosine via aziridinium ion intermediate (Scheme 1).13,20 It is 
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believed that aziridinium ion formation is the rate-determining step in N-mustard 
alkylation and hydrolysis.20 This requires the nitrogen lone pair to be "active" for 
nucleophilic attack, but in turn can be controlled by electron-withdrawing groups in an 
aromatic system.18 The benzotriazine ring in TPZ (1) contains two electron withdrawing 
N-oxides.21 Upon reduction to its mono-N-oxide metabolite (4), the electronic structure 
of the benzotriazine ring changes.  We theorized we could modulate N-mustard activity 
when grafted onto the TPZ core.  It has been shown that anchimeric assistance in 
nucleophilic displacement reactions involving nucleophiles either in or attached to aryl 
rings can be highly sensitive to substituent effects (Scheme 2).22-24 
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 Aromatic compounds with strong electron-withdrawing substituents like -NO2 
groups cause electron deficiencies in the ring.  This in turn reduces the electron density of 
the nitrogen lone pair on an aromatic nitrogen-mustard substituent and inhibiting 
aziridinium ion formation.  Reduction of the -NO2 will change the electronic distribution 
of the ring, resulting in a more nucleophilic nitrogen lone pair for faster aziridinium 
generation.  Scheme 3 describes how an electron donating substituent at position 6 
(Chapter 1, Figure 1) will show inductive effects with N-4.  The N-4-oxide is an electron-
withdrawing group capable of deactivating N-mustard substituents at the 6-position 
(Scheme 3).  When reduced, the N-mustards are activated and will alkylate DNA faster 
via aziridinium ion formation. (Scheme 3)  This change in reactivity would result in 
selective DNA-alkylation under hypoxic conditions in cells, introducing a new class of 
oxygen sensors.  Changes in the electronic properties of molecules have widely been used 
to "switch on" the reactivity of functional groups.11 This reports the first use of these 
benzotriazine structures to modulate alkylating potential of nitrogen mustards.  Here we 
describe TPZ analogues in which the mono-N-oxide metabolite is no longer an inert 
compound, but an activated species after bioreduction of the parent 1,4-di-N-oxide.  
Scheme 3 
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2.2 Preparation of Tirapazamine mustards 
 The synthesis of benzotriazine mustards is summarized in Scheme 4 using 
compounds presented in Chapter 1.  The first route explored involved sulfonation of the 
diol containing 1-oxide 36 and 1,4-dioxide 38, which were prepared by aromatic 
substitution of fluorine containing benzotriazines with diethanolamine (Chapter 1).  It is 
interesting to note the remarkable difference in electrophilicity at the 6-F position 
between compounds 19 and 31 (Chapter 1) to obtain diol-containing 36 and 38. The 
substantial difference in reaction conditions required for synthesis provided first evidence 
that the 4-N-oxide core would serve as an effective electron-withdrawing group for 
deactivation of nitrogen mustards at the 6-position (Figures 1 and 2). 
 1-Oxide mustards 54 and 56 can be prepared from 36 using their respective 
sulfonyl chlorides (Scheme 4).  Synthesis of the corresponding 1,4-dioxides (55 and 57) 
was challenging, as sulfonation in the presence of a nucleophilic 4-N-oxide21 produced 
side reactions giving a mixture of products by TLC.  One major product (58) isolated by 
column chromatography was a compound possibly from a nucleophilic aromatic 
deoxygenation reaction (proposed mechanism in Scheme 5).21 A crystal structure of this 
product was obtained to confirm its identity (Experimental section, crystal structure 1).  
Other products obtained could possibly result from sulfonation of the 3-amino group, 
explaining the less polar products seen on TLC.  This hypothesis is supported by previous 
work in the Gates group.25 Acetylation of the 3-amino group of the benzotriazine ring is 
facilitated in the presence of the 4-N-oxide.25 We conclude sulfonation would 
significantly occur at the 4-N-oxide.  For these reasons, the "deactivated" 1,4-dioxide N-
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mustards 55 and 57 were prepared instead by N-oxidation of the 1-oxides (54 and 56) 
with Oxone or mCPBA in low yield.   
Scheme 4 
 
 
 We also prepared -Cl, -Br, and -I containing benzotriazine N-mustards as well 
(Scheme 4).  They were prepared by nucleophilic substitution of compound 54 with the 
corresponding halide salt in DMF with heat to yield 59, 60, and 61.  Chlorine mustard 59 
was oxidized to 62 with mCPBA to afford the "deactivated" halide mustard as well. 
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Scheme 5 
 
Scheme 5.  Proposed reaction mechanism of formation for compound 58. 
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 To show that the 1,4-dioxide analogs (55, 57, and 62) contained "deactivated" N-
mustards, and their corresponding 1-oxide analogs (54, 56, and 59) were "active", we 
monitored rates of hydrolysis by 1H NMR.  The reactivities of all N-mustards (~1 mM) 
were measured as time-course experiments under pseudo-1st-order reaction conditions 
inside NMR tubes as solutions of 50% CD3CN in D2O heated to 50 °C.  At each time-
point, the reactions were cooled quickly to room temperature and a 1H NMR spectrum 
was taken.  Disodium maleate (5 mM) was used as an internal standard for all 1HNMR 
spectra.  Integration of methyl or methylene peaks was monitored over time in order to 
calculate N-mustard rate of hydrolysis.  Figure 1 shows the deactivation of compounds 
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56 showed an approximate 5-fold increase in reactivity while the ditosyl mustard 54 
showed about a 3-fold increase when compared their 1,4-dioxides 57 and 55, respectively 
(Table 1).  These results confirm our initial hypothesis that the 4-N-oxide effectively 
deactivates the nucleophilicity of the 6-position N-mustard nitrogen of the benzotriazine 
core. 
Figure 1 
 
 
 
Figure 1.  Rate of decay for compounds 54, 55, 56, and 57 in 1:1 acetonitrile-d6/D2O 
measured by 1H-NMR in at 50 °C.  Compounds 54 and 56 were monitored for 2 weeks 
and compounds 55 and 57 were monitored for 2 months. 
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electron density on the N-mustard nitrogen, resulting from the electronic interaction with 
the 4-N-oxide.  It is interesting to note that mesylate mustards 56 and 57 reacted faster 
than tosylate mustards 54 and 55, as literature precedents support that tosylates are 
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possible the hydrophobic interaction slows aziridinium ion formation, but this hypothesis 
was not tested further.   
Table 1. Summary of Rates of Hydrolysis for Sulfonate N-Mustards 
 
 Hydrolysis Conditions: 50% acetonitrile-D3 in D2O at 50 °C 
 
 We observed slightly slower hydrolysis rates for 60, and 61, and significantly 
slower rates with chlorine mustards 59 and 62. Chloride mustard 59 ("activated") gave a 
calculated half-life of 51 days showing 85% remaining SM after 10 days, whereas 62 (the 
di-oxide "deactivated" mustard) showed no noticeable reaction occurring. While typically 
chlorines are used for N-mustard activity, we chose to only study the sulfonate mustards 
further for their higher reactivity.  The sulfonate mustards also improved solubility over 
the halide mustards.  The hydrolysis conditions discussed were chosen to allow for 
comparison of reactivity for molecules of differing solubility at concentrations needed for 
sufficient signal detection.  The 50% organic conditions slowed the reaction rates enough 
N
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R2 +N
N+N
O
R1
R3
R2
O
1-oxide 1,4-dioxide
Compound R1 R2 R3 Oxidation t½ (d) 
54 -NH2 -N(CH2CH2OTs)2 -H 1-oxide 5.46 ± 0.06 
55 -NH2 -N(CH2CH2OTs)2 -H 1,4-dioxide 15.4 ± 0.7 
56 -NH2 -N(CH2CH2OMs)2 -H 1-oxide 2.68 ± 0.62 
57 -NH2 -N(CH2CH2OMs)2 -H 1,4-dioxide 15.4 ± 0.7 
65 -H -N(CH2CH2OTs)2 -H 1-oxide 13.9 ± 1.1 
66 -H -N(CH2CH2OTs)2 -H 1,4-dioxide 12.6 ± 1.4 
67 -H -H -N(CH2CH2OTs)2 1-oxide 6.48 ± 0.79 
68 -H -H -N(CH2CH2OTs)2 1,4-dioxide 6.54 ± 0.06 
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for easy measurement by 1H NMR.  It should be noted that the reactivity of sulfur 
mustards can significantly change with increasing water concentrations.28 Consequently, 
accurate biological hydrolysis rates cannot be inferred from these results.  But we have 
shown proof of concept for the controlled deactivation of a N-mustard substituted at the 
6-position in the presence of the 4-N-oxide (Scheme 3). 
Scheme 6 
 
 
 We were also interested to see if placing the nitrogen mustard moiety in other 
positions would observe the same deactivation.  To do this, we looked to synthesize 
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position counterparts 54 and 55.  In terms of N-mustard activity this equates to faster 
rates of reaction.  At the time other attempts were made towards synthesis of structure 39, 
utilizing Pd catalyzed reactions in particular but because of insolubility, the products 
observed in these reactions could not be isolated or characterized.   
 Instead we sought to use structures that did not contain the exocyclic -NH2 in 
order to reduce electron density of the aromatic system.  In Chapter 1 we prepared fluoro-
containing benzotriazines missing the exocyclic -NH2 (compounds 27 and 32), which 
were aminated with diethanolamine under mild conditions to give compounds 28 and 33.  
As described in chapter 1, we did this by deamination with tert-butyl nitrite in DMF to 
form desamino fluoro-containing derivatives 27 and 32 following a procedure in Boyd et 
al.29 Nucleophilic aromatic substitution with diethanolamine provided the diol containing 
N-mustard scaffolds.  Deamination at the 3-position made positions 6 and 7 (containing 
fluorine atoms) more susceptible towards substitution reactions.  A significant increase in 
organic solubility was also observed allowing more versatility in solvent choice.  
Compounds 27 and 32 were sulfonated with tosyl chloride to give N-mustards 65 and 67 
with tosyl chloride (Scheme 7).  The 1,4-dioxide mustards 66 and 68 were obtained by N-
oxidation in low yield. 
Scheme 7 
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 These low oxidation yields result from removing the electron donating -NH2 at 
the 3-position.  This caused the endocyclic 4-nitrogen to become less nucleophilic 
towards N-oxidation.  This is even more noticeable with oxidation of 67 to 68.  As 
predicted before, the electron withdrawing effects of the 4-N-oxide would not have 
significant affects on a N-mustard in the 7-position.  It holds that the 7-position would not 
provide any electron donating effects to assist the N-oxidation at the 4-N-position.  After 
preparation of these new synthetic targets, their rates of hydrolysis were measured by 1H 
NMR like before (Table 1).   
 As predicted, no significant difference in reactivity was observed for compounds 
67 and 68.  Confirming that the 7-position is not appreciably deactivated by the presence 
of a 4-N-oxide (Figure 2).  It is interesting to note that 65 did not result in a significanly 
faster rate of hydrolysis than the dioxide 66, and both were still much less reactive than 
the 7-position mustards 67 and 68.  For the 6-position analogs lacking the 3-amino group 
(65 and 66), we also did not observe a significant difference in reactivity.  The 3-amino 
group must serve to mitigate some of the strong electron-withdrawing interactions of the 
benzotriazine ring.  Furthermore, compounds 65 and 66 have hydrolysis rates resembling 
that of 55 and 57.  The 4-N-oxide group must exert such a strong electron-withdrawing 
(deactivating) effect on the mustard unit in the 6-position thereby preventing the 
participation of this nitrogen’s lone pair in aziridinium ion formation altogether.  The 
combination of these results suggests a tunable reactivity of substituents located at the 6-
position on the TPZ core.  
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2.4 Preparation and Hydrolysis Rate Measurements of Quinone Methide Analogs 
 These results showing proof of concept sparked interest towards investigating if 
other substituents with DNA alkylating potential could be modulated.  Quinone methides 
are highly reactive intermediates that have been utilized both in synthetic and medicinal 
chemistry.  For example, mytomycin C (69), is a DNA cross-linking agent that is 
bioreductively activated in cells (Scheme 8).30  Enzymatic reduction initiates a series of 
reactions, which involve a set of quinone methide-like chemistry to alkylate DNA via 
conjugate addition (Scheme 8).  We set out to incorporate quinone methide-like 
structures onto the benzotriazine core. 
Scheme 8 
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Scheme 9 
 
 
 Our goal was to utilize an exocyclic aromatic amine with a benzyl substituent to 
generate a quinone methide-like enamine structure shown in Scheme 9.  We theorize this 
would act similar to actual quinone methides, performing Michael Addition reactions.  
We prepared two sets of compounds including the mono- and di-N-oxide analogues, one 
substituted at the 3-position 71 and 72 and another substituted at the 6-position 76 and 77.  
 The preparation is described in Scheme 10.  Compound 73 was prepared by 
condensation of cyanamide with the corresponding nitroaniline.  Deamination with tert-
butyl nitrite provided 74.  With compounds 5 and 74, we utilized Buchwald coupling 
presented in Chapter 1 to prepare the benzyl alcohol derivatives 70 and 75.  Acetylation 
of the benzyl alcohol yielded "activated" compounds 71 and 76.  Subsequent oxidation 
with mCPBA gave "deactivated" analogues 72 and 77 in low yield.   
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Scheme 10 
 
 
 
 
Table 2. Methide Analog Rates of Hydrolysis 
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 The rates of reaction were measured as before using 1H NMR in 50% D3-ACN in 
D2O solutions at 50°C.  The calculated half-lives are listed in Table 2.  In summary, the 
reaction rates of all compounds are significantly faster compared to the N-mustard 
analogues, with calculated half-lives of 1.26 days for compound 71 and 0.41 days for 
compound 76.  Both reacted more than 2-fold faster than the dimesylate mustard 56.  We 
also observe deactivation of quinone methide analogues in the presence of the 4-N-oxide 
(72 and 77).  Although the degree of deactivation is not as striking as with the N-mustard 
analogues, we see about a 50% decrease in hydrolysis rate for compounds 71 and 72 and 
a two-fold decrease for compounds 76 and 77.  Most likely the small change in reactivity 
results from only partial contribution of the amine to the benzyl carbocation formation.  
This suggests that significant benzyl carbocation formation occurred without assistance 
of the amine.  Presumably using poorer leaving groups like -OCH3 could be used to tailor 
the change in reactivity at the expense of slower reaction rates.  Overall these results 
further support the use of the benzotriazine core to modulate the reactivity of exocyclic 
substituents at not only the 6-position, but the 3-position as well (Chapter 1, Figure 1).  
 
2.5 Hypoxia-Selective, In Vitro Metabolic Conversion of 38 to 36 
 Successful deployment of the activated mustard 56 requires hypoxia-selective 
enzymatic reduction of the dioxide 57.  Thus, it was important to demonstrate that the 
dialkylamine substituent at the 6-position of tirapazamine did not prevent bioreductive, 
deoxygenative metabolism of the 1,2,4-benzotriazine 1,4-dioxide core.  We performed 
enzymatic assays with the NADPH:cytochrome P450 reductase (POR) as the 
bioreductive enzyme for this test, as it is thought to be responsible for bioactivation of 
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TPZ (1).6, 12, 31-33 Conditions similar to literature precedent were utilized for this 
experiment.2  To avoid complex product analysis by the mesylate containing N-mustards, 
we decided to utilize the diol containing N-mustard 38 for this experiment.  Compound 
38 was incubated under anaerobic conditions in aqueous sodium phosphate (25 mM, pH 
7) degassed with argon in the presence of NADPH (500 mM) and POR (1 U/mL) for 24 h 
at room temperature protected from light.  Integration of peaks absorbing at 420 nM were 
used to estimate a percent reduction of ~16% 36 relative to unreduced 38 remaining 
(Figure 2A).  A control was run using the same buffer system but under aerobic 
conditions.  In the presence of oxygen, no generation of 36 was observed (Figure 2B).  
When the anaerobic conditions were repeated using TPZ (1) for comparison, 
approximately 47% reduction was obtained (Figure 2C).  The 6-diethanolamine 
substituted TPZ analogue 38 showed lower efficiency towards reduction when compared 
to its predecessor 1.  This was to be expected, as literature reports that TPZ analogues 
containing an e- donating group at the 6-position, like in compound 38, have lower 
reduction potentials (more negative).34 Nonetheless, the results provide evidence that 38 
can undergo hypoxia-selective metabolism in a manner similar to the parent compound 
Tirapazamine. 
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Figure 2 
 
Figure 2.  HPLC chromatogram showing the in vitro metabolic conversion of 38 to 36 
and 1 to 4 by cytochrome P450:NADPH reductase under anaerobic conditions: (A) 
Reduction of 38 under anaerobic conditions, (B) same but under aerobic conditions, and 
(C) reduction of 1 under anaerobic conditions. 
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2.6 Assessment of Hydrolysis Products of Benzotriazine N-Mustards 
 We felt it necessary to confirm the identity of N-mustard hydrolysis products 
formed.  Compounds 56 and 57 were selected for their higher reactivity and superior 
aqueous solubility.  Hydrolysis reactions were monitored by HPLC in buffered aqueous 
solution.  The N-mustards (250 µM, 2.5% DMF) were heated to 50 °C in sodium 
phosphate buffer (25 mM, pH 7) in H2O over 24 hours.  HPLC chromatograms 
monitoring integrated absorbance values at 280 nM were taken at various time intervals 
to determine the rate of disappearance.  Using linear regression, we determined half-lives 
for 56 and 57 to be 12 ± 0.5 h and 96 ± 21 h, respectively, under aforementioned 
conditions (Figure 2).  As expected, the hydrolysis rates of 56 and 57 were substantially 
faster under these conditions than when compared to the 50:50 CD3CN-D2O mixture 
employed in the NMR experiments.35 Here the “activated” mono-N-oxide metabolite 56 
reacted approximately seven times faster than the parent dioxide 57.  Comparison with 
authentic synthetic standards revealed that the major products generated in the 
decomposition of 57 were the diol 36 and the morpholino 79, both presumably formed 
via the half-mustard 78 (Scheme 11).  This was also observed with 1H NMR, and is 
consistent with reported aryl N-mustard hydrolysis products.36 The two products were 
estimated to be about a 2:1 ratio of morpholino (79) and diol (36) for the hydrolysis of 1-
oxide mustard 56.  Under the same conditions 57 did not show significant formation of 
analogous hydrolysis products, consistent with the deactivation of N-mustard activity. 
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Figure 3 
 
Figure 3. Representative HPLC chromatograms showing the hydrolysis of compounds 
56 (left) and 57 (right) (250 µM) in sodium phosphate buffer (25 mM, pH 7) containing 
DMF (2.5% v/v) at 50 °C. Compounds were detected by their absorbance at 280 nm.  The 
disappearance of compound 56 and appearance of hydrolysis products 36 and 78 over a 
24 h time period is shown on the left.  The disappearance of compound 57 over a 24 h 
time period is shown on the right. 
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Scheme 11 
 
 
2.7 Measurement of the Electron-Withdrawing Power of the Benzotriazine Ring 
Systems. 
 We felt it would be useful to quantitatively measure the electron-withdrawing 
power of the triazine ring systems in 56 and 57.  Electronic effects exerted by various 
substituents on an aromatic ring typically are measured using Hammett sigma (σ) 
constants.37  Hammett σ values are determined by measuring the affect of the substituent 
on the acidity of a carboxylic acid group (Scheme 12) on the aromatic ring system, where 
σsubstituent = log(Ka(substituted benzoic acid)/Ka(benzoic acid)).  Therefore, we prepared the carboxylic 
acid derivatives 80 and 81 via reaction of guanidine with 3-fluoro-4-nitrobenzoic acid 
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measured pKa of 2.9 we were able to calculate a σ value of 1.3 for the mono-N-oxide 80.  
The establishes the 1,2,4-triazine-1-oxide ring as a strongly electron-withdrawing 
substituent comparable to a p-sulfonyl cyanide group (–SO2CN).37  Unfortunately, we 
were not able to accurately measure the pKa for the di-N-oxide 81 but a similar titration 
allowed us to estimate a pKa  between 1.5 and 2.0.  The UV-vis spectral changes for 81 
associated with protonation of the carboxylic acid group were obscured by another 
process, perhaps involving protonation of the oxygen in the 4-oxide group. 
Scheme 12 
 
 
Figure 4 
 
Figure 4.  pKa determination for 80.  Absorbance spectra (left) and titration curves (right) 
with least squares fitting for compound 80 from pH 2.18-5.47. 
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that are the subject of this work,40 we felt this measurement would nonetheless provide a 
useful evaluation of the electronic properties of the triazine mono-oxide and dioxide ring 
systems.  Therefore, we synthesized the phenol derivatives 82 and 83 by hydrolysis of the 
corresponding fluoro compounds 19 and 38 respectively (Scheme 1341  We then 
measured the acidity of these compounds by monitoring the changes in their UV-vis 
spectra as a function of pH (Figure 5).  The pKa of 82 was found to be 6.3 and that of 83 
was 5.3.  The pKa measurements allowed us to calculate σ – values of 1.81 for the 1,2,4-
triazine 1-oxide “substituent” in 82 and 2.31 for the 1,2,4-triazine 1,4-dioxide 
“substituent” in 83.  These values indicate that both the triazine mono-N-oxide and the di-
N-oxide rings are strongly electron withdrawing.  By way of comparison, the sulfonyl 
perfluoropropane group (-SO2(CF2)2CF3) has a σ – value of 1.75 and the diazonium group 
(-N2+) has a σ – value of 3.43.37 Importantly, there is a substantial difference (0.5) 
between the σ – values between the 1,2,4-triazine 1-oxide and 1,2,4-triazine 1,4-dioxide 
substituents in 82 and 83.  This is similar to the difference between σ – values of the nitro 
group (1.27) and the acetyl group (0.84).37   
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Figure 5 
 
Figure 5.  pKa determination for compounds 31 and 32.  UV/Vis spectra of compounds 
82 (A) and 83 (C) from pH 3.4 → 9.0 (82) and pH 2.4 → 9.0 (83).  Titration curves with 
least squares fitting of compounds 82 (B) and 83 (D) from pH 3.35-9.00. 
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Figure 6 
 
Figure 6. pH-Dependent changes in the absorbance spectra of compounds 4 and 1.  The 
results show that the changes in the pH-dependent absorbance spectra (pH > 2) for 80, 
82, and 83 are likely associated with protonation and deprotonation of the carboxylate 
and phenol groups. 
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is the preferential site for DNA alkylation.  In fact this property is used for Maxam-
Gilbert G-selective DNA sequencing reactions.42 Alkylation (and protonation) of G-
residues at N-7 destabilizes the glycosidic bond, resulting in depurination.43 This reaction 
results in hydrolysis of the DNA base from the sugar-phosphate backbone, leaving you 
with what is termed an apurinic (Ap) site. (Scheme 14, 84)  Ap sites are common DNA 
lesions, and can undergo α,β-elimination reactions resulting in DNA single strand breaks 
(Ap*, 85) as they equilibrate between a closed ring hemiacetal and open chain aldehyde 
form (Scheme 14).43-45 We catalyzed this reaction via Schiff base formation with a hot 
piperidine treatment (1 M, 95 °C, 30 min) to quantitate the extent of DNA alkylation 
measure by DNA cleavage.  In our experiments, any bands that move faster than the 
unreacted 32P-labeled single-strand oligonucleotides in the gel correspond to cleavage 
products resulting from DNA alkylation and depurination.   
Scheme 14 
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Compounds 36 (lane 2) and 57 (lane 3) are used as controls serving as "dead" or 
"deactivated" N-mustards, for which one would not expect aziridinium ion formation.  
Compound 36 contains poor leaving groups to be used as an effective alkylating agent, 
and compound 57 contains the deactivating 4-N-oxide function.  We also incubated 
duplex A with a clinically used nitrogen mustard, chlorambucil.46 Chlorambucil is an 
aromatic N-mustard (86, lane 5) approved by the FDA to treat chronic lymphatic 
leukemia.  Incubations were done for 3 d to allow for adequate alkylation at 37 °C in 
HEPES buffer (50 mM, pH7) and NaCl (100 mM) with an N-mustard (1 mM, 10% 
DMF).  After ethanol precipitation to remove excess salts and reagents, the DNA was 
further treated with piperidine (1M) with heat to generate cleavage products resulting 
from DNA alkylation.  The reaction mixtures were analyzed by 20% PAGE, shown in 
Figure 7.  It should be noted that there are two possible G-alkylation sites in duplex A, 
marked by bands generated from Maxam-Gilbert G-sequencing (Figure 7, lane 6).   
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Figure 7 
 
Figure 7.  DNA alkylation by 56.  20% denaturing polyacrylamide gels of 32P labeled 
Duplex DNA treated with piperidine after incubation in the presence (or absence) of the 
indicated N-mustard.  Conditions: HEPES buffer (50 mM, pH 7), NaCl (100 mM), N-
mustard (1 mM unless specified otherwise), 10% DMF, 37 °C for 3 days followed by 
piperidine cleavage (1M, 95°C 30 min).  Panel A: duplexes A and B used to test for DNA 
alkylation of N-mustards.  Panel B:  Lane 1: duplex A (no mustard), Lane 2: duplex A 
with 36, Lane 3: duplex A with 57, Lane 4: duplex A with 56, Lane 5: duplex A with 86, 
Lane 6: G-sequencing of duplex A.  Panel C:  Lane 1: duplex B (no mustard), Lanes 2-4: 
duplex B with 56 at 0.25, 0.5, and 1mM concentrations, Lane 5: duplex B with 87 (0.25 
mM), Lane 6: duplex B with 86 (0.25 mM), and Lane 7: G-sequencing of duplex B. 
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 DNA cleavage is seen in varying amounts for DNA incubated with compounds 56 
and 86 (lanes 4 and 5), and importantly no significant cleavage above background is seen 
for duplex A incubated in control lanes 1,2, and 3.  While 56 with 86 observed 
comparable amounts of DNA alkylation, it is interesting to note the unequal distribution 
of G-alkylation seen between G1 and G2 (Figure 7B, duplex A).  This observation could 
result from selective alkylation of each dG-residue, most likely resulting from nearest 
neighbor effects of DNA sequences.  Kohn et al has shown previously that DNA 
alkylation of mechlorethamine (87) correlates with electrostatic potentials of guanines 
with different nearest neighboring bases.47 Mechlorethamine is a potent DNA alkylating 
and cross-linking agent no longer used in clinic because of its potent unselective 
reactivity.  Kohn's ranking is listed in Figure 8: where higher electrostatic potential 
correlates with higher propensity for DNA alkylation by 87.  It is important to note that 
this correlation is only observed for mechlorethamine (87).  To probe if this correlation 
applies to the benzotriazine mustard, we designed a sequence that contained several of 
these 5`-NGN local sequences (Figure 7, duplex B).  We incubated benzotriazine mustard 
56 at different concentrations as well as 86 and 87 with duplex B and analyzed the 
reaction products as before.  While mechlorethamine (87) seems to follow the ranking 
described in Kohn et al, it seems chlorambucil (86) and the mesylate-containing 
benzotriazine 56 did not..47 Interestingly, the dimesyl benzotriazine mustard (56) shows 
preferential alkylation at 5`-GT sequences, a sequence on the low end of the alkylation 
site ranking.  In fact, G2 in duplex A (Figure 7) fulfills that 5`-TGT sequence context and 
actually alkylates significantly more than the 5`-TGA sequence at G1 (which ranks higher 
on Kohn's list, Figure 8).47   
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Figure 8 
 CGC<AGC<TGC<CGT<TGT=AGT<AGA=TGA<CGA<GGC<CGG<GGT<AGG=TGG<GGA<GGG 
Figure 8.  Sequence preference of N-7 guanine alkylation by Mechlorethamine (87) with 
5`-CGC having the lowest alkylating potential and 5`-GGG having the highest. 
 
 This unique preference for 5-`TGA for the compounds tested is striking, and 
could possibly be explained simply by the difference in mustard structure between 56 and 
87.  It is possible that mesylate mustards alkylate differently than chloride mustards, but 
Kohn et al describe how the molecular structure of N-mustards could influence 
preferential alkylation on DNA.47 Potentially a similar interaction could be exhibited by 
the compound 56, where the benzotriazine ring system is interacting with the duplex 
through a Hoogstein base pair interaction.  We modeled this hypothesis with PyMOL by 
placing a chemdraw structure of compound 56 containing the aziridinium ion near a 5`-
GT duplex developed from PDB file 4OKL obtained from the online RCSB Protein 
Database (Figure 9).  From this we can clearly see the possibility for hydrogen bonding 
interaction between the exocyclic -NH2 and N-4 of compound 56 with the N-7 and 
exocyclic N-6-NH2 of the adenine residue.  It places the aziridinium ring close to the N-7 
of the guanine residue in the 5`-GT sequence shown, supporting our observations of the 
preferential alkylation of 5`-GT sequences by compound 56. 
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Figure 9 
 
Figure 9.  Molecular modeling generated with PyMOL displaying a Hoogstein base 
pairing of 56 with deoxyadenine, placing the N-mustard in close proximity with the N-7 
guanine. 
 
2.9  DNA "Cross-Linking" of Benzotriazine 1-Oxde N-Mustard 
 We were interested in testing the DNA cross-linking capabilities of our 
synthesized mustard 56.  It is known that alkyl nitrogen mustards (87) generate DNA 
interstrand cross-links at 5`-GNC sequences.48 This is thought to occur first by alkylation 
at a single dG-residue, causing a destabilization of the DNA duplex possibly from the 
positive charge placed on the N-7 of guanine (Scheme 14) resulting in a bend of the 
duplex toward the major groove.13-14, 48 This change in the duplex allows for adequate 
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"reach" of the mustard to the second guanine residue and is well characterized for 
mechlorethamine 85. 
 To test the potential for DNA cross-linking capabilities, compound 56 was 
incubated with 32P labeled oligonucleotide DNA duplexes that contained a 5`-GNC 
central sequence (Figure 10A, Duplex C).  Duplex C was treated with the 1-oxide (56), 
1,4-dioxide (57) mustards and diol 36 (0.25-1mM, 10% DMF) in HEPES buffer (50 mM 
pH 7) and NaCl (100 mM) at 37 °C for up to 3 d.  After ethanol precipitation and 
suspension in formamide buffer the reaction mixtures were analyzed with 20% 
denaturing PAGE (Figure 10B).  A slower moving band was only seen for compound 56 
(lane 3) for all concentrations tested.  This observation suggests a covalent attachment 
has been made between the two strands of the DNA duplex, as oligonucleotide strands 
not covalently bound would dissociate under denaturing PAGE conditions.  Moreover, 
the absence of slow moving band with respect to full length single-strand DNA (lane 1) 
was not seen for compound 36 (lane 2) or 57 (lane 4), consistent with the observations 
seen in earlier experiments (Figure 7B).  Finally, a faster moving band was seen for 
compound 56 without piperidine treatment, indicative of DNA alkylation followed by 
depurination (84) and spontaneous cleavage (85) as described before.  Incubation of 
duplex C under matching conditions with mechlorethamine (87) and chlorambucil (86) 
showed a similar slow moving band for both compounds in comparable crosslink yields 
(~1-2% yield) (Figure 10C, lanes 4 and 5).  This further confirms that the slow moving 
band seen in the gel is due to cross-linking of the two DNA strands.   
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Figure 10 
 
Figure 10.  DNA cross-linking by 56, 86, and 87.  20% denaturing polyacrylamide gels 
of 32P labeled duplex C incubated in the presence (or absence) of the indicated N-
mustard.  Conditions: HEPES buffer (50 mM, pH 7), NaCl (100 mM), N-mustard (1 mM 
unless specified otherwise), 10% DMF, 37 °C for 3 days.  Panel A: 32P labeled duplexes 
C used for DNA cross-link formation.  Panel B:  Lane 1: control (no mustard), Lane 2: 
36, Lane 3: 56, Lane 4: 57.  Panel C:  Lane 1: control (no mustard), Lanes 2: 56, Lane 3: 
57, Lane 4: 87, and Lane 5: 86. 
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single base-pair changes in order to effectively remove either guanine from the 5`-GNC 
sequence.  Thus 5`-32P-labeled duplexes D and E were prepared (Figure 11).  Using 
conditions described before, we incubated N-mustards with all three duplexes and 
analyzed by PAGE.  The slow moving band was seen for all duplexes incubated with 56 
(Figure 11, Lanes 3, 5, and 7).  This result is not consistent with previously described N-
mustard cross-linking.48 Removing either dG from the 5`-GNC base paired sequence 
should prevent DNA cross-linking resulting from alkylation of dG-residues on opposing 
strands of a duplex.  This means that the slow moving band seen in Figure 10 was not 
caused by traditional N-mustard cross-linking between two dG residues.   
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Figure 11 
 
Figure 11.  DNA cross-linking by 56 (lanes 2-7) and 87 (lanes 8-13) in duplexes C-E.  
20% denaturing polyacrylamide gels of 32P labeled duplexes C (lanes 1-3, 8, 9, and 14), 
D (lanes 4, 5, 10, 11, and 15) or E (lanes 6, 7, 12, 13, and 16) incubated in the presence 
of the indicated N-mustard (left) or after treatment of dilute HCl (right).  Conditions: 
(Left) HEPES buffer (50 mM, pH 7), NaCl (100 mM), and N-mustard (1 mM, 10% 
DMF) at 37 °C for 3 h (lanes 2, 4, 6, 8, 10, 12) or 3 d (lanes 3, 5, 7, 9, 11, 13).  (Right) 
HCl (10 mM), 37 °C for 3 h, then HEPES buffer (50 mM, pH 7) and NaCl (100 mM) at 
37 °C for 3 d. 
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 The Gates lab has published papers describing DNA interstrand cross-links 
involving the reaction of Ap-sites with opposing deoxyguanosine (dG) or deoxyadenine 
(dA) residues on the complimentary strand.49-51 We reported that dA-Ap derived cross-
links (Scheme 15) are formed in 5`-ApT sequences.51 This topic is discussed further in 
Chapters 3 and 4.  We hypothesize that cross-links resulting from the reaction between an 
abasic site and a dA residue.  This results from initial G-alkylation followed by 
depurination to yield Ap-sites (Scheme 16, a " b " h " i).  Scheme 15 describes a 
map of the all the possible reactions involved from N-mustard alkylation of dG residues 
of a duplex containing a central 5`-GNC sequence.  Previous groups have reported 
crosslink formation by mechlorethamine within hours,13, 48, 52 prompting us to believe our 
longer incubation times allow ample depurination from dG alkylation (d " e or f).  This 
would result in the absence of traditional N-mustard cross-links which may have formed 
early during the reaction. 
 To test this hypothesis, we incubated compound 56 and 87 with duplexes C, D, 
and E for a short 3-hour time period and analyzed by PAGE alongside incubations done 
for 3-days (Figure 11).  Results show a dark band formed from reaction of 
mechlorethamine 87 (lane 8) for 3 hours for duplex C, whereas the band disappeared for 
the longer incubation time (lane 9). Additionally this strong band was not seen for the 
same treatment of duplexes D or E, which were missing the central 5`GNC sequence 
required for N-mustard cross-linking.  This suggests that the dark band resulted from G-
to-G cross-linking at the 5`-GNC sequence (e, Scheme 16) in duplex C.  We also do not 
observe this product for 56, indicating that only mono-alkylation (b or c) occurs before 
depurination (h or k).  Additionally, this fast forming product (e) possessed a faster 
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mobility than the cross-linked product resulting from long incubation times (Lanes 3, 5, 
7, 9, 11, and 13).   
 We were able to generate the same slow forming band by incubation of duplexes 
C, D, and E in dilute acid for a short duration followed by the typical 3-day incubation 
after neutralization of the acid with buffer (Figure 11, lanes 14-16).  In the absence of 
alkylating agent, we have shown that depurination by acid-treatment can generate the 
same slow migrating, slow forming band.  This further supports our claim that these 
cross-links result from dG depurination, generating Ap-sites that form covalent 
attachments with the deoxyadenine residue (Scheme 15).  This discovery has not been 
previously characterized, though evidence of such species is present in literature, as gels 
presented sometimes contain bands unaccounted for in their experiments.52-53   
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Scheme 16 
 
Scheme 16.  Mechanistic route to all possible products resulting from N-mustard 
alkylated 5`GNC sequences. 
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 We confirmed this hypothesis by selectively incorporating Ap-sites (84) into our 
DNA duplex C template.  Using deoxyuracil containing DNA duplexes (F and G), we 
generated Ap-sites by treatment with uracil DNA glycosylase (UDG).  This selectively 
incorporated an Ap-site in place of the deoxyguanine residue in the 5`GT sequence for 
duplex C.49-51 Alkylation of duplex C or treatment with UDG generate Ap-sites capable 
of cross-linking with the opposing deoxyadenine residue in the resulting 5`-ApT 
sequence (Scheme 16).  After UDG treatment, the Ap-containing duplexes were 
incubated in HEPES (50 mM, pH 7) and NaCl (100 mM) to form the dA-Ap cross-link 
(Figure 12, lanes 4 and 5).  Analysis by 20% denaturing PAGE showed a slow moving 
band indicative of a cross-link formed for both duplexes F and G.  Only UDG treated 
duplex F (lane 5) provided the same cross-link product as N-mustard alkylated duplex C 
(Figure 12, lanes 2 and 3).  This means that an Ap-derived DNA interstrand cross-link 
has been formed at the indicated G1 (Figure 12, duplex C).  UDG treated duplex G 
generated a slightly faster moving cross-link band not seen after alkylation of duplex C.  
The difference in mobility resulted from attachment at a separate site.  We are confident 
to conclude that DNA alkylating agents in general have the potential to form Ap-derived 
cross-links in duplex DNA along with their drug-derived cross-links that have been well 
characterized. 
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Figure 12 
 
Figure 12.  Identification of abasic site derived cross-link.  20% denaturing 
polyacrylamide gels of 32P labeled duplex C (lanes 2 and 3) incubated in the presence of 
the indicated N-mustard and .32P labeled duplexes G (lane 4) and F (lane 5) after 
treatment with UDG.  Conditions: Lanes 2 and 3: HEPES buffer (50 mM, pH 7), NaCl 
(100 mM), N-mustard (1 mM), 10% DMF, 37 °C for 3 days.  Lane 4 : Uracil DNA 
Glycosylase (20 U/mL) in UDG buffer (1X) at 37 °C for 30 min, then enzyme removal 
and EtOH precipitation, finally HEPES buffer (50 mM, pH 7) and NaCl (100 mM) at 37 
°C for 3 d. 
 
2.10 Chapter 2 Summary 
 In the work described here, we explored whether the hypoxia-selective enzymatic 
reduction of 1,2,4-benzotriazine 1,4-dioxides to the corresponding 1,2,4-benzotriazine 1-
oxide metabolites can be exploited for the selective generation of DNA-alkylating species 
in the oxygen-poor cells found in oxygen-poor tumor tissue.  We found that the mono-N-
oxide mustard 56 is, in fact, 5-7 fold more reactive than the di-N-oxide mustard 57, as 
measured by the rates of hydrolysis.  Hammett sigma and sigma-minus values measured 
for the 3-amino-1,2,4-benzotriazine 1-oxide and 3-amino-1,2,4-benzotriazine 1,4-dioxide 
“substituents” in 56 and 57, respectively, confirmed that removal of the 4-oxide causes a 
1 2 3 4 5
32P-5`- AGT ATT AAT UTA GAC TAA AGC TAC -3`
3`- TCA TAA TTA CAT CTG ATT TCG ATG -5`
32P-5`- AGT ATT AAT ATA GAC TAA AGC TAC -3`
3`- TCA TAA TTA CAT CTU ATT TCG ATG -5`
32P-5`- AGT ATT AAT GTA GAC TAA AGC TAC -3`
3`- TCA TAA TTA CAT CTG ATT TCG ATG -5`
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C
G
1
1
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significant decrease in the electron-withdrawing effects exerted by the triazine ring 
system on substituents at the 6-postion of the benzo ring. 
In contrast to the tirapazamine analogs 56 and 57, the reactivities of the mustard 
units in the desamino series 65, 66, 67, and 68 were unaffected by the presence or 
absence of the 4-oxide group. It is interesting to consider why the reactivities of the 
mustard groups in the 3-desaminotirapazamine analogs are not “switched” by 
deoxygenation.  First, it may be noteworthy that the N=N(O) group in 56 and 57 is cross-
conjugated with the mustard nitrogen at the 6-position and the 3-amino group.  Thus, in 
these tirapazamine analogs, the 3-amino group may serve to mitigate the electron-
withdrawing properties of the N=N(O) group.  On the other hand, in analogs 65 and 66 
that lack the 3-amino group, the N=N(O) group may exert a strong electron-withdrawing 
(deactivating) effect on the mustard unit in the 6-position.  This would prevent altogether 
the participation of the nitrogen’s lone pair in aziridinium ion formation.  The hydrolysis 
rates of 67 and 68 are higher than those of 65 and 66, but are unaffected by the presence 
or absence of the 4-oxide unit.  Evidently, the N=N(O) unit attached "meta" to the 
mustard unit is less electron-withdrawing than in the "para" position.  In this regard, the 
N=N(O) group behaves in a manner similar to the nitro group.  The observation that the 
reactivity of mustard unit in the 7-position is not affected by the presence or absence of 
the 4-oxide unit, may be rationalized by the fact that the nitrogen lone pair of the mustard 
substituent is not “through conjugated” with the 4-oxide unit. 
 The DNA alkylating function of the nitrogen mustard unit in the mono-N-oxide 
56 is “switched on” compared to that the parent di-N-oxide 57.  Under our assay 
conditions, the activated analog 56 generates approximately 30-fold greater yields of 
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guanine alkylation than does 57.  The mono-N-oxide 56 displays a striking and 
unexpected preference for reaction at guanine residues located in 5’-GT sequences.  In 
contrast, typical mustards such as mechlorethamine (87) alkylate guanine residues with 
rather modest sequence selectivity (lane 5 of Figure 3C).47  We speculate that the 
sequence specificity of 56 may arise via formation of Hoogsteen-type hydrogen bonds 
between the 3-amino-1,2,4-benzotriazine ring system and the adenine residue in the 
target 5’-GT/5’-AC sequence.  Such an interaction could deliver the mustard unit of 56 to 
the N7-atom of the guanine residue in the major groove of the duplex (Figure 9).  A 
similar scenario has been proposed to explain other DNA alkylating sequence 
specificities.47  Finally, we provided evidence that the dialkylamino substituent on the 6-
position of the 3-amino-1,2,4-benzotriazine 1,4-dioxide ring in analogs 57 is compatible 
with the hypoxia-selective enzymatic deoxygenative metabolism required to deploy the 
activated mustards such as 56. 
 The compounds described here result from the combination of two well-studied 
anticancer drugs.  The agent tirapazamine generates oxidative DNA damage selectively 
under hypoxic conditions1-2, 54 and nitrogen mustards are clinically-used DNA-alkylating 
agents.46  This work provides evidence that the combination of these two anticancer drug 
motifs can yield new agents with the potential to deliver both DNA-alkylating and DNA-
oxidizing power selectively to hypoxic tumor tissue.  More generally, our results provide 
evidence that the 1,2,4-benzotriazine 1,4-dioxide unit can serve as an oxygen-sensing 
prodrug platform for the selective release or activation of various bioactive agents in 
hypoxic tissue. 
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2.11 Experimental 
Materials and Methods:  All chemicals were used as purchased from chemical 
suppliers.  The compound 5-fluoro-2-nitroaniline was purchased from Ak Scientific.  The 
compound 3-fluoro-4-nitrobenzoic acid was purchased from Oakwood Chemical.  All 
other reagents were purchased from Sigma Aldrich or Fisher Scientific.  For the kinetic 
measurements in the NMR, S500 select series NMR tubes from Norell were used.  NMR 
spectra were recorded at 500 MHz for 1H-NMR and 125 MHz for 13C-NMR.  
Oligonucleotides were obtained from Integrated DNA Technologies.  T4 polynucleotide 
kinase was purchased from New England Biolabs.  [γ-32P]-ATP (6000 Ci/mmol) was 
purchased from Perkin-Elmer. 
 
Measurement of Mustard Hydrolysis Rates Using 1H-NMR.  Solutions containing the 
1,2,4-benzotriazine nitrogen mustards (1 mM final concentration) were prepared in 
CD3CN/D2O (1:1) containing disodium maleate (5 mM) as an internal standard.  
Solutions were placed in a capped S500 Norell NMR tube and warmed in a 50 °C water 
bath.  At various time points the NMR tubes were removed from the heat bath, cooled in 
a room temperature water bath, and 1H-NMR spectra obtained.  Spectra were obtained 
using a Bruker DRX500 equipped with a 5 mm HCN cryo-probe.  The probe temperature 
was 298 K during the experiment.  Total number of scans acquired was 32 with repetition 
delay of 4.1719923 sec to ensure that the integration of resonances in various compounds 
in the mixture was quantitatively accurate.  The amount of unreacted mustard at each 
time point was assessed by measuring the integration of the -CH2- resonances of the 
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starting material in comparison to the -CH2- peak of the internal standard at each time 
point.  The pseudo-first-order rates for the hydrolysis reactions were obtained by a least 
squares fit to the equation ln A/A0 = –kt. 
 
Measurement of Mustard Hydrolysis Rates and Decomposition Products Using 
HPLC.  Solutions of the mono- or di-N-oxide mustards (250 µM) were prepared in 
sodium phosphate buffer (25 mM, pH 7) containing 2.5% DMF (v/v).  The samples were 
incubated at 50 °C for 24 h.  At various time-points aliquots were removed and frozen at 
–20 °C for later analysis.  The samples were then analyzed by HPLC using a Varian 
Microsorb-MV C-18 column (100 Å sphere size, 5 µm pore size, 250 mm length, and 2.6 
mm i.d. eluted with a gradient mobile phase composed of solvent A (0.5% AcOH in H2O) 
and solvent B (methanol).  For compound 56 a gradient of 25-50% B over 5 min, 
followed by 50-100% B over 5 min, followed by 100% B for 5 min was used.  The 
mobile phase was returned to 25% B over 5 min and held at 25% B for 5-min post-run.  
For compound 57 the mobile phase was held at 25% B for 5 min following injection, 
before increasing to 50% B over 5 min and holding at 50% B for 4 min.  The mobile 
phase was then returned to 25% B over 1 min and held at 25% B for 5-min post-run.  The 
products were detected by monitoring absorbance at 280 nm.  The identity of the major 
hydrolysis products was confirmed by comparison to authentic synthetic standards. 
 
pKa Determination of 80, 81, 82, and 83.  UV/Vis spectra were taken for compounds 
80, 81, 82, and 83 (50 µM) in solutions with pH values from 0-9 using HCl solutions and 
universal buffers prepared as in Britton and Robinson except containing 0.5% DMF 
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(v/v).[Britton, 1931 #3396]  Buffer pH was determined with via pH meter.  Absorbance 
values were measured at 256 nm and 282 nm for 80, 260 nm and 270 nm for 81, 345 nm 
and 400 nm for 82, and 360 nm and 400 nm for compound 83.  Changes in absorbance 
were plotted against pH and the pKa values were calculated from the midpoint for 
wavelengths monitored using least squares fitting.  To confirm that pKa values measured 
reflected protonation of the 6-COOH or 6-OH substituents, pH-absorbance measurements 
were performed with 1 and 4 to show that these control compounds displayed no 
significant changes in absorbance in the pH regions of interest. 
 
Examination of the DNA-Alkylating Properties of 56 and 57.  The 2’-
deoxyoligonucleotides (A and B, Figure 3) were labeled on the 5’-end with 32P and 
annealed to their complements using standard methods.42 DNA duplexes were mixed 
with the indicated compounds (1 mM final concentrations), incubated at 37 °C for 3 d in 
HEPES buffer (50 mM, pH 7) containing NaCl (100mM) and DMF  (10% v/v).  The 
DNA was then ethanol precipitated, washed with 80% ethanol twice, and briefly dried in 
a SpeedVac concentrator (5 min at room temperature).  The DNA was resuspended in 
piperidine (1 M in water) and heated to 95 °C for 30 min.  The piperidine solution was 
removed under vacuum in a SpeedVac concentrator and the resulting residue resuspended 
in formamide loading buffer,42 warmed briefly, and loaded onto a 20% denaturing 
polyacrylamide gel.  The gel was electrophoresed for 3 h at 1500 V to resolve the labeled 
DNA fragments.  The labeled DNA fragments in the gel were visualized using a Personal 
Molecular Imager (BIORAD) with Quantity One software (v.4.6.5). 
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Hypoxia-Selective Enzymatic Reduction of N-Mustard Containing 1,2,4-
Benzotriazine 1,4-Dioxides with Cytochrome P450.  For experiments involving in vitro 
hypoxic metabolism, sodium phosphate buffer and HPLC-grade water were degassed by 
bubbling argon through the solutions for at least 30 min inside a glove bag filled with 
argon gas.  Stock solutions of compounds 38 or 1 in DMF were degassed by three cycles 
of freeze-pump-thaw inside pyrex tubes.  The tubes were then torch-sealed, scored, and 
transferred to the Argon-purged glove bag.  The enzyme NADPH:cytochrome P450 
reductase was used without degassing.  The enzyme substrate NADPH was dissolved in 
degassed water inside the glove bag.  In the glove bag, solutions containing sodium 
phosphate buffer (25 mM, pH 7), the di-N-oxide 38 (100 µM), NADPH (500 µM), and 
NADPH:cytochrome P450 reductase (1 unit/mL) and DMF (1% v/v) were incubated in a 
sealed microcentrifuge tube at room temperature protected from light for 24 h.  A similar 
reaction was prepared using non-degassed solutions and incubated open to air as a 
aerobic control.  After 24 h, the solutions were passed through Millipore (YM-3) 
centrifuge filters (30 min, 7500 xg).  The filtrate was analyzed by HPLC using a Varian 
Microsorb-MV C-18 column (100 Å sphere size, 5 µm pore size, 250 mm length, and 2.6 
mm i.d.).  The column was eluted with a mobile phase composed of solvent A (0.5% 
AcOH in H2O) and solvent B (methanol).  The column was eluted at a flow rate of 0.9 
mL/min for 2 min at 10% B, a gradient of 10-50% B over 8 min, 50% B for 5 min, then 
returned to 10% B over 5 min and held at 10% B for 5 min post-run.  Compounds were 
detected by their absorbance at 420 nm and the identity of products 36 and 4 confirmed 
by comparison to authentic synthetic standards. 
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Preparation of 3-amino-6-(bis(2-(tosyloxy)ethyl)amino)-1,2,4-benzotriazine 1-oxide 
(54).  Compound 36 (126 mg, 0.5 mmol) was suspended in a biphasic mixture of THF (2 
mL) and NaOH (1.5 mL of a 4 M solution in water) and cooled in an ice bath.  To this 
orange biphasic mixture was added dropwise an ice cold solution of p-toluenesulfonyl 
chloride (200 mg, 2.2 equiv) in THF (3 mL).  The resulting suspension was stirred 
vigorously with cooling in an ice bath for 5 h.  During this time the mixture turned 
yellow.  The mixture was then poured into an ice-water slurry (10 mL) and stirred for 20 
min to give a bright yellow powder.  This solid was collected by vacuum filtration and 
washed with water and then diethyl ether, and then dried in a desiccator in to give 54 in 
74% yield.  1H NMR (500 MHz, DMSO-d6) δ 7.73 (d, J = 9.7 Hz, 1 H), 7.60 (d, J = 8.2 
Hz, 4 H), 7.24 (d, J = 8.1 Hz, 4 H), 6.97 (bs, 2 H), 6.63 (dd, J = 9.7, 2.5 Hz, 1 H), 6.15 (d, 
J = 7.5 Hz, 1 H), 4.13 (t, J = 5.1 Hz, 4H), 3.64 (t, J = 5.1 Hz, 4H), 2.25 (s, 6H); 13C NMR 
(125 MHz, DMSO-d6) δ 160.6, 151.4, 150,4, 144.9, 131.6, 129.9, 127.4, 122.5, 120.6, 
113.7, 101.1, 67.29, 48.9, 20.9; HRMS (ESI) m/z calculated for C25H27N5O7S2 (M+H+) 
574.1425, found 574.1433.  Crystals suitable for X-ray crystallography were prepared by 
slow evaporation of ethanol.  The crystal structure and crystallographic data for 54 are 
shown in Crystal Structure 2 and the crystallographic data table respectively 
 
Preparation of 3-amino-6-(bis(2-(tosyloxy)ethyl)amino)-1,2,4-benzotriazine 1,4-
dioxide (55).  Compound 54 (501 mg, 0.9 mmol) was dissolved in THF (100 mL) and 
cooled with stirring in an ice bath.  To this mixture was added m-CPBA (300 mg, ~1.5 
equiv, of a 77% maximum purity material) and the reaction stirred overnight in an ice 
bath.  An additional portion of m-CPBA was added and the reaction stirred at room 
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temperature for an additional 3 d.  The solution was concentrated under vacuum, poured 
into cold water, and the solid collected by vacuum filtration.  The material was purified 
by column chromatography on silica gel eluted with a gradient of 1-3% methanol in 
CH2Cl2 to give 55 as a yellow solid in 37% yield: 1H NMR (500 MHz, DMSO-d6) 7.84 
(bs, 2 H), 7.80 (d, J = 9.8 Hz, 1 H), 7.60 (d, J = 8.2 Hz, 4 H), 7.22 (d, J = 8.1 Hz, 4 H), 
6.86 (dd, J = 9.8, 2.7 Hz, 1 H), 6.65 (d, J = 2.7 Hz, 1 H), 4.19 (t, J = 5.0 Hz, 4 H), 3.67 (t, 
J = 4.9 Hz, 4 H), 2.24 (s, 6 H); 13C NMR (125 MHz, DMSO-d6) δ 151.6, 151.5, 144.9, 
139.3, 131.6, 129.9, 127.4, 123.0, 122.1, 115.6, 92.2, 67.1, 48.9, 20.8; HRMS (ESI) m/z 
calculated for C25H27N5O8S2 (M+H+) 590.1374, found 590.1371. 
 
Synthesis of 3-amino-6-(bis(2-((methylsulfonyl)oxy)ethyl)amino)-1,2,4-benzotriazine 
1-oxide (56).  Compound 36 (500 mg, 1.9 mmol) was dissolved in DMF (4.5 mL), 
followed by the addition of triethylamine (800 µL, 3 equiv) and cooling in an ice bath.  
Methanesulfonyl chloride (370 µL, 2.5 equiv) was added dropwise over 15 min as an ice 
cold solution in DMF (0.5 mL) and the resulting mixture stirred at room temperature for 
2.5 h.  The solution was poured into 30 mL of cold water with stirring and refrigerated 
overnight at 4 °C.  The resulting orange precipitate was collected by vacuum filtration.  
The solid was washed with water and diethyl ether and dried in a desiccator to give 56 in 
72% yield.  1H NMR (500 MHz, DMSO-d6) δ 7.94 (d, J = 9.6 Hz, 1 H), 7.06 (dd, J = 9.7, 
1.8 Hz, 2 H), 6.98 (bs, 2 H), 6.56 (s, 1 H), 4.38 (t, J = 5.3 Hz, 4 H), 3.90 (t, J = 5.2 Hz, 4 
H), 3.17 (s, 6 H); 13C NMR (125 MHz, DMSO-d6) δ 161.0, 152.8, 151.1, 123.1, 121.6, 
114.4, 101.6, 67.4, 49.7, 37.1; HRMS (ESI) m/z calculated for C13H19N5O7S2 (M+H+) 
422.0799, found 422.0800. 
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Preparation of 3-amino-6-(bis(2-((methylsulfonyl)oxy)ethyl)amino)-1,2,4-
benzotriazine 1,4-dioxide (57).  Compound 56 (70 mg, 0.17 mmol) and NaHCO3 (86 
mg, 6 equiv) were suspended in methanol (25 mL).  Oxone (245 mg, 1.2 equiv) was 
added, followed by water (10 mL).  The mixture was stirred at 50 °C under a N2 
atmosphere for 24 h.  Thin layer chromatographic analysis indicated that most of the 
reaction progress occurred within the first 5 h.  The reaction was cooled to room 
temperature and the white solid was removed by vacuum filtration and washed with 
CH2Cl2 (10 mL).  The filtrate was extracted with CH2Cl2 (2 x 125 mL), dried with 
anhydrous sodium sulfate, evaporated under reduced pressure, and the resulting residue 
subjected to column chromatography on silica gel eluted with a gradient of 1-5% 
methanol in CH2Cl2 to give 57 as an orange solid in 15% yield: 1H NMR (500 MHz, 
DMSO-d6) δ 8.01 (d, J = 9.8 Hz, 1 H), 7.82 (bs, 2 H), 7.28 (dd, J = 9.9, 2.7 Hz, 2 H), 
7.09 (d, J = 2.7, 1 H), 4.43 (t, J = 5.3 Hz, 4 H), 3.97 (t, J = 5.3 Hz, 4 H), 3.19 (s, 6 H); 13C 
NMR (125 MHz, DMSO-d6) δ 153.0, 151.9, 140.1, 123.7, 123.2, 116.2, 92.8, 67.2, 49.7, 
37.1; HRMS (ESI) m/z calculated for C13H19N5O8S2 (M+H+) 438.0748, found 438.0746. 
 
Synthesis of 3-amino-5-tosyl-6-(bis(2-hydroxyethyl)amino)-1,2,4-benzotriazine 1-
oxide (58).  Compound 38 (52 mg, 0.18 mmol) was suspended in a stirred solution of 
pyridine in an ice bath and tosyl chloride (172 mg, 5 equiv) was added.  The mixture was 
stirred in an ice bath for 12 h, poured into ice-cold water (20 mL) and extracted with 
methylene chloride (5 x 25 mL).  The combined organic fractions were washed with 
brine, dried over Na2SO4 and solvent by rotary evaporation.  Column chromatography on 
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silica gel eluted with 1% methanol in methylene chloride gave 58 in 10% yield: 1H NMR 
(500 MHz, DMSO-d6) δ 7.85 (d, J = 9.8 Hz, 1H), 7.75 (d, J = 8.2 Hz, 2H), 7.739 (d, J = 
8.2 Hz, 2H), 7.19 (d, J = 9.8 Hz, 1H), 6.94 (bs 2H), 4.65 (t, J = 5.1 Hz, 2H), 3.47-3.40 
(m, 8H); 13C NMR (125 MHz, DMSO-d6) δ 160.1, 148.2, 145.9, 145.5, 132.6, 129.5, 
128.8, 126.6, 123.6, 118.8, 118.7, 58.4, 54.3, 21.3; HRMS (ESI) m/z calculated for 
C7H5FN4O (M+H+) 436.1285, found 436.1293.  Crystals suitable for X-ray 
crystallography were prepared by vapor diffusion with ethyl acetate and hexane.  The 
crystal structure and crystallographic data for 58 are shown in Crystal Structure 1 and the 
crystallographic data table respectively. 
 
Synthesis of 3-amino-6-(bis(2-chloroethyl)amino)-1,2,4-benzotriazine 1-oxide (59). 
Compound 54 (200 mg, 0.35 mmol) and LiCl (148 mg, 10 eq.) were dissolved in DMF 
(1.5 mL) and heated at 110 °C for 2 h under a N2 atmosphere before being cooled on ice 
and mixed with ice cold water (20 mL).  The resulting yellow precipitate was collected 
by vacuum filtration, washed with water, diethyl ether, and then dried in a desiccator to 
give 59 in 94% yield.  1H NMR (500 MHz, DMSO-d6) δ 7.95 (d, J = 9.6 Hz, 1 H), 7.04 
(dd, 9.7, 2.6 Hz, 1 H), 6.98 (bs, 2 H), 6.48 (d, J = 2.5 Hz, 1 H), 3.89 (t, J = 6.6 Hz, 4 H), 
3.80 (t, J = 6.6 Hz, 4 H); 13C NMR (125 MHz, DMSO-d6) δ 160.7 (d, J = 253.90 Hz), 
152.1, 150.8, 122.8, 121.4, 113.9, 101.1, 51.8, 40.9; HRMS (ESI) m/z calculated for 
C11H13Cl2N5O (M+H+) 302.0570, found 302.0576.  
 
Synthesis of 3-amino-6-(bis(2-bromoethyl)amino)-1,2,4-benzotriazine 1-oxide (60). 
Compound 54 (310 mg, 0.54 mmol) and LiBr (464 mg, 10 eq.) were dissolved in DMF 
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(2.25 mL) and heated at 110 °C for 1.5 h under a N2 atmosphere before being cooled on 
ice and mixed with ice cold water (20 mL).  The resulting yellow precipitate was 
collected by vacuum filtration, washed with water, diethyl ether, and then dried in a 
desiccator to give 60 in 93% yield: 1H NMR (500 MHz, DMSO-d6) δ 7.95 (d, J = 9.7 Hz, 
1 H), 7.02-6.99 (comp, 3 H), 6.44 (d, J = 2.6 Hz, 1 H), 3.92 (t, J = 7.2 Hz, 4 H), 3.65 (t, J 
= 7.2 Hz, 4 H); 13C NMR (125 MHz, DMSO-d6) δ 160.7, 151.7, 150.8, 122.8, 121.5, 
113.8, 101.3, 51.6, 29.3; HRMS (ESI) m/z calculated for C7H5FN4O (M+H+) 302.0570, 
found 302.0576.  
 
Synthesis of 3-amino-6-(bis(2-iodoethyl)amino)-1,2,4-benzotriazine 1-oxide (61). 
Compound 54 (300 mg, 0.52 mmol) and potassium iodide (869 mg, 10 eq.) were 
dissolved in DMF (2.25 mL) and heated at 110 °C for 30 min under a N2 atmosphere 
before being cooled on ice and mixed with ice cold water (20 mL).  The resulting yellow 
precipitate was collected by vacuum filtration, washed with water, diethyl ether, and then 
dried in a dessicator to give 61 in 90% yield: 1H NMR (500 MHz, DMSO-d6) δ 7.96 (d, J 
= 9.6 Hz, 1 H), 7.00 (bs, 2H), 6.95 (dd, 9.7, 2.5 Hz, 1 H), 6.35 (d, J = 2.5 Hz, 1H), 3.87 
(t, J = 7.7 Hz, 4 H), 3.55 (t, J = 7.7 Hz, 4 H); 13C NMR (125 MHz, DMSO-d6) δ 160.7, 
151.2, 150.8, 122.8, 121.6, 113.6, 100.8, 52.4, 2.31; HRMS (ESI) m/z calculated for 
C7H5FN4O (M+H+) 302.0570, found 302.0576.  	  
Preparation of 3-amino-6-(bis(2-chloroethyl)amino)-1,2,4-benzotriazine 1,4-dioxide 
62.  Compound 59 (50 mg, 0.17 mmol) and NaHCO3 (42 mg, 3 eq) were suspended in 
methanol (25 mL).  Oxone (122 mg, 1.2 eq) was added, followed by water (10 mL).  The 
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mixture was stirred at 50 °C under a N2 atmosphere.  The reaction mixture was filtered 
while still warm and the solids washed with methanol (5 mL).  The filtrate was cooled to 
room temperature, diluted with water (50 mL), and extracted methylene chloride (3 x 100 
mL).  Column chromatography on silica gel eluted with a gradient of 2-6% methanol in 
CH2Cl2 gave 62 as an orange solid in 30% yield: 1H NMR (500 MHz, DMSO-d6) δ 8.01 
(d, J = 9.8, Hz, 1 H), 7.81 (bs 2 H), 7.27 (dd, J = 9.8, 2.7 Hz, 1 H), 7.05 (d, J = 2.7 Hz, 1 
H), 3.96 (t, J = 6.7 Hz, 4 H), 3.85 (t J = 6.7 Hz, 4 H); 13C NMR (125 MHz, DMSO-d6) δ 
152.3, 151.5, 139.7, 123.4, 123.0, 115.8, 92.2; HRMS (ESI) m/z calculated for 
C11H13Cl2N5O2 (M+H+) 318.0519, found 318.0519. 
 
Synthesis of compounds 6-(bis(2-(tosyloxy)ethyl)amino))-1,2,4-benzotriazine 1-oxide 
(65) and 7-(bis(2-(tosyloxy)ethyl)amino)benzo[e][1,2,4]triazine 1-oxide (67):  
Compound 28 (200 mg) was dissolved in a biphasic mixture of THF (9 mL) and NaOH 
(2.4 mL of a 4 M solution in water) and cooled in an ice bath.  To this orange biphasic 
mixture was added dropwise an ice cold solution of p-toluenesulfonyl chloride (455 mg, 
3 equiv) in THF (1.5 mL).  The resulting mixture was stirred vigorously in an ice bath for 
1.5 h.  During this time the mixture turned yellow.  The mixture was then poured into an 
ice-water slurry (100 mL) and stirred for 30 min to give a yellow precipitate.  The solid 
was collected by vacuum filtration, then washed with water, diethyl ether, and dried in a 
desiccator to give 65 in 95% yield: 1H NMR (500 MHz, DMSO-d6) δ 8.87 (s, 1 H), 7.96 
(d, J = 9.2 Hz, 1 H), 7.57 (d, J = 8.3 Hz, 4 H), 7.19 (d, J = 8.0, 4 H), 7.14 (dd, J = 9.8, 2.6 
Hz, 1 H), 6.64 (d, J = 2.7 Hz, 1 H), 4.18 (t, J = 5.1 Hz, 4 H), 3.71 (t, J = 5.1 Hz, 4 H), 
2.20 (s, 6 H); 13C NMR (500 MHz, DMSO-d6) δ 154.8, 152.1, 149.2, 145.2, 131.9, 130.2, 
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127.8, 127.4, 120.7, 120.3, 103.7, 67.6, 49.3, 21.2; HRMS (ESI) m/z calculated for 
C25H26N4O7S2 (M+H+) 559.1316, found 559.1320.  Compound 67 was prepared in 80% 
yield from 33 using the same conditions: 1H NMR (500 MHz, DMSO-d6) δ 8.89 (s, 1 H), 
7.73 (d, J = 9.4 Hz, 1 H), 7.56 (d, J = 8.2 Hz, 4 H), 7.44 (dd, J = 9.5, 2.8, 1 H), 7.16 (d, J 
= 8.1 Hz, 4 H), 6.86 (d, J = 2.8 Hz, 1 H), 4.19 (t, J = 5.0 Hz, 4 H), 3.69 (t, J = 5.0 Hz, 4 
H), 2.17 (s, 6 H); 13C NMR (125 MHz, DMSO-d6) δ 150.2, 148.6, 145.2, 140.7, 135.8, 
132.0, 130.1, 129.5, 127.7, 125.0, 94.8, 67.5, 49.1, 21.2; HRMS (ESI) m/z calculated for 
C25H26N4O7S2 (M+H+) 559.1316, found 559.1317. 
 
Preparation of 6-(bis(2-(tosyloxy)ethyl)amino))-1,2,4-benzotriazine 1,4-dioxide (66):  
Compound 65 (20 mg, 0.04 mmol) and NaHCO3 (30 mg, 10 equiv) were suspended in 
methanol (6.25 mL).  Oxone (245 mg, 5 equiv) was added, followed by water (2.5 mL) 
and the mixture was stirred at 50 °C under an atmosphere of nitrogen gas for 16 h.  The 
reaction was cooled to room temperature and extracted with methylene chloride (5 x 10 
mL).  The organic layers were combined, washed with brine, dried over anhydrous 
sodium sulfate.  Column chromatography on silica gel eluted with 1% MeOH in CH2Cl2 
gave compound 66 in 10% yield with 50% recovery of starting materials: 1H NMR (500 
MHz, DMSO-d6) δ 9.15 (s, 1 H), 7.96 (d, J = 9.8 Hz, 1 H), 7.57 (d, J = 8.2 Hz, 4 H), 
7.25-7.18 (m, 5 H), 6.84 (d, J = 2.8 Hz, 1 H), 4.21 (t, J = 5.0 Hz, 4 H), 3.70 (t, J = 4.9 Hz, 
4 H), 2.25 (s, 6 H); 13C NMR (125 MHz, DMSO-d6) δ 152.0, 145.3, 142.5, 140.7, 132.0, 
130.2, 127.8, 127.3, 122.4, 120.9, 84.6, 67.4, 49.1, 21.2; HRMS (ESI) m/z calculated for 
C25H26N4O8S2 (M+H+) 575.1265, found 575.1263. 
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Synthesis of 7-(bis(2-(tosyloxy)ethyl)amino)-1,2,4-benzotriazine 1,4-dioxide (68):  A 
procedure adapted from Pchalek and Hay was followed.55  Trifluoroacetic anhydride (300 
µL) and methylene chloride (1.5 mL) were mixed with stirring in an ice bath and 70% 
H2O2 (105 µL) was added dropwise.  The mixture was stirred for 10 min and then 
allowed to warm to room temperature.  This solution was cooled  in an ice bath and 
slowly added to an ice cold solution of 67 (110 mg, 0.2 mmol) in methylene chloride (10 
mL).  The reaction was stirred in an ice bath for 30 min before being diluted with 
methylene chloride (100 mL) and washed with cold water, cold NaHCO3 (saturated), and 
then brine.  The organic layer was dried over anhydrous sodium sulfate and column 
chromatography on silica gel eluted with 0.5% MeOH in CH2Cl2 gave 68 in 1% yield: 1H 
NMR (500 MHz, DMSO-d6) δ 9.06 (s, 1 H), 7.96 (d, J = 9.7 Hz, 1 H), 7.57 (d, J = 8.3 
Hz, 4 H), 7.41 (dd, J = 9.7, 2.7, 1 H), 7.22 (d, J = 8.0 Hz, 4 H), 6.85 (d, J = 2.6 Hz, 1 H), 
4.19 (t, J = 5.0 Hz, 4 H), 3.67 (t, J = 4.9 Hz, 4 H), 2.25 (s, 6 H); 13C NMR (125 MHz, 
DMSO-d6) δ 149.3, 144.9, 138.8, 135.6, 131.8, 131.7, 129.9, 127.4, 123.2, 119.5, 96.1, 
67.1, 48.6, 20.9; HRMS (ESI) m/z calculated for C25H26N4O8S2 (M+H+) 575.1265, found 
575.1275. 
 
Synthesis of 3-((4-(1-hydroxyethyl)phenyl)amino)-1,2,4-benzotriazine 1-oxide (70):  
A seal tube was charged with compound 5 (1.03 g, 5.6 mmol), 4-1`-hydroxyethylaniline 
(853 mg, 1.2 equiv), K3PO4 (4.8 g, 4 equiv), Pd(OAc)2 (63 mg, 5%), SPhos (230 mg, 
10%), tetrahydrofuran (10 mL) and Toluene (50 mL).  The mixture was degassed by 
bubbling N2 through the suspension for 20 min then sealed.  The reaction was stirred at 
100 °C for 14 h (overnight) resulting in a bright orange precipitate.  The reaction was 
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cooled to room temperature and diluted with tetrahydrofuran (40 mL) before being 
filtered through celite.  The celite was washed with a minimal amount of tetrahydrofuran 
and the filtrate was concentrated by rotary evaporation.  The mixture was diluted with 
ethyl acetate (200 mL) and washed with 1M HCl (3x 100 mL, aq), then bicarbonate 
solution and brine. Purification was done by column chromatography on silica gel with 
0.5% MeOH in CH2Cl2 to afford 70 in 65% yield: 1H NMR (500 MHz, DMSO-d6) δ 
10.19 (s, 1 H), 8.22 (d, J = 8.5 Hz, 1 H), 7.87 (ddd, J = 8.2, 7.2, 1.0 Hz, 1 H), 7.77 (d, J = 
8.5 Hz, 2 H), 7.73 (d, J = 8.4 Hz, 1 H), 7.46 (appt, J = 81, 7.4 Hz, 1 H), 7.32 (d, J = 8.5 
Hz, 2 H), 5.08 (d, J = 4.2 Hz, 1 H), 4.70 (dt, J = 6.3, 6.2 Hz, 1 H), 1.33 (appd, J = 6.4 Hz, 
3 H); 13C NMR (125 MHz, DMSO-d6) δ 156.5, 147.7, 141.9, 137.7, 136.0, 130.9, 126.6, 
125.8, 125.6, 119.9, 119.3, 67.8, 25.9; HRMS (ESI) m/z calculated for C15H14N4O2 
(M+H+) 283.1117, found 283.1194. 
 
Synthesis of 3-((4-(1-acetoxyethyl)phenyl)amino)-1,2,4-benzotriazine 1-oxide (71):  
Compound 70 (116 mg, 0.4 mmol) was dissolved in tetrahydrofuran (2 mL) and acetic 
acid (2 mL).  Sodium acetate (11 mg, 10% equiv) was added and then the mixture was 
stirred under N2 atmosphere at 50 °C for 8 h.  The reaction was cooled to room 
temperature and poured into an ice-water slurry (40 mL) and stirred until the ice melts.  
The resulting precipitate was collected by vacuum filtration, washed with a minimal 
amount of cold water, and dried under vacuum.  Compound 76 was collected as an 
orange solid in 70% yield: 1H NMR (500 MHz, DMSO-d6) δ 10.27 (s, 1 H), 8.22 (d, J = 
7.8 Hz, 1 H), 7.88 (ddd, J = 8.3, 7.2, 1.2 Hz, 1 H), 7.83 (d, J = 8.6 Hz, 2 H), 7.74 (d, J = 
8.4 Hz, 1 H), 7.48 (appt, J = 8.3, 1.0 Hz, 1 H), 7.36 (d, J = 8.6 Hz, 2 H), 7.78 (q, J = 6.6 
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Hz, 1 H), 2.04 (s, J = 6.7 Hz, 3 H), 1.48 (d, J = 6.6 Hz, 3 H); 13C NMR (125 MHz, 
DMSO-d6) δ 169.7, 156.4, 147.6, 138.8, 136.1, 135.9, 131.0, 126.6, 126.5, 126.0, 119.9, 
119.4, 71.4, 21.9, 21.0; HRMS (ESI) m/z calculated for C17H16N4O3 (M+H+) 325.1295, 
found 325.1299. 
 
Synthesis of 3-((4-(1-acetoxyethyl)phenyl)amino)-1,2,4-benzotriazine 1,4-dioxide 
(72):  Compound 71 (43 mg, 0.13 mmol) was dissolved in Acetone (1.5 mL) cooled to 0 
°C.  To this solution was added dimethyl dioxirane (4 mL) (prepared as in Murray and 
Singh)56.  The reaction was stirred in a cold room (4 °C) overnight and solvent removed 
by rotary evaporation.  The crude solid was purified by column chromatography on silica 
gel with 0.5% MeOH in CH2Cl2 to give 72 in 6% yield: 1HNMR (500 MHz, DMSO-d6) δ 
10.25 (bs, 1 H), 8.27-8.24 (comp, 2 H), 8.00 (appt, J = 7.5, 7.4 Hz, 1 H), 7.67-7.62 
(comp, 3 H), 7.39 (d, J = 8.4 Hz, 2 H), 5.79 (q, J = 6.5 Hz, 1 H), 2.05 (s, 3 H), 1.49 (d, J 
= 6.6 Hz, 3 H); 13C NMR (125 MHz, DMSO-d6) δ 169.7, 147.8, 138.4, 137.8, 136.4, 
135.6, 131.2, 127.9, 126.4, 122.2, 121.2, 117.4, 71.3, 22.0, 21.0; HRMS (ESI) m/z 
calculated for C17H16N4O4 (M+H+) 341.1245, found 341.1252. 
 
Synthesis of 3-amino-6-chloro-1,2,4-benzotriazine 1-oxide (73):    (adopted from Hay, 
M.P. et al.)34  5-chloro-2-nitroaniline (5.6 g, 32 mmol) and cyanamide (15 g, 10 equiv) 
were heated together at 100 °C for 15 minutes until a melt is achieved.  The mixture was 
cooled slightly and conc. HCl (20 mL) was added dropwise while stirring over a 30-
minute period.  (CAUTION: A violent exothermic reaction may occur during or after 
HCl addition).  After addition of acid was complete stirring was continued for an 
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additional 10 minutes, adding more cyanamide to help stir if needed.  The mixture was 
heated to 100°C for 3 hours and cooled to room temperature with continued stirring.  
NaOH (100mL, 8 M) was added and the mixture stirred vigorously at 100°C for 2 h.  The 
orange suspension was cooled to room temperature, poured into 500 mL H2O, and 
filtered.  The resulting precipitant was washed thoroughly with H2O and Et2O and dried 
in the oven overnight.  Compound 73 was obtained as a bright yellow powder in 45% 
yield: 1H NMR (500 MHz, DMSO-d6) δ 8.13 (d, J = 9.4 Hz, 1 H), 7.60 (d, J = 2.1 Hz, 1 
H), 7.53 (bs, 2 H), 7.33 (dd, J = 9.1, 2.1 Hz, 1 H); 13C NMR (125 MHz, DMSO-d6) δ 
160.8, 149.5, 140.4, 128.9, 124.8, 124.5, 122.1; HRMS (ESI) m/z calculated for 
C7H5ClN4O (M+H+) 197.0225, found 197.0228. 
 
Synthesis of 6-chloro-1,2,4-benzotriazine 1-oxide (74): Using the general procedure of 
Boyd et al.29 73 (1.07 g, 5 mmol) was dissolved in anhydrous DMF (50 mL) and the 
mixture degassed by bubbling argon through the solution for 30 min.  To this mixture t-
butyl nitrite (3.5 mL, 5 equiv, 90%) was added by syringe and the mixture heated in a 60 
°C oil bath for 2 h under an atmosphere of argon gas.  The reaction was cooled and the 
solvent removed under vacuum.  The resulting dark residue was taken up in ethyl acetate 
(300 mL) and mixed with brine (150 mL) and stirred vigorously.  The phases were 
allowed to separate and the organic layer was washed with brine (2 x 150 mL), dried over 
anhydrous sodium sulfate, and solvent removed by rotary evaporation.  Column 
chromatography on silica gel eluted with a gradient of 0-10% ethyl acetate in CH2Cl2 
gave 74 in 50% yield: 1H NMR (500 MHz, DMSO-d6) δ 9.21 (s, 1H), 8.41 (d, J = 9.2 
Hz, 1 H), 8.27 (d, J = 2.2 Hz, 1 H), 7.92 (dd, J = 9.2, 2.2 Hz, 2 H); 13C NMR (125 MHz, 
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DMSO-d6) δ 155.2, 147.7, 140.9, 134.2, 131.9, 127.7, 122.0; HRMS (ESI) m/z calculated 
for C7H4ClN3O1 181.0043, found 181.0043 
 
Synthesis of 6-((4-(1-hydroxyethyl)phenyl)amino)-1,2,4-benzotriazine 1-oxide (75):  
A seal tube was charged with compound 74 (379 mg, 2.1 mmol), 4-1`-
hydroxyethylaniline (340 mg, 1.2 equiv), K3PO4 (1.75 g, 4 equiv), Pd(OAc)2 (23 mg, 
5%), SPhos (85 mg, 10%), Toluene (28 mL), and tetrahydrofuran (4.5 mL).  The mixture 
was degassed by bubbling N2 through the suspension for 30 min then sealed.  The 
reaction was stirred at 100 °C for 14 h (overnight) resulting in a bright orange precipitate.  
The reaction was cooled to room temperature and diluted with ethyl acetate (300 mL) 
before being filtered through celite.  The celite was washed with a minimal amount of 
ethyl acetate and filtrate collected.  The solvent was removed by rotary evaporation and 
Purification was done by column chromatography on silica gel with 1-2% MeOH in 
CH2Cl2 to afford 75 in 85% yield: 1H NMR (500 MHz, DMSO-d6) δ 9.50 (s, 1 H), 8.83 
(s, 1 H), 8.21 (d, J = 9.5 Hz, 1 H), 7.45 (dd, J = 9.5, 2.5 Hz, 1 H), 7.41 (d, J = 8.3 Hz, 2 
H), 7.28 (d, J = 8.4 Hz, 2 H), 7.11 (d, J = 2.4 Hz, 1 H), 5.16 (d, J = 4.3 Hz, 1 H), 4.73 
(dq, J = 6.4, 6.3 Hz, 1 H), 1.35 (d, J = 6.5 Hz, 3 H); 13C NMR (125 MHz, DMSO-d6) δ 
155.0, 151.8, 150.2, 144.0, 138.2, 128.7, 127.0, 123.7, 121.8, 121.7, 103.1, 68.1, 26.2; 
HRMS (ESI) m/z calculated for C15H14N4O2 (M+H+) 283.1119, found 283.1187. 
 
Synthesis of 6-((4-(1-acetoxyethyl)phenyl)amino)-1,2,4-benzotriazine 1-oxide (76):  
Compound 75 (435 mg, 1.5 mmol) was dissolved in tetrahydrofuran (8 mL) and acetic 
acid (8 mL).  Sodium acetate (13 mg, 10% equiv) was added and then the mixture was 
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stirred under N2 atmosphere at 60 °C for 6 h.  The reaction was cooled to room 
temperature and diluted with CH2Cl2 (300 mL).  After the organic layer was washed with 
saturated sodium bicarbonate and then brine, the solution was dried over Na2SO4 and 
concentrated by rotary evaporation.  Refrigeration overnight precipitated the product that 
was collected by vacuum filtration, washed with a minimal amount of diethyl ether, and 
dried under vacuum.  Compound 76 was collected as an orange solid in 70% yield.  If 
further purification is needed, it was done using column chromatography on silica gel 
with 20% ethyl acetate in CH2Cl2: 1H NMR (500 MHz, DMSO-d6) δ 9.57 (s, 1 H), 8.85 
(s, 1 H), 8.22 (d, J = 9.5 Hz, 1 H), 7.47 (dd, J = 9.5, 2.4 Hz, 2 H), 7.43 (d, J = 8.4 Hz, 1 
H), 7.32 (d, J = 8.5 Hz, 2 H), 7.18 (d, J = 2.4 Hz, 1 H), 5.81 (q, J = 6.6 Hz, 1 H), 2.05 (s, 
3 H), 1.49 (d, J = 6.6 Hz, 3 H); 13C NMR (125 MHz, DMSO-d6) δ 169.7, 154.7, 150.9, 
149.7, 139.1, 137.3, 128.5, 127.4, 123.4, 121.5, 121.1, 103.3, 71.3, 21.9, 21.0; HRMS 
(ESI) m/z calculated for C17H16N4O3 (M+H+) 325.1295, found 325.1299. 
 
Synthesis of 6-((4-(1-acetoxyethyl)phenyl)amino)-1,2,4-benzotriazine 1,4-dioxide 
(77):  Compound 76 (17 mg, 0.05 mmol) was dissolved in CH2Cl2 (3 mL) and cooled to 0 
°C.  To this mixture, a cold solution of MCPBA (17mg, 1.5 equiv) in CH2Cl2 was added 
and the resulting mixture was stirred at room temperature for 3 d.  The reaction was 
diluted with CH2Cl2 (30 mL) and washed with cold NH4OH (3x 20 mL) followed by 
brine.  After drying with Na2SO4, purification was done using column chromotography 
on silica gel with 1-2% MeOH in CH2Cl2 to yield 77 in 6% yield with 23% recovery of 
starting material (76): 1H NMR (500 MHz, DMSO-d6) δ 9.82 (s, 1 H), 9.09 (s, 1 H), 8.19 
(d, J = 9.5 Hz, 1 H), 7.52 (dd, J = 9.4, 2.5 Hz, 1 H), 7.49 (d, J = 2.4 Hz, 1 H), 7.47 (d, J = 
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8.4 Hz, 2 H), 7.32 (d, J = 8.4 Hz, 2 H), 5.82 (q, J = 6.6 Hz, 1 H), 2.06 (s, 3 H), 1.50 (d, J 
= 6.6 Hz, 3 H); 13C NMR (125 MHz, DMSO-d6) δ 169.7, 150.9, 142.3, 141.4, 138.7, 
138.0, 128.4, 127.5, 123.7, 123.2, 121.5, 94.3, 71.2, 21.9, 21.0; HRMS (ESI) m/z 
calculated for C17H16N4O3 (M+Na+) 363.1069, found 363.1072. 
 
Synthesis of 3-amino-6-morpholino-1,2,4-benzotriazine 1-oxide (79):  Compound 19 
(503 mg, 2.8 mmol) and morpholine (0.72 mL, 3 equiv) were suspended in 1-methyl-2-
pyrrolidinone (4 mL) and heated to 100 °C overnight.  The resulting orange suspension 
was cooled to room temperature and diluted with water (40 mL) and filtered.  The 
precipitate was washed with water and diethyl ether and then dried in an oven overnight 
at 70 ˚C.  The orange-yellow powder was collected by vacuum filtration in 94% yield: 
mp 245-250 °C dec; 1H NMR (500 MHz, DMSO-d6) δ 7.94 (d, J = 9.6 Hz, 1 H), 7.16 
(dd, J = 9.7, 2.5 Hz, 2 H), 7.00 (bs, 2 H), 6.60 (d, J = 2.5, 1 H), 3.73 (t, J = 4.7 Hz, 4 H), 
3.38 (t, J = 4.8 Hz, 4 H); 13C NMR (125 MHz, DMSO-d6) δ 160.7, 155.3, 150.8, 123.3, 
120.9, 115.2, 103.0, 65.8, 46.8; HRMS (ESI) m/z calculated for C11H15N5O3 (M+H+) 
248.1142, found 248.1142 
 
Synthesis of 3-amino-6-carboxy-1,2,4-benzotriazine 1-oxide (80):  Compound 80 was 
prepared using a modified method of Suzuki and Kawakami.38	  NaOH (528 mg, 10 equiv) 
was dissolved in hot ethanol (30 mL), guanidine hydrochloride (1.2 g, 10 equiv) added, 
and the resulting mixture stirred for 20 min.  The reaction was cooled to room 
temperature and filtered to remove the white precipitate.  To the filtrate THF (20 mL) and 
3-fluoro-4-nitrobenzoic acid (230 mg, 1.2 mmol) were added and the resulting 
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heterogeneous mixture refluxed for 4 h.  Potassium tert-butoxide (150 mg, 10 equiv) 
were added and the mixture stirred at reflux for an additional 2 h.  After the reaction was 
complete, the THF was decanted off and water (60 mL) added with vigorous stirring.  
Acidification with HCl (1 M) resulted in precipitation of a yellow solid that was collected 
by vacuum filtration and washed with dilute HCl, followed by minimal amounts of water 
and diethyl ether.  The solid was then dried in an oven overnight at 70 ˚C to give 80 in 
95% yield: mp >280 °C; 1H NMR (500 MHz, DMSO-d6) δ 13.63 (bs, 1 H), 8.20 (d, J = 
8.9 Hz, 1 H), 7.98 (d, J = 1.5 Hz, 1 H), 7.74 (dd, J = 2 Hz, 1.6 Hz, 1 H), 7.52 (s, 1 H); 13C 
NMR (125 MHz, DMSO-d6) δ 166.1, 160.6, 148.6, 137.1, 131.7, 127.4, 123.6, 120.7; 
HRMS (ESI) m/z calculated for C8H6N4O3 (M+H+) 207.0513, found 207.0519. 
 
Synthesis of 3-amino-6-carboxy-1,2,4-benzotriazine 1,4-dioxide (81):  Compound 80 
(40 mg, 0.2 mmol) was suspended in trifluoroacetic acid (1 mL) and H2O2 (70%, 0.8 mL) 
and the mixture was stirred at 50 °C for 48 h.  After the reaction was complete (as judged 
by thin layer chromatography), the solvent was removed by rotary evaporation under 
reduced pressure and the resulting residue triturated with ethanol (5 mL).  The resulting 
suspension was chilled and the red precipitate collected by vacuum filtration.  The solid 
was washed with cold ethanol and dried under vacuum to provide compound 80 in 36% 
isolated yield: mp 260 °C dec; 1H NMR (500 MHz, DMSO-d6) δ 13.84 (bs, 1 H), 8.61 (s, 
1 H), 8.28 (d, J = 8.8 Hz, 1 H), 8.19 (bs, 2 H), 7.94 (d, J = 8.7 Hz, 1 H); 13C NMR (125 
MHz, DMSO-d6) δ 165.6, 151.8, 138.3, 136.3, 132.1, 125.8, 122.2, 118.8; HRMS (ESI) 
m/z calculated for C8H6N4O4 (M+H+) 223.0462, found 223.0467. 
 
	  
Hypoxia Selective DNA Alkylating Analogs of Tirapazamine                               Chapter 2 
	   162	  
Synthesis of 3-amino-6-hydroxy-1,2,4-benzotriazine 1-oxide (82):  Using a procedure 
adapted from Cantrell et al.41 compound 19 (504 mg, 2.8 mmol) was suspended in 1-
methyl-2-pyrrolidinone (4 mL) and an aqueous solution of NaOH (400 mg in 20 mL, 4 
eq) was added.  To this mixture, a solution of H2O2 (30%, 480 µL, 2 equiv) was added 
and the mixture stirred for 4 h at 60 °C.  The reaction was cooled to room temperature 
and filtered to remove undissolved starting material.  Na2S2O3 (700 mg) was added to 
decompose any remaining H2O2.  The resulting solution was acidified with HCl (1 M), 
and the resulting precipitate collected by vacuum filtration.  The solid was then washed 
with water and diethyl ether and dried in an oven overnight at 70 ˚C to give 82 in 50% 
yield: mp 210 °C dec; 1H NMR (500 MHz, DMSO-d6) δ 10.94 (bs, 1 H), 8.00 (d, J = 9.3 
Hz, 1 H), 7.13 (bs, 2 H), 6.84 (dd, J = 9.3 Hz, 1.9 Hz, 1 H), and 6.68 (d, J = 1.9 Hz, 1 H); 
13C NMR (125 MHz, DMSO-d6) δ 163.8, 160.6, 151.1, 124.4, 122.0, 117.2, 106.1; 
HRMS (ESI) m/z calculated for C7H6N4O2 (M+H+) 179.0564, found 179.0566. 	  
Synthesis of 3-amino-6-hydroxy-1,2,4-benzotriazine 1,4-dioxide (83):  Compound 37 
(160 mg, 0.83 mmol) was suspended in 1-methyl-2-pyrrolidinone  (1.2 mL) and NaOH 
(120 mg, 4 equiv, in 6 mL of water) was added.  To this mixture was added H2O2 (30%, 
144 µL, 2 equiv), followed by stirring for 1.5 h at 50 °C.  The reaction was cooled to 
room temperature and acidified with HCl (1 M).  The resulting precipitate was collected 
by vacuum filtration and washed with water and diethyl ether.  Drying under vacuum 
gave 83 as a dark red solid in 51% yield: mp 202 °C dec; 1H NMR (500 MHz, DMSO-d6) 
δ 11.51 (bs, 1 H), 8.08 (d, J = 9.5 Hz, 1H), 7.92 (bs, 2 H), 7.31 (d, J = 2.5 Hz, 1 H), and 
7.04 (dd, J = 9.5 Hz, 2.5 Hz, 1 H); 13C NMR (125 MHz, DMSO-d6) δ 164.1, 151.5, 
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140.1, 125.1, 123.7, 119.2, 98.0; HRMS (ESI) m/z calculated for C7H6N4O3 (M+H+) 
195.0513, found 195.0516. 
 
Crystal Structures 
Crystal Structure 1 
 
 
Crystal Structure 2 
 
Crystal Structure 2.  X-ray crystal structure of compound 54 (right).  Different 
orientations (left) show possibility of intramolecular hydrophobic interactions between 
the tosylgroup and the benzoring. 
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Crystallographic Data Crystal Structure 1 Crystal Structure 2 
Empirical formula C18 H21 N5 O6 S C25 H27 N5 O7 S2 
Formula weight 435.46 573.64 
Temperature, (K) 173(2) 173(2) 
W. length, (Å) 0.71073 0.71073 
Crystal system Monoclinic Monoclinic 
Space group P 21/c P 21/c 
a, (Å) 11.8137(17) 13.310(3) 
b, (Å) 7.0470(10) 8.7186(17) 
c, (Å) 24.199(4) 23.074(5) 
α, (deg) 90 90 
β, (deg) 101.033 105 
γ, (deg) 90 90 
Volume, (Å3) 1977.4(5) 2576.0(9) 
Z/calculated density (Mg/m3) 4/1.463 4/1.479 
Absorption coefficient (mm-1) 0.211  0.263  
Crystal size (mm) 0.50 x 0.35 x 0.10 0.50 x 0.25 x 0.15 
Reflections collected/unique 22323 / 4574 [R(int) = 
0.0261] 
29329 / 5903 [R(int) = 
0.0347] 
Data/restraints/parameters 4574 / 0 / 276 5903 / 0 / 354 
GOF 1.047 1.040 
R indices (all data) R1 = 0.0413, wR2 = 
0.0972 
R1 = 0.0505, wR2 = 
0.1051 
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2.12 NMR Spectra for Compound Characterization
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Chapter 3.  DNA Interstrand Cross-Links Between an Abasic 
Site and the Opposing Guanine Residue of 5`-CAp Sequences 
in Duplex DNA 
 
 
3.1 Introduction 
 Apurinic/apyrimidinic (Ap) sites are among the most common DNA lesions that 
form spontaneously in cells most often through a process termed depurination (1, Scheme 
1).1-2 Depurination results from the spontaneous hydrolytic cleavage of the glycosidic 
bond resulting in loss of the DNA base, leaving the deoxyribose sugar (Scheme 1).  It is 
estimated about 10,000 Ap sites form per cell per day.3-5 Exogenous mutagens and anti-
cancer drugs can increase this rate, resulting in greater abundance of Ap sites, which can 
be cytotoxic and mutagenic.6-7 DNA repair enzymes such as Uracil DNA Glycosylase 
(UDG) form Ap-sites (1) by removal misincorporated uracil residues.8  This like other 
base excision repair (BER) enzymes contribute to the generation of Ap-sites.3, 6, 9-10 
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Scheme 1 
 
 Ap sites are estimated to be in equilibrium as either a closed ring hemiacetal 
(~99%, 1) or open chain aldehyde (~1%, 2).11 Aldehydes are known to be reactive 
functional groups towards nucleophilic attack.2 Imine formation involves a reversible 
reaction between a primary or secondary amine and an aldehyde or ketone (Scheme 2).  
Imines have been shown to occur between heterocyclic bases in DNA with various 
aldehyde-containing carcinogens such as acrolein or oxidation products from lipid 
peroxidation (Scheme 2).2, 12-13 Generally duplexes containing Ap-sites have significant 
structural diversity, but it is suggested that B-DNA structure is often retained.14-16 We 
hypothesized that the DNA bases could form imine linkages with opposing Ap-sites. 
 We have studied and reported the formation of DNA interstrand cross-links 
between the aldehyde of an Ap-site and the exocyclic amine of an opposing guanine (dG) 
or adenine (dA) residue in a DNA duplex via imine formation.17-19 Our early work 
employed conditions of reductive amination to capture the dG-Ap cross-link between in 
5`-CApA sequences.17 This chapter will discuss the formation and stability of the 
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(unreduced) dG-Ap cross-link formed under physiologically relevant conditions, and how 
the reduced dG-Ap cross-links were used to infer chemical structure.18 
Scheme 2 
 
3.2 dG-Ap DNA Interstrand Cross-links Trapped by Reductive Amination 
 Interstrand cross-links cause severe problems for cellular DNA repair systems.20 
These lesions can block DNA transcriptions and replication, resulting in cell dysfunction, 
death, and aging.21-22 The deleterious nature of these cross-links suggests that small 
amounts of Ap-derived cross-links could be contributing to the observed biological 
significance of Ap-sites in Genomic DNA.  This makes characterization of structure and 
biological importance for this lesion crucial.   
 Previous work involved capturing interstrand cross-links formed by the reaction 
of Ap-sites with deoxyguanosine residues using NaCNBH3.  This mild reducing agent is 
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commonly used for selective reduction of imines.  Our experiments utilized uracil-
containing strands to selectively introduce Ap-sites into the duplex quickly with UDG 
(Scheme 1).  This technique has proven useful for selectively generating Ap-sites at 
defined locations in all duplexes tested (Chapter 4).  Further incubation of UDG treated 
uracil-containing DNA generated cross-links in 5`CAp sequences.  We conducted several 
experiments to determine that the mechanism of cross-link generation involves imine 
formation between the exocyclic -NH2 of guanine residues and the aldehyde of abasic-
sites (Scheme 3). 
Scheme 3 
 
 
 These conditions of reductive amination23 were designed to facilitate detection of 
the cross-link via irreversible reduction of the anticipated imine intermediate 8 to give a 
stable amine linkage (Scheme 1).24-26 In the current work, we examined cross-link 
formation in several 21-30 bp 2’-deoxyoligonucleotide duplexes, with the goal of 
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characterizing the formation, structure, and properties of the dG-Ap cross-link formed at 
5’-CAp sequences in duplex DNA. 
 32P-labeled oligonucleotides 15-mer base pairs long (duplex A Figure 1) were 
originally used to detect cross-links captured reductively with NaCNBH3 in pH 5.5 buffer 
(MES, 50 mM) at 30 °C in low yields (2-3%) over several days.17 Here we used duplexes 
of 21-30 base pairs in length (duplex B-G).  The increase is length resulted in higher 
yields of reductively captured cross-links in significantly shorter incubation periods. We 
hypothesized the lower yields obtained with the 15-mer sequences resulted from partial 
dissociation of the Ap-containing duplexes upon incubation, preventing cross-link 
formation.  Ap-sites have been shown to drastically affect the melting temperature of 
DNA duplexes.27 Using a longer more thermally stable duplex allowed for higher 
temperature incubations assisting in shorter incubation times. 
 We used gel mobility experiments to confirm the identity of the DNA interstrand 
cross-links.  Duplexes C, D, or E were designed from duplex B containing 3`-lengthened 
tails (5 base pairs) on either the Ap containing strand, complimentary strand, or both 
strands.  After separation by PAGE, these tails produced gel-shifted bands.  The 
lengthened 32P-labeled 26-mer strands would travel slower than the 32P-labled 21-mer 
strands because of the change in size.  Additionally, any interstrand cross-links that form 
also travel slower than the corresponding single strand DNA, as it would contain both the 
32P-labeled Ap-containing and unlabeled complimentary strands.   
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Figure 1 
 
Figure 1. Interstrand cross-link formation in duplexes B-E under conditions of reductive 
amination.  Duplex B, lanes 1-5, C, lanes 6-10, D, lanes 11-15, and E, lanes 16-20.  The 
uracil-containing precursor 2’-deoxyoligonucleotides appear in lanes 1, 6, 11, and 16. 
The abasic-site-containing duplexes without further incubation appear in lanes 2, 7, 12, 
and 17.  The abasic-site-containing duplexes cleaved by treatment with piperidine (1 M, 
95 ˚C, for 25 min) appear in lanes 3, 8, 13, and 18).  The cross-linking reactions 
involving incubation of the abasic-site-containing duplex in sodium acetate buffer (750 
mM, pH 5.2) and NaCNBH3 (250 mM) at 37 ˚C appear in lanes 4, 9, 14, and 19.  The 
abasic-site-containing duplexes in sodium acetate buffer (750 mM, pH 5.2), NaCNBH3 
(250 mM), and methoxyamine hydrochloride (2 mM) at 37 ˚C appear in lanes 5, 10, 15, 
and 20.  The 32P-labeled 2’-deoxyoligonucleotides were resolved on a sequencing gel and 
the radioactivity in each band quantitatively measured by phosphorimager analysis. 
1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5
5`-32P-ATAGATGAACApAAGACATATA
3`-CGATATATCTACTTG A TTCTGTATAT
5`-32P-ATAGATGAACApAAGACATATA
3`-TATCTACTTG A TTCTGTATAT
5`-32P-ATAGATGAACApAAGACATATAATACG
3`-TATCTACTTG A TTCTGTATAT
5`-32P-ATAGATGAACApAAGACATATAATACG
3`-CGATATATCTACTTG TTCTGTATATA
5`-32P-GATGATCApAAGACATT
3`-CTACTAG A TTCTGTAA
B
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We generated duplexes B-E (Figure 1), containing authentic Ap sites by treatment 
of the corresponding 2’-deoxyuridine-containing 2’-deoxyoligonucleotide duplexes with 
uracil DNA glycosylase (UDG).28-30 Prior to annealing and treatment with UDG, the 
uracil-containing strand of the duplexes B-E were 5’-32P-labeled using standard methods 
to allow detection of the products following separation on 20% denaturing 
polyacrylamide gels (PAGE).31 
 Incubation of 21-base pair duplex B in NaOAc buffer (pH 5.2, 750 mM) with 
NaCNBH3 (250 mM) at 37 °C over a 24 h produced substantially greater cross-link yield 
(~20%).  These cross-link reactions are analyzed by 20% denaturing PAGE as described 
in Chapter 2 and Figure 1 displays a representative gel of the results.  Uracil-containing 
DNA (lanes 1, 6, 11, and 16, Figure 1) were treated with UDG (50 U/mL, 45-90 min, 37 
°C) (lanes 2, 7, 12, and 17, Figure 1) and incubated further with the aforementioned 
conditions with NaOAc and NaCNBH3 (lanes 4, 9, 14, and 19, Figure 1) to yield slower 
moving bands for each duplex.  Piperidine cleavage (lanes 3, 8, 13, and 18, Figure 1) of 
Ap-containing DNA showed full uracil to Ap conversion.  Inhibition by the aldehyde 
trapping agent methoxyamine (CH3ONH2!HCl, 2 mM, Scheme 3) (lanes 5, 10, 15, and 
20, Figure 1) further provided evidence that the aldehyde is involved in the formation of 
the slow moving band indicative of cross-linked DNA. 
 Installment of the 5-base pair tails to each of the strands resulted in gel shifts of 
either the bands corresponding to single strand DNA, the slower moving cross-linked 
bands, or both depending on where the tail was attached.  If the tail is attached to the 
complimentary strand (duplex C, lanes 6-10) only the cross-linked band was gel shifted.  
When the tail is incorporated on the uracil/Ap-containing strand (duplex D, lanes 11-15) 
the bands corresponding to full-length single strand DNA shifts as well as the band 
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corresponding to cross-linked DNA.  Finally, placing the tail on both strands (duplex E, 
lanes 16-20) of the duplex resulted in an even greater shift in the cross-linked DNA band.  
These results provide proof that the slower moving bands (lanes 4, 9, 14, and 19) contains 
both oligonucleotide strands (the 32P-labeled Ap-containing and complimentary strands) 
indicative of a DNA interstrand cross-link. 
 We tested to see if both the pH 5.2 NaOAc buffer and NaCNBH3 for were 
required for significant detection of cross-link.  We obtained highest crosslink yields 
when incubating Ap-containing duplex B in the combination of NaOAc buffer (pH 5.2, 
750 mM) and NaCNBH3 (250 mM) at 37 °C.  The reaction conditions were optimized to 
achieve the highest yields of reduced cross-link.  Additionally incubating duplex B with 
either pH 5.2 NaOAc buffer or NaCNBH3 alone did not yield significant reduced cross-
link.  Additionally, incubation of Ap-containing duplex B in neutral pH 7 NaOAc buffer 
in the presence of NaCNBH3 did not yield significant cross-link as well.  This is an 
interesting result, suggesting that the slightly acidic pH facilitates cross-link capture by 
NaCNBH3.  It is known that imine formation is catalyzed by acid (and base), 
equilibrating faster at pH's closer to 5 or lower.32-33  
 A time-course of formation for this presumably reduced dG-Ap cross-link was 
performed (Figure 2).  We determine that under the reductive amination conditions, 
highest yields of the cross-link are obtained after 24 hours incubation (~20%), with an 
apparent half-time to completion of ~4.5 hours.  Presumably competing reduction of the 
aldehyde by NaCNBH3 prevented higher yields from being obtained.   
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Figure 2 
 
Figure 2.  Time course for the formation of cross-linked duplex B under conditions of 
reductive amination.  Duplex B was incubated in sodium acetate buffer (750 mM, pH 
5.2) and NaCNBH3 (250 mM) at 37 ˚C and at 0, 1, 2, 4, 6, 8, 12, and 23 h aliquots were 
removed from the reaction and frozen prior to sequencing gel analysis (lanes 5-12).  The 
lower bands correspond to the full length labeled 2’-deoxyoligonucleotides and the upper 
band correspond to the cross-linked DNA.  Lane 1 is the 32P-labeled uracil-containing 
precursor 2’-deoxyoligonucleotide, lane 2 is the 32P-labeled abasic-site-containing duplex 
without incubation, and lane 3 is the 32P-labeled abasic-site-containing duplexes cleaved 
by treatment with piperidine (1 M, 95 ˚C, for 25 min).  Lane 4 is the abasic-site-
containing duplex incubated in HEPES buffer (50 mM, pH 7) and NaCl (100 mM) for 24 
h at 37 ˚C.  The 32P-labeled 2’-deoxyoligonucleotides were resolved on a sequencing gel 
and the radioactivity in each band quantitatively measured by phosphorimager analysis.   
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Figure 3 
 
Figure 3.  Hydroxyl radical footprinting of duplex F to locate the site of cross-link 
attachment.  Lane 1 is a Maxam-Gilbert G-specific cleavage (sequencing) reaction of the 
labeled 2’-deoxyoligonucleotide strand in duplex F.  Lane 2 is an A+G specific cleavage 
(sequencing) reaction of the labeled 2’-deoxyoligonucleotide strand in duplex F.  Lanes 
3-5 the hydroxyl radical footprinting reaction of the labeled 2’-deoxyoligonucleotide 
strand in duplex F.  Lanes 6-9 are the hydroxyl radical footprinting reaction of the slow-
migrating, cross-link band generated by incubation of duplex F in sodium acetate buffer 
(750 mM, pH 5.2) and NaCNBH3 (250 mM) at 37 ˚C.  The 32P-labeled 2’-
deoxyoligonucleotides were resolved on a sequencing gel and visualized by 
phosphorimager analysis.(Panel A) and used to develop densitometry traces (Panels B-
D).  Panel B is the trace of lane 1.  Panel C is the trace of lane 2.  Panel D is the trace of 
lane 4. 
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 To provide evidence that the cross-link obtained involved adduction of the 
deoxyguanine residue (Figure 1) onto the Ap-site, and not some other base of the DNA 
duplex we conducted two experiments to test this.  One to identify that the guanine was 
the base attached to the Ap-site, and the second showing the attachment was at the 
exocyclic N2-amino group of guanine.  The first experiment involved hydroxyl radical 
footprinting of the crosslink generated with duplex F.  Isolated cross-linked duplex F was 
subjected to cleavage by H2O2-iron-EDTA,34-35 and the resulting mixture of labeled DNA 
fragments as a "ladder" resolved on a sequencing gel.  In this experiment, the presence of 
a cross-link results in an interruption of the “ladder” of DNA fragments at the site of 
cross-link attachment.  Placement of the 32P-label on the opposing strand identifies which 
DNA base provided the attachment between both strands.  Duplex F generated similar 
yields of crosslink to duplex B-E, and the longer duplex moved important bands out of a 
"salt-flare" zone for clearer results.  Here, we observed a clear interruption in the 
fragment ladder at G4 of the labeled strand (Figure 3 and 4).  This result provided specific 
evidence that the cross-link extends from the Ap site to the opposing guanine residue in 
the central 5’-CAp sequence of this duplex (Scheme 2). 
Figure 4 
 
Figure 4.  Molecular modeling of a 5`-CAp base paired sequence 
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 To show that the exocyclic amine of guanine (Figure 4) is the site of attachment, 
we substituted the guanine in the 5`-CApA duplex B for a non-natural DNA base inosine 
(Figure 5, duplex G).  This substitution results in the specific loss of the N2-amino group 
of guanine (structure shown in Figure 5). Incubation of duplex G in NaOAc buffer (pH 
5.2, 750 mM) with NaCNBH3 (250 mM) at 37°C (Figure 5, lane 4) did not yield the same 
slow moving cross-link band as duplex B under the same conditions (lane 3).  This result 
provided further evidence for the involvement of the guanine residue, specifically the N2-
amino group in cross-link formation at the 5’-CAp sequences in duplexes B-E.   
Figure 5 
 
Figure 5.  Cross-link formation was abrogated by replacement of the opposing guanine 
residue in the 5’-CAp sequence with an inosine residue.  The lower bands correspond to 
the 32P-labeled full length labeled 2’-deoxyoligonucleotides and the upper band cross-
linked 2’-deoxyoligonucleotides.  Lane 1 is the abasic-site-containing duplex B without 
incubation.  Lane 2 is the abasic-site-containing duplex B cleaved by treatment with 
piperidine (1 M, 95 ˚C, 25 min).  Lane 3 is duplex B incubated in sodium acetate buffer 
(750 mM, pH 5.2) and NaCNBH3 (250 mM) at 37 ˚C.  Lane 4 is duplex G incubated in 
NaOAc buffer (750 mM, pH 5.2) and methoxyamine (250 mM) at 37 ˚C.  The 32P-labeled 
2’-deoxyoligonucleotides were resolved on a sequencing gel and the radioactivity in each 
band quantitatively measured by phosphorimager analysis.  The image shows the region 
of the gel where full-length oligonucleotide and cross-link migrate. 
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3.3 MALDI Mass Spectrometric Analysis of Reduced Cross-Link 
 We prepared a cross-link of duplex B without the 5’-32P group on the Ap-
containing strand, using our reductive amination conditions in NaOAc buffer (pH 5.2, 
750 mM) with NaCNBH3 (250 mM) at 37°C.  Preparative gel electrophoresis was used to 
separate the cross-linked material from the native single strands, and the DNA was 
visualized in the gel by UV-shadowing against a fluorescent TLC plate.  The slow-
moving, cross-linked band was excised and eluted from the gel, and further purified by 
desalting using a C18 cartridge, and precipitating in ethanol.  MALDI-TOF mass 
spectrometric analysis (Figure 6) of the DNA obtained in this manner gave a strong 
signal that closely matched that expected for a reduced cross-link structure 10 such as in 
Scheme 3.  We observed an m/z for [M–H]– =12,720.8 with a calculated [M–H]– 
=12,721.5.  This equates to a relative mass error of 55 ppm.   
Figure 6 
 
Figure 6.  MALDI-MS of the dG cross-linked duplex B formed under reductive 
amination conditions using duplex B. 
5`-ATAGATGAACApAAGACATATA 
3`-TATCTACTTG ATTCTGTATAT 
 
Mass Calc’d 12,720.3 	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3.4 Cross-Linking of Ap-Containing DNA in Neutral Aqueous Solution 
 We examined formation of dG-Ap cross-links in the absence of reducing agent 
under neutral, more biologically relevant conditions.  So we incubated Ap-containing 
duplex B in HEPES buffer (pH 7, 50 mM) and NaCl (100 mM) at 37°C and analyzed 
reaction on denaturing PAGE like before.  Under these conditions, we saw a slow-
migrating band of low yield (~2%) in the region where the previously characterized 
reduced cross-link duplex migrated (lane 5, Figure 7 and lane 4, Figure 2).  Incubation in 
the presence of methoxyamine (CH3ONH2!HCl, 2 mM) inhibited the formation of this 
slow moving band (lane 4, Figure 7).  Similarly to the previous section, incubation of 
duplex G containing the inosine residue in the 5`-CApA sequence under neutral pH did 
not yield this slow moving band (lane 9).  Together these results suggest that this slow-
moving band was an unreduced dG-Ap interstrand cross-link, as the ability to form the 
reduced alkyl amine linkage is indicative of an unreduced imine cross-link.  This native 
cross-link must be an intermediate captured under reductive amination conditions.   
 The native, unreduced cross-link could be resolved from the reduced cross-link 
using a 20% denaturing polyacrylamide gel when the products are run at least 12 cm 
from the well.  Figure 8 shows a gel with clear separation of the unreduced cross-link 
(lanes 1 and 2) from the reduced cross-link (lanes 2 and 3).  It is interesting to note how 
such a small change in structure could lead to a significant gel shift.  As shown in 
Scheme 3, the unreduced cross-link would likely be stabilized in the closed-ring 
hemiaminal form 9, as opposed to an open ring imine species 8.  On the other hand, 
reducing the imine intermediate (10) secures the linkage, and prevents cyclization of the 
deoxyribose sugar.  This in turn gives the reduced cross-link more "reach" and flexibility 
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to travel through the gel slightly faster.  A comparison of the reduced and unreduced dG-
Ap linkage is discussed further in the next section.   
 
Figure 7 
 
Figure 7.  Detection of native (unreduced) dG-Ap cross-link duplex B and evidence that 
replacement of the opposing guanine residue in the 5’-CAp sequence of duplex B with 
inosine in duplex G abrogates cross-link formation.  The lower bands correspond to the 
full-length 32P-labeled 2’-deoxyoligonucleotides and the upper band cross-linked DNA.  
Lane 1 is the uracil-containing precursor of duplex B.  Lane 2 is the abasic-site-
containing duplex B without incubation.  Lane 3 is the abasic-site-containing duplex B 
cleaved by treatment with piperidine (1 M, 95 ˚C, 25 min).  Lane 4 is duplex B incubated 
in with methoxyamine hydrochloride (2 mM) in HEPES buffer (50 mM, pH 7) containing 
NaCl (100 mM) at 37 ˚C.  Lane 5 is duplex B incubated in HEPES buffer (50 mM, pH 7) 
containing NaCl (100 mM) at 37 ˚C.  Lane 6 is the abasic-site-containing duplex G 
without incubation.  Lane 7 is the abasic-site-containing duplex G cleaved by treatment 
with piperidine (1 M, 95 ˚C, 25 min).  Lane 8 is duplex G incubated in with 
methoxyamine hydrochloride (2 mM) in HEPES buffer (50 mM, pH 7) containing NaCl 
(100 mM) at 37 ˚C.  Lane 9 is duplex G incubated in HEPES buffer (50 mM, pH 7) 
containing NaCl (100 mM) at 37 ˚C.  The 32P-labeled 2’-deoxyoligonucleotides were 
resolved on a sequencing gel and the radioactivity in each band quantitatively measured 
by phosphorimager analysis.  The image shows the region of the gel where full-length 
oligonucleotide and cross-link migrate. 
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Figure 8 
 
Figure 8.  The reduced and unreduced dG-Ap cross-linked duplexes can be resolved by 
gel electrophoresis.  Lane 1 is the native (unreduced) cross-link generated by incubation 
of duplex B in HEPES buffer (50 mM, pH 7) containing NaCl (100 mM) at 37 ˚C for 3 d.  
Lane 2 is a mixture of the native (Lane 1) and reduced (Lane 3) cross-links.  Lane 3 is the 
reduced cross-link generated by incubation of duplex B in sodium acetate buffer (750 
mM, pH 5.2) and NaCNBH3 (250 mM) at 37 ˚C for 1 d.  The image shows the region of 
the gel where the cross-link migrates. 
 
3.5  Formation and Stability of the Native Unreduced dG-Ap Cross-Link 
 Presumably the unreduced native cross-link would be reversible, as imine 
formation is described to exist in aqueous media as equilibrium mixtures of amine, 
aldehyde, hemiaminal and imine (Scheme 3).32-33, 36 So unreduced cross-link reactions are 
described in terms of equilibrium yields.  We expect this is a major contributor to why 
the unreduced cross-link yield is low.  Incubation of duplex B in HEPES buffer (pH 7, 50 
mM) and NaCl (100 mM) revealed that the native (unreduced) dG-Ap cross-link formed 
quickly.  A time course showed us that easily detectable amount of cross-link formed 
within the first 1 h of incubation at 37°C, and often during the Ap-site generation by 
UDG from uracil-containing DNA duplex.  In fact, incubation under the neutral 
conditions provided us with an apparent half-time to completion of the cross-linking 
reaction was less than 24 h (Figure 9).  This rapid formation indicates that this cross-link 
should be biologically significant. Knowing the approximate rate of Ap-site formation in 
cells and number of DNA bases in the genome, this rapid cross-link formation indicates 
great biological significance towards cell proliferation. 
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Figure 9 
 
Figure 9.  Time course for the formation of the native (unreduced) dG-Ap cross-link.  
Duplex B was incubated in HEPES buffer (50 mM, pH 7) containing NaCl (100 mM) at 
37 ˚C.  At various times aliquots were removed and the DNA ethanol precipitated.  The 
32P-labeled 2’-deoxyoligonucleotides were resolved on a sequencing gel, the radioactivity 
in each band quantitatively measured by phosphorimager analysis, and the yield of slow-
migrating (cross-linked DNA) band plotted versus time.  Time = 0 was defined as the end 
of the 1.5 h reaction of the uracil-containing B duplex with UDG to generate the Ap-
containing duplex B.  Detectable amounts of cross-link were already evident at this time. 
 
 We were interested to determine the viability of these cross-links for use in 
additional experiments.  Following cross-link formation, the reaction mixtures were 
subjected to a variety of post-formation conditions.  We exposed the cross-links reaction 
mixtures with heat, dilute piperidine, acidic or basic buffers, as well as various amines for 
15 min each and the resulting mixtures analyzed by PAGE.  The remaining yield of 
cross-link for each treatment were normalized against untreated control samples (Figure 
10, panel A), run side-by-side in an analytical polyacrylamide gel.  We found that the 
unreduced cross-link was by diminished slightly by 60 °C heat and significantly in 90 °C.  
NaOAc buffer (pH 3, 25 mM) had no effect on cross-link yield, whereas phthalate buffer 
(pH 10, 25 mM) buffer increased overall cross-link yield slightly.  Dilute piperidine (100 
mM) treatment at 60 °C decreased unreduced cross-link yield significantly as well.  The 
reduced cross-link was not affected by these post-formation treatments, consistent with 
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reduction of a reversible-imine linkage into a more robust alkyl-amine bond.  The 
stability of the reduced cross-link makes it useful as a model for further studies in DNA 
repair and polymerization studies (provided in Chapter 4).   
 The unreduced cross-link was additionally treated with DMEDA, methoxyamine, 
and hydrazine (20 mM) at room temperature.  We expected cross-link yield to diminish 
for all three amine treatments, each acting as aldehyde trapping agents and reversing the 
equilibrium to give lower cross-link yields.  Instead we find that both DMEDA and 
hydrazine increased the total cross-link while only methoxyamine decreased the yield 
slightly.   
 As we already described the formation of Ap-derived cross-links as an 
equilibrium reaction, it should hold that the decay would be as well.  We wanted to see 
how fast "isolated" unreduced dG-Ap cross-links return to equilibrium yields.  The low 
yield of the cross-link does not allow for easy isolation by gel purification.  Additionally 
a series of purification steps most likely would result in substantial cross-link decay.  So 
instead we used a different approach, instead of isolating the cross-link, we "removed" all 
un-reacted Ap-containing SS DNA.  We did by treating the cross-link mixture after 
incubation with Apurinic Endonuclease 1 (APE1), an enzyme that selectively catalyzes 
single-strand breaks on Ap-containing DNA.37-38 After incubation with APE1, the 
resulting mixture was further incubated in HEPES (50 mM, pH 7) and NaCl (100 mM) at 
37 °C with aliquots taken at various time-points and separated on a 20% denaturing 
polyacrylamide gel.  The time course shows the cross-link returns to equilibrium yield 
after ~48 hours, with a half-life of 14.7 ± 0.9 hours.  This measurement tells us that the 
cross-link decays at a comparable rate to which it forms.  This is consistent with an imine 
equilibrium, the formation and reversal thereof.36, 39  
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Figure 10 
 
Figure 10.  Stability of the reduced and native dG-Ap cross-link in duplex DNA against 
various post-formation conditions (panel A) and relative yield of the native (unreduced) 
cross-link formed under various reaction conditions (panel B).  The light gray bars 
represent the relative yields of unreduced cross-link and the dark gray bars represent the 
relative yields of reduced cross-link.  The yields of native (unreduced) cross-link 
obtained in reactions examining the formation and stability of native cross-link were 
normalized against a standard control cross-linking reaction involving incubation of 
duplex B in HEPES buffer (50 mM, pH 7) containing NaCl (100 mM) at 37 ˚C.  
Similarly, reactions examining the stability of the reduced cross-link were normalized 
against a standard control cross-linking reaction involving incubation of duplex B in 
sodium acetate buffer (750 mM, pH 5.2) and NaCNBH3 (250 mM) at 37 ˚C.  Following 
formation of the cross-links, the reaction mixtures were subjected to the following work-
up conditions as shown from left to right in Panel A:  60 ˚C, 15 min; 90 ˚C, 15 min, pH 
adjusted to 3, 15 min; pH adjusted to 10, 15 min; 100 mM piperidine, 60˚ C, 15 min; 
N,N-dimethylethylenediamine (20 mM, 15 min); methoxyamine hydrochloride (20 mM, 
15 min); and hydrazine sulfate (20 mM, 15 min).  Panel B.  The formation of native 
cross-link was examined under various conditions.  These experiments examine the 
effects of different conditions during the cross-linking reaction.  Yields relative to a 
standard cross-linking reaction involving incubation of duplex B in HEPES buffer (50 
mM, pH 7) containing NaCl (100 mM) at 37 ˚C (labeled “Control”).  The conditions 
shown from left to right in Panel B are:  std reaction with glutathione (1 mM); 
dithiothreitol (1 mM), diaminopurine (1 mM), adenine (1 mM), lysine (1 mM), arginine 
(1 mM), or 4-chloroaniline (1 mM).  The reactions examining salt effects contained 
HEPES (50 mM, pH 7) and NaCl (200 mM or 50 mM) or MgCl2 (50 mM).  The reactions 
carried out in different buffers did not employ HEPES, rather contained NaCl (100 mM) 
and MOPS (50 mM, pH 7), sodium phosphate (50 mM, pH 7), sodium cacodylate (50 
mM, pH 7), Bis-tris (25 mM, pH 7), DTPA (5 mM), sodium acetate (5 mM), or MES (50 
mM, pH 5.0). 
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 We felt it necessary to show that this cross-link could form under a variety of 
reaction conditions (buffers and salts), and in the presence of biologically relevant 
nucleophiles.  Figure 10B summarizes the conditions used and nucleophiles included.  
Essentially we find that the dG-Ap cross-link will form in the presence of biologically 
relevant thiols such as GSH and amines like adenine and lysine.  The cross-link yield was 
affected significantly by salt concentration and buffer identity.  Higher salt concentrations 
tend to increase cross-link yields, consistent with increased DNA duplex flexibility from 
relieved charged repulsion of negatively charged phosphates.40-41 Additionally it seems 
that carboxylate-containing buffers (DTPA) lower pH buffers (pH 5) also increase cross-
link yield.  Imine formation has been shown to be catalyzed by acetate.32   
 
3.6 Chapter 3 Summary 
 The experiments described here examined the formation and properties of 
interstrand dG-Ap cross-links formed at 5’-CAp sequences in duplex DNA.  Other 
groups have characterized related cross-links generated by oxidized Ap sites in DNA;42-44 
however, it is important to emphasize that the structure and reactivity of the oxidized Ap 
sites are distinct from that of the “native” Ap site that is the focus of our work. 
We found that incubation of DNA duplexes containing an abasic-site in a 5’-CAp 
sequence under physiologically-relevant conditions in the absence of reducing agents 
yields detectable amounts of a slow-moving cross-linked duplex within 1 h, monitored by 
denaturing polyacrylamide gel electrophoresis.  A slow-moving band on the gel was 
indicative of an interstrand cross-link resulting from the reaction of the Ap-aldehyde 
group with the opposing guanine residue.  Formation of this product was inhibited by 
methoxyamine capping of the Ap site and by an inosine-for-guanine replacement at the 
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5’-CAp site.  We hypothesize that the equilibrium formation of the cyclic hemiaminal 9 
is favored and makes this cross-link more stable than a typical imine or hemiaminal 
linkage.  Cross-link formation was not highly sensitive to buffer identity, salt 
concentration, or the presence of the biological thiol glutathione (1 mM).   
Incubation of duplexes containing an 5’-CAp sequence in the presence of the 
reducing agent NaCNBH3 in pH 5.2 buffer generated good yields (~20%) of a slow-
moving band on denaturing polyacrylamide gels.  The results of MALDI-TOF mass 
spectrometry, and gel mobility experiments provided evidence that the slow-moving band 
generated under these conditions of reductive amination did contain both full-length 
strands of the starting duplex.  The cross-link generated under reducing conditions was 
structurally distinct from the native cross-link, as it could be resolved from the native 
unreduced cross-link on denaturing gels.  Methoxyamine capping, inosine-for-guanine 
replacement, and hydroxyl radical footprinting further provided evidence that cross-link 
formation involved attachment of the Ap-aldehyde group to the opposing guanine residue 
at the 5’-CAp sequences.  The cross-link generated under reducing conditions was stable 
against all of the workup conditions examined here (Figure 10, panel A). 
Overall, we provided evidence consistent with the chemical mechanism for cross-
link formation at 5’-CAp sequences illustrated in Scheme 3, in which reaction of the Ap-
aldehyde residue with the N2-amino group of the opposing guanine residue yields 
hemiaminal, imine, or cyclic hemiaminal linkages (structures 7-10).  Under conditions of 
reductive amination (NaCNBH3/pH 5.2), equilibrium amounts of the imine can be 
irreversibly converted to the amine linkage.  Le Chatelier’s principle tells us that the 
reduced cross-link has the potential to accumulate beyond the equilibrium levels of its 
structures 9 and 10.  The system is complex and irreversible reduction of the cross-link 
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likely must compete with reduction of the abasic aldehyde and decomposition of reducing 
agent in solution. 
The yields of the reduced dG-Ap cross-link obtained in this more recent work 
were substantially greater than those reported.45 The Ap-containing duplexes used here 
were longer than the 15 bp duplexes employed in the original studies and it is possible 
that partial melting of the duplexes in our early work limited cross-link yields.  In 
addition, in the 21 bp duplex used here, a thymine rather than an adenine residue rests on 
the 3’-side of the guanine residue involved in the cross-linking reaction and it is shown in 
Chapter 4 that the flanking bases affect the cross-link yield.  Finally, the sodium acetate 
buffer used in the current reductive amination experiments may catalyze cross-link 
formation.46-48 
We believe that the exocyclic N2-amino group of guanine is the nucleophile that 
reacts with the Ap aldehyde to generate the dG-Ap cross-link as postulated in Scheme 2.  
A wealth of precedents show that the N2-amino group of guanine residues in DNA can 
react with aldehyde groups in small molecules to form covalent adducts (Scheme 2).49-53  
At the same time, it is important to recognize chemical precedents showing that 
intramolecular reactions of aldehydes with endocyclic nitrogens can yield covalent 
adducts.52, 54 Thus, the exact chemical structure of the dG-Ap cross-links remains 
uncertain and efforts are underway to synthesize authentic standards of the putative cross-
linked nucleoside analogs of 9 and 10 for use in structure elucidation. 
Our observations of Ap-derived interstrand DNA-DNA cross-links could be 
relevant to the cytotoxic and mutagenic properties of Ap sites in DNA.  The highly 
deleterious nature of cross-links suggests that even small amounts of Ap-derived cross-
links could make a significant contribution to the overall biological effects stemming 
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from the generation of Ap sites in cellular DNA.  Some of the cross-linked duplexes 
reported here may be useful substrates for the study of cross-link repair.  Overall, our 
results provide a foundation for future investigations of the structure, occurrence, and 
biological consequences of Ap-derived cross-links in cellular DNA. 
 
3.7 Experimental 
Materials and Methods.  Oligonucleotides were purchased from Integrated DNA 
Technologies.  T4-Polynucleotide Kinase and Uracil DNA Glycosylase were from New 
England Biolabs (Ipswich, MA, USA).  [γ-32P]-ATP (6000 Ci/mmol) was purchased from 
Perkin Elmer.  C-18 sep-pak cartridges were purchased from Waters and BS Polyprep 
columns were obtained from BioRad.  Quantification of radioactivity in polyacrylamide 
gels was carried out using a Personal Molecular Imager (BIORAD) with Quantity One 
software (v.4.6.5).  All other reagents were purchased from Sigma-Aldrich. 
 
Representative procedure for cross-link formation under conditions of reductive 
amination.   Single-stranded 2’-deoxyoligonucleotides were 5’-labeled using standard 
procedures.31  Labeled DNA was annealed31 with its complimentary strand and treated 
with the enzyme UDG (50 units/mL, final concentration) at 37 °C for 1.5 h to generate 
Ap-sites.  The enzyme was removed by phenol-chloroform extraction.31  In individual 
cross-linking reactions, the Ap-containing double-stranded DNA was incubated in 
sodium acetate buffer (750 mM, pH 5.2) containing NaCNBH3 (250 mM) at 37 ˚C for 24 
h unless otherwise specified.  The DNA was ethanol precipitated from the reaction 
mixture,31 resuspended in formamide loading buffer,31 loaded onto a 20% denaturing 
polyacrylamide gel, and the gel electrophoresed for 4 h at 1000 V.  The amount of 
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radiolabeled DNA in each band on the gel was measured by phosphorimager analysis.  
The time course for the formation of the native cross-link was carried out by incubating a 
solution containing labeled DNA (approximately 200,000 cpm), sodium acetate buffer 
(750 mM, pH 5.2) containing NaCNBH3 (250 mM) at 37 ˚C.  At specified time points, 
aliquots (20 µL) were removed and frozen at –20 ˚C, followed by ethanol precipitation 
and gel analysis as described above. 
 
Representative procedure for cross-link formation at pH 7 in the absence of 
reducing agent.  Duplex DNA containing a 32P-labeled Ap-containing strand, prepared 
as described above, was incubated in a buffer composed of HEPES (50 mM, pH 7) 
containing NaCl (100 mM) at 37 ˚C for 72 h unless otherwise specified.  The DNA was 
ethanol precipitated, resuspended in formamide loading buffer, loaded onto a 20% 
denaturing polyacrylamide gel, and the gel electrophoresed for 4 h at 1000 V.  Control 
experiments involving direct loading of cross-linking reactions showed that ethanol 
precipitation does not markedly alter the yield of the slow-migrating, cross-link band.  
The amount of radiolabeled DNA in each band on the gel was measured by 
phosphorimager analysis. 
 
Hydroxyl radical footprinting of cross-linked duplexes.  We employed literature 
protocols to footprint the cross-linked duplexes.42, 55  In these experiments, the strand 
opposing the Ap-containing oligonucleotide was 5’-labeled using standard procedures.31  
Labeled DNA was annealed with the uracil-containing complement and treated with 
UDG to generate the abasic site as described above.  The Ap-containing double-stranded 
DNA (~500,000 cpm) was incubated in sodium acetate buffer (750 mM, pH 5.2) 
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containing NaCNBH3 (250 mM) at 37 ˚C for 24 h.  The DNA was ethanol precipitated, 
suspended in formamide loading buffer, and separated on a 0.4 mm thick 20% denaturing 
polyacrylamide gel.  The slow-migrating cross-linked duplex band was visualized using 
X-ray film, the band cut out of the gel, the gel slice crushed, and the gel pieces vortexed 
in elution buffer (NaCl 200 mM; EDTA, 1 mM) at room temperature for at least 1 h.  The 
mixture was filtered through a poly-prep column to remove gel fragments and the filtrate 
desalted using a C18 Sep-pak (100 mg size).  The resulting solution was evaporated using 
a Speed-Vac concentrator, the residue redissolved in water (24 µL), split evenly into three 
microcentrifuge tubes, and diluted with 2x oxidation buffer (10 µL of a solution 
composed of sodium phosphate, 20 mM, pH 7.2; NaCl, 20 mM; sodium ascorbate, 2 
mM; H2O2, 1 mM).  To this mixture was added a solution of iron-EDTA (2 µL, EDTA, 
70 mM; Fe(NH4)2(SO4)2•6H2O, 70 mM) to start the reaction, the mixture vortexed 
briefly, and incubated at room temperature for 1, 2, and 3 min before addition of thiourea 
stop solution (10 µL of a 100 mM solution in water).  Hydroxyl radical footprinting 
reactions, Maxam-Gilbert G, and Maxam-Gilbert A+G reactions were performed on the 
labeled single-strand to generate marker lanes.56  The resulting DNA fragments were 
analyzed using gel electrophoresis as described above. 
 
Preparation of reduced cross-linked duplexes for mass spectrometric analysis.  An 
unlabeled version of DNA duplex B, prepared as described above, was incubated in 
sodium acetate (750 mM, pH 5.2) and NaCNBH3 (250 mM) at 37 ˚C for 24 h.  The DNA 
was ethanol precipitated, resuspended in formamide loading buffer, and the DNA 
fragments separated on a 20% denaturing polyacrylamide gel.  DNA bands were 
visualized with UV-shadowing.  The reduced crosslink band was cut out of the gel, the 
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gel slice crushed, and the solution vortexed in elution buffer (NaCl, 1 M; EDTA, 500 
mM, pH 8) at room temperature for at least 1 h.  The solution was filtered through a Poly-
prep column, the filtrate desalted using a C18 Sep-pak (100 mg size), and the DNA 
ethanol precipitated.  MALDI-TOF mass spectrometric analyses were carried out on an 
AB Sciex Voyager DE™ Pro mass spectrometer (Framingham, MA).  The aqueous 
sample solution was combined in a 1/1/1 (V/V/V) ratio with triammonium citrate (0.1 M, 
aq) and 2′,4′,6′-trihydroxyacetophenone (0.1 M in acetonitrile) for application to a 
polished stainless steel target for analysis.  Negative ion spectra were acquired over a 
mass range of 5-14 kDa at a 25 kV accelerating potential in the linear delayed-extraction 
mode using an oligonucleotide of known mass as an external calibrant.57-58   
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Chapter 4.  Ap-Derived DNA Interstrand Cross-Links are 
Sequence Dependent  
 
 
4.1 Introduction 
 DNA insterstrand cross-links are a deleterious type of DNA damage in cells.  
Their bioactivity results from prevention of strand separation, required for both DNA 
transcription and replication.1  DNA repair processes, such as nucleotide excision repair 
(NER) are needed to fix these biologically important DNA lesions.  NER is thought to be 
the mechanism of interstrand cross-link repair.1-3 We discussed the biological 
significance of Ap sites DNA in Chapter 3, and presented evidence for DNA interstrand 
cross-links resulting from the reaction of an Ap-site with an opposing deoxyguanine (dG) 
residue.  However we did not present evidence of other DNA bases forming covalent 
adducts with Ap-sites in DNA.  Here we will discuss the effects of changing the local 
DNA sequence surrounding an Ap-site, and present a new high yielding Ap-derived 
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crosslink formed under neutral conditions resulting from adduction of an Ap-site with 
deoxyadenine (dA). 
 
4.2 Structure of Ap-Derived DNA Interstrand Cross-Link Changes Depending on 
the Sequence 
 In the previous Chapter, we utilized sequences where a dG residue generated 
cross-links via imine formation.4-5 However, understanding there are many (43 = 64) 
possibilities of Watson-Crick base paired combinations in a 5`-NApN sequence, where N 
is any nucleobase, we realized it would be important to examine as many Ap-site 
containing DNA sequences as possible.  Starting with single base pair substitutions, we 
designed three sequences similar to duplex B that varies the flanking base on the 3` side 
of the Ap-site (duplexes H-J, Figure 1).  Incubating the 5`-32P-labeled Ap-containing 
strands for duplexes B, H ,I , and J in HEPES buffer (pH 7, 50 mM) with NaCl (100 
mM) at 37 °C yielded striking results.  Upon analysis by 20% denaturing PAGE, we saw 
significantly different cross-link yields were obtained for each sequence, indicated by the 
slower moving band in lanes 4, 9, 14, and 19.  Where duplex H and J resulted in virtually 
no cross-link at all, we see a substantial increase in cross-link yield for duplex I (~60%, 
lane 14, Figure 1) when compared to duplex B (~2%, lane 4, Figure 1).  This result 
suggests two possibilities.  The first being that the change in local DNA structure 
surrounding the Ap-site allowed for easier attachment of the deoxyguanine residue with 
the Ap-site on the 32P-labeled strand.  The second possibility being that the cross-linking 
site has changed.  Described throughout this chapter, we examined 38 Ap-containing 
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sequences where both sequence and site of cross-link attachment are major contributors 
to the varied yields (~1-96%) of DNA cross-links. 
 
Figure 1 
 
Figure 1.  Interstrand cross-link formation in 32P-labeled 2’-deoxyoligonucleotides 
duplexes B, H, I, and J under native (pH 7) conditions.  Duplex B, lanes 1-5, H, lanes 6-
10, I, lanes 11-15, and J, lanes 16-20.  The uracil-containing duplex appear in lanes 1, 6, 
11, and 16. The Ap-containing duplexes without incubation appear in lanes 2, 7, 12, and 
17.  The Ap-containing duplexes cleaved by treatment with piperidine (1 M, 95 ˚C, for 25 
min) appear in lanes 3, 8, 13, and 18).  The cross-linking reactions involving incubation 
of the Ap-containing duplex in HEPES buffer (50 mM, pH 7) and NaCl (100 mM) at 37 
˚C for 3 d appear in lanes 4, 9, 14, and 19.  The Ap-containing duplexes in HEPES buffer 
(50 mM, pH 7), NaCl (100 mM), and methoxyamine hydrochloride (2 mM) at 37 ˚C for 3 
d appear in lanes 5, 10, 15, and 20.  The were resolved on a sequencing gel and the 
radioactivity in each band quantitatively measured by phosphorimager analysis. 
 
5`-32P-ATAGATGAACApAAGACATATA
3`-TATCTACTTG A TTCTGTATAT
5`-32P-ATAGATGAACApGAGACATATA
3`-TATCTACTTG A CTCTGTATAT
5`-32P-ATAGATGAACApTAGACATATA
3`-TATCTACTTG A ATCTGTATAT
5`-32P-ATAGATGAACApCAGACATATA
3`-TATCTACTTG A GTCTGTATAT
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 19 20
5`-CXA
3`-GAT
5`-CXC
3`-GAG
5`-CXT
3`-GAA
5`-CXG
3`-GAC
B
H
I
J
18
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 We examined various Ap-containing DNA structures obtained from the PDB 
database that were generated using 2D-NMR.6-8 In general, a DNA duplex containing a 
single Ap-site is modeled to retain B-form DNA structure.6-8 But upon closer 
examination, we see that the Ap-site orientation within the duplex can vary wildly.  The 
structures of different Ap-containing duplexes can develop "kinks" in the DNA, or they 
can completely collapse around the Ap-site to relieve the missing base pair stacking 
(Figure 2).6-8  The important thing to remember is that the DNA double helix is not a 
static structure.  We developed an Ap-containing model of duplex I (Figure 3) generated 
from the PDB file 2HPX.9 Here we removed a thymine residue to construct an Ap-site 
opposing the adenine residue to model duplex I.  It is important to note that the N2-amino 
group of the guanine is located in the minor groove, whereas the N6-amino group of 
adenine is located in the major groove.  While located in two distinct positions, the 
exocyclic amines are pointed in the direction of the Ap-site.  Minor twists of the DNA 
bases would provide optimal positioning for nucleophilic attack of the Ap-aldehyde of 
the dG or dA residue.   
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Figure 2 
 
Figure 2.  Ap-containing DNA molecular models obtained from the RCSB protein 
databank.  PDB files obtained have matching sequences except the directly opposing 
base: 2O7W (left, dG), 2O82 (middle, dC), and 2O7Y (right, dT).  The DNA duplex is 
depicted as wire frames with the Ap-site indicated as bolded sticks. 
 
Figure 3 
 
Figure 3.  Abasic site containing molecular model with opposing dG and dA residues. 
 
We measured the distance between the exocyclic nitrogen atoms of each base to the 
aldehyde carbon of the Ap-site (Figure 3).   We see that the N2-amino group of guanine 
was ~3.3 Å closer to the Ap site than the N6-amino group of adenine.  For this reason one 
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may not initially suspect a cross-link would form between either exocyclic amino group 
and the Ap-aldehyde.  Though in aqueous solutions DNA is fluid and flexible, dependent 
on the ionic strength of the solution.10 This flexibility may explain why Ap-sites are 
capable of forming cross-links.  It is important to remember the directly opposing adenine 
residue (in between the dG and dA in duplex I) did not form detectable cross-links.  
While this base positioned closer to the Ap-site than the 3`-dA or 5`-dG, the exocyclic 
amine is not positioned well for an appropriate nucleophilic attack on the Ap-aldehyde. 
 If DNA sequence can directly affect position of Ap-sites in DNA duplexes,6-9 then 
that could have a pronounced effect on how the Ap-site can cross-link.  The results in 
Figure 1 obligated us to determine the site of attachment for the high yielding cross-link 
of duplex I.  We performed DNA footprinting reactions as described in Chapter 3.  
Figure 4 displays the hydroxyl radical footprinting of duplex K, a longer DNA sequence 
containing the core 5`-CApT sequence.  After incubation of Ap-containing duplex K in 
HEPES buffer (50 mM, pH 7) with NaCl (100 mM) at 37 °C, the resulting cross-link was 
purified by 20% denaturing PAGE and subjected to !OH cleavage.  From the gel, we can 
see a clear interruption of the ladder in lanes 6-8 containing the cross-link treated with the 
H2O2-iron-EDTA complex.  The labeled adenines from duplex K were listed above their 
corresponding peaks in the histograms, showing us that A6 (in red) was indeed the 
adenine cross-linked to the Ap-site.  We published these results in the Journal of the 
American Chemical Society, accepted at the beginning of 2014.  This chapter discusses 
the formation of this high yielding dA-Ap cross-link, as well as how variation in local 
sequence affects the Ap-derived cross-links in general.   
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Figure 4 
 
Figure 4.  Hydroxyl radical footprinting of duplex K to locate the site of cross-link 
attachment.  Lane 1 is a Maxam-Gilbert G-specific cleavage (sequencing) reaction of the 
labeled 2’-deoxyoligonucleotide strand in duplex K.  Lane 2 is an A+G specific cleavage 
(sequencing) reaction of the labeled 2’-deoxyoligonucleotide strand in duplex K.  Lanes 
3-5 the hydroxyl radical footprinting reaction of the labeled 2’-deoxyoligonucleotide 
strand in duplex K.  Lanes 6-9 are the hydroxyl radical footprinting reaction of the slow-
migrating, cross-link band generated by incubation of duplex K in HEPES buffer (50 
mM, pH 7) and NaCl (100 mM) at 37 ˚C.  32P-labeled 2’-deoxyoligonucleotides were 
resolved on a polyacrylamide gel visualized by phosphorimager analysis (Panel A) and 
used to develop densitometry traces (Panels B-D).  Panel B is the trace of lane 1.  Panel C 
is the trace of lane 2.  Panel D is the trace of lane 8. 
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4.3  Formation and Stability of the High Yielding dA-Ap 
 It is astounding that duplex I generated such a high yielding cross-link.  This 
would allow easy and efficient preparation of an Ap-site derived cross-link for further 
experimentation.  Performing a time-course reaction under neutral conditions shows us 
that the cross-link can form in yields of up to ~78% after incubating for 5 d (Figure 5), 
the majority of which is formed in under 3 d.  With a half-time to completion calculated 
to be 16.3 ± 0.7% h, we see significantly more cross-link formed in 1 hour (~5 %) for 
duplex I, than in 3 days for duplex B (~2%).  This means that deoxyadenine residues 
opposing an Ap-site in the 3`-direction cross-links more efficiently than guanine 
opposing an Ap-site in the 5`-direction (Figure 3). Additionally, purification of the cross-
link by PAGE followed by further incubation under the same conditions resulted in only 
~20 % loss of cross-link from imine equilibration.  This suggesting a more stable linkage 
than the previously described low-yielding dG-Ap cross-link, consistent with a higher 
yielding cross-link equilibrium. 
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Figure 5 
 
 
Figure 5.  Time course for the formation of cross-link in duplex I.  The abasic-site-
containing duplex was incubated in HEPES buffer (50 mM, pH 7.0) and NaCl (100 mM) 
at 37 ˚C and aliquots were removed from the reaction and frozen prior to sequencing gel 
analysis.  The lower bands correspond to the full length labeled 2’-deoxyoligonucleotides 
and the upper band cross-linked DNA.  The 32P-labeled 2’-deoxyoligonucleotides were 
resolved on a polyacrylamide gel and the radioactivity in each band quantitatively 
measured by phosphorimager analysis.  The left panel shows a representative gel 
depicting the first 28 h of the cross-linking reaction.  The right panel shows results from 
obtained from full time course experiments. 
 
 The enormous difference in yield between duplexes I and B is most likely 
attributed to the higher nucleophilicity of the N6-amine on adenine compared to the N2-
amine on guanine (unpublished results by Catalino, M.).  In our follow-up paper 
discussing the dG-crosslink in 2012,5 we used the non-native nucleotide 2-aminopurine 
(P) to test this hypothesis (duplex L, figure 6).  2-aminopurine is a structural isomer of 
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adenine, in that the N6-amine is essentially migrated to the N2-position.  This amine 
migration results in a "more nucleophilic guanine," and that is precisely what we saw in 
our experiments.  This is similar to the inosine (I, Figure 6) experiments described in 
Chapter 3, using a non-native nucleotide substitution.  But instead of preventing imine 
formation as with inosine, we expected to see increased yields of cross-link using 2-
aminopurine.  Yields of up to ~20% were obtained when incubating an Ap-containing 
duplex that replaced the guanine-cytosine base pair with the 2-aminopurine-thymine base 
pair under native conditions.  This is a similar yield obtained when incubating duplex B 
under the reductive amination conditions (Chapter 3). 
Figure 6 
 
Figure 6.  Evidence for cross-link formation in 2-aminopurine-containing (P) 32P-labeled 
duplex L.  The lower band corresponds to full-length labeled single strand DNA and the 
upper band cross-linked DNA.  Lane 1 is the uracil-containing precursor of duplex L.  
Lane 2 is the abasic-site-containing duplex L without incubation.  Lane 3 is the abasic-
site-containing duplex L cleaved by treatment with piperidine (1 M, 95 ˚C, 25 min).  
Lane 4 is duplex L incubated with methoxyamine hydrochloride (2 mM) in HEPES 
buffer (50 mM, pH 7) containing NaCl (100 mM) at 37 ˚C for 72 h.  Lane 5 is duplex L 
incubated in HEPES buffer (50 mM, pH 7) containing NaCl (100 mM) at 37 ˚C for 72 h.  
The reaction mixtures were resolved on a sequencing gel and the radioactivity in each 
band quantitatively measured by phosphorimager analysis.   
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compete with the adenine in the 3`-direction from the Ap-site for cross-link formation 
(duplex M).  Incubation of this 2-aminopurine-containing duplex in HEPES buffer (50 
mM, pH 7) with NaCl (100 mM) at 37 °C for 3 d provided two bands of slowed mobility.  
This indicates the presence of two structurally different cross-links as we expected 
(Figure 7).  The yields obtained were 8.2% and 10.7%.  This result shows that two DNA 
bases of isomeric structure formed cross-links in comparable yields, suggesting adenine 
and 2-aminopurine form Ap-derived cross-links to a similar degree.  It is interesting that 
the sum of both yields do not equate to the 60-80% typically obtained in duplex I, but as 
discussed before that may be attributed to differences in DNA sequence structure.6-8   
Figure 7 
 
Figure 7.  Evidence for cross-link formation in 2-aminopurine-containing duplex M.  
Lane 1 is the uracil-containing precursor of 2’-deoxyoligonucleotide duplex M.  Lane 2 is 
the abasic-site-containing 2’-deoxyoligonucleotide duplex M without incubation.  Lane 3 
is the abasic-site-containing 2’-deoxyoligonucleotide duplex M cleaved by treatment 
with piperidine (1 M, 95 ˚C, 25 min).  Lane 4 is duplex M incubated in HEPES buffer 
(50 mM, pH 7) containing NaCl (100 mM) at 37 ˚C for 72 h.  Lane 5 is duplex M 
incubated with methoxyamine hydrochloride (2 mM) in HEPES buffer (50 mM, pH 7) 
containing NaCl (100 mM) at 37 ˚C for 72 h.  The reaction mixtures were resolved on a 
sequencing gel and the radioactivity in each band quantitatively measured by 
phosphorimager analysis.   
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 We tested the stability of this high yielding dA-Ap cross-link using post-
formation work-up conditions employed in Chapter 3.  Figure 8 displays the results.  
After 15-minute treatments, changes in pH did not affect cross-link yield, and dilute 
piperidine (100 mM) treatment at 60 °C halved the yield.  We saw that 90 °C heat will 
dissociate the cross-link almost completely, but most interesting was that 60 °C heat 
alone only gave us a minor decrease in remaining cross-link.  This potentially owes to a 
greater stability of the dA-cross-link in duplex I over the dG cross-link in duplex B, 
evident of substantially greater cross-link equilibrium yield.  An Ap-containing duplex 
that favor's cross-link formation, should therefore be harder to reverse.   
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Figure 8 
 
Figure 8. Stability of the cross-linked duplex I when subjected to various post-formation 
work-up conditions.  Panel A displays the remaining amount of cross-linked DNA after 
various treatments compared with untreated cross-link.  Lane 1 is the uracil-containing 
precursor of 2’-deoxyoligonucleotide duplex I.  Lane 2 is the abasic-site-containing 2’-
deoxyoligonucleotide duplex I without incubation.  Lane 3 is the abasic-site-containing 
2’-deoxyoligonucleotide duplex I cleaved by treatment with piperidine (1 M, 95 ˚C, 25 
min).  Lane 4 is duplex I incubated in HEPES buffer (50 mM, pH 7) containing NaCl 
(100 mM) at 37 ˚C, ethanol precipitated and stored in water for 15 min.  Lanes 5-9 show 
cross-linked DNA generated as described for lane 4 except subjected to various work-up 
conditions:  lane 5, 60 ˚C, 15 min; lane 6, 90 ˚C, 15 min; lane 7, pH adjusted to 3, 15 
min; lane 8, pH adjusted to 10, 15 min; lane 9, 100 mM piperidine, 60˚ C, 15 min.  Panel 
B is a bar graph with a quantitative illustration of the data from the gels.  The yields of 
the cross-linked DNA obtained remaining after various work-ups were normalized 
against the amount of cross-link present in the sample that was similarly precipitated, but 
not subjected to any work-up (lane 4). 
 
 Incubation of duplex I in the presence of various additives directly affected the 
equilibrium yield of cross-links (Figure 9).  The Ap-derived cross-link formed in the 
presence of biologically relevant thiol (1 mM), and actually observed a slight increase in 
yield in the presence of GSH.  Aromatic and aliphatic amines (1 mM) significantly 
inhibited cross-link formation, most likely through competing imine formation.  Various 
known DNA intercalators ethidium bromide, daunomycin, and proflavine (1 mM) were 
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also examined.  These agents inhibited cross-link formation.  We postulated that the 
intercalation between bases physically blocks cross-link formation and rigidifies the 
DNA duplex through the added aromatic stacking interactions as well.  This would result 
in a less flexible duplex, and thus make it harder for the N6-amine of adenine to "reach" 
the electrophilic aldehyde.  As seen in Chapter 3, the aldehyde trapping agent 
methoxyamine also inhibited cross-link formation. 
 
Figure 9 
 
Figure 9.  Formation of native dA-Ap cross-link examined in the presence of various 
nucleophiles.  Yields relative to a standard cross-linking reaction (Control, no additive) 
involving incubation of duplex I in HEPES buffer (50 mM, pH 7) containing NaCl (100 
mM) and the listed additive (1 mM) at 37 ˚C for 72 h. 
 
 We were curious whether incubating duplex I under the reductive amination 
conditions employed in Chapter 3 would provide improved yields of a stable reduced 
cross-link (structure 4, Figure 10).  Unfortunately through several attempts we could not 
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fact, incubation of duplex I under the reductive amination conditions yielded a pair of 
bands with distinct gel mobility.  Figure 10 shows two sets of data for duplexes B and I 
run side by side, both incubated under the neutral conditions and reductive amination 
conditions.  Based upon gel mobility, lane 4 shows that duplex I generated a band that 
was also formed under neutral conditions (structure 3, lane 3).  Additionally, a slightly 
slower moving band with the same mobility as the reduced dG cross-link resulting from 
incubation of duplex B under reductive amination conditions was also seen (structure 2, 
lane 2).  This tells us that the dG-Ap cross-link (Figure 10, structure 1) is reduced (Figure 
10, structure 2) selectively under our conditions, and that duplex I has the potential to 
still form dG-Ap cross-links as well as dA-Ap cross-links.  We assume that since the dA-
Ap cross-link (Figure 10, structure 3) yield is so high, that it predominates over the dG-
Ap cross-link making it difficult to detect.   
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Figure 10 
 
Figure 10.  Generation of reduced dG-Ap cross-link in duplex I.  Lane 1 is duplex B 
incubated in HEPES buffer (50 mM, pH 7) containing NaCl (100 mM) at 37 ˚C for 72 h.  
Lane 2 is duplex B incubated in sodium acetate buffer (750 mM, pH 5.2) containing 
NaCNBH3 (250 mM) at 37 ˚C for 24 h.  Lane 3 is duplex I incubated in HEPES buffer 
(50 mM, pH 7) containing NaCl (100 mM) at 37 ˚C for 72 h.  Lane 4 is duplex I 
incubated in sodium acetate buffer (750 mM, pH 5.2) containing NaCNBH3 (250 mM) at 
37 ˚C for 24 h.  Reactions were ethanol precipitated before being resolved on a 
sequencing gel. 
 
 We were curious why the dA-Ap cross-link characterized does not seem to 
undergo reduction under the reductive conditions employed in these studies.  We 
speculate that imine formation between adenine residues behaves differently than with 
guanosine, preventing reduction of any the imine that may (or may not) form in solution.   
 Nanospray QTOF MS of a cross-link generated from dupex I-2 under native (non-
reductive) conditions (Figure 11) yielded a mass of 7162.3 Da (calc. mass: 7162.8).  This 
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3 (Figure 10), following a similar mechanism of formation described in Chapter 3, 
Scheme 3.  We are unsure why we cannot stabilize the dA-Ap cross-link by reduction, 
but it is possible the imine intermediate is trapped by ring closure too quickly, preventing 
hydride reduction.  While chemically interesting, we did not pursue this further for our 
studies. 
Figure 11 
 
Figure 11.  Nanospray QTOF MS of a cross-linked duplex containing the same core 
sequence found in duplex I (I-2) prepared by incubating in HEPES (50 mM, pH 7) and 
NaCl (100 mM) at 37 °C for 3 d and isolated from a 20% denaturing polyacrylamide gel. 
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incubated in HEPES buffer (50 mM, pH 7) with NaCl (100 mM) at 37 °C for 3 d or 
NaOAc buffer (750 mM, pH 5.2) with NaCNBH3 (250 mM) for 1 d.  Following 
incubation, the reactions were ethanol precipitated and analyzed by 20% denaturing 
polyacrylamide gel electrophoresis as before.  Table 1 and 2 summarizes the equilibrium 
yields of all cross-links obtained, under the biologically relevant neutral conditions or 
chemically stabilized reductive amination conditions. 
 Quickly skimming through Tables 1 and 2, one can see that cross-link yields vary 
greatly, despite the fact that the sequence variations are subtle.  It may be useful to 
compare the yields listed for each sequence to entries a (Table 1) and aa (Table 2), as 
those correspond to duplexes I and B respectively.  We obtained cross-link yields varied 
between 0.2-95.5%.  Generally dA-Ap cross-linking duplexes containing 5`-ApT 
sequences (entries a-q) generated high yielding cross-links under the native pH 7 
conditions.  Base pair changes in both the 5`-direction and 3`-direction of the cross-
linking sites greatly affected the dA-Ap cross-link yields (b-j) and reduced dG-Ap cross-
link yields (bb-ii).  The unreduced dG-Ap cross-links were not affected as significantly in 
regards to overall cross-link yield.  The use of non-natural bases inosine (I), 2-
aminopurine (P), and 2,6-diaminopurine (D) (Figure 6) provided expected results on 
cross-link formation: inosine prevented cross-links from forming, while 2-aminopurine 
and 2,6-diaminopurine increased cross-link yields, as well as resulting in multiple cross-
links (Tables 1 and 2). 
 Other than non-natural nucleobases, base pair mismatches generally had the 
largest impact on relative cross-link yield (entries k-o and jj-mm).  Entries containing A-
A mismatches near the cross-linking dA residue (3`-direction, entries m-o) produced high 
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yields of dA-Ap cross-link, while mismatches on the opposite side (5`-direction, entries k 
an l) significantly decreased cross-link yield.  Entry jj, which does not contain a dA 
residue in the dA-Ap cross-linking position on the opposing strand in the 3`-side of the 
Ap-site, surprisingly produced a high yield of cross-link under the neutral pH 7 
incubation conditions.  This is interesting because a dG residue capable of cross-linking 
still resides in the sequence, though we have not yet observed such a high dG cross-link 
yield formed under native conditions.  We set out to footprint this reaction to determine if 
the A-C mismatch resulted in a higher yielding dG-Ap cross-link, or if some other 
nucleobase forged an attachment with the Ap-site in this sequence. 
 
Table 1.  Survey of Various dA-Ap Cross-Linking DNA Sequences.   
 
 
 
Table 1.  Ap-containing duplexes were incubated in HEPES buffer (50 mM, pH 7) with 
NaCl (100 mM) at 37 °C for 3 d or NaOAc buffer (750 mM, pH 5.2) with NaCNBH3 
(250 mM) for 1 d.  Reactions were resolved on a sequencing gel and quantified by 
autoradiography.  Yields listed as % of total 32P-labeled DNA in the reaction.  Bases 
marked in red indicates sequence changes made based off entry a. 
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Table 2.  Survey of Various dG-Ap Cross-linking DNA Sequences.   
 
 
Table 2.  Ap-containing duplexes were incubated in HEPES buffer (50 mM, pH 7) with 
NaCl (100 mM) at 37 °C for 3 d or NaOAc buffer (750 mM, pH 5.2) with NaCNBH3 
(250 mM) for 1 d.  Reactions were resolved on a sequencing gel and quantified by 
autoradiography.  Yields listed as % of total 32P-labeled DNA in the reaction.  Bases 
marked in red indicate sequences changes made based off entry aa. 
 
 
 
 
 
 
 
 
 
 
	  
Ap-Derived DNA Interstrand Cross-Links are Sequence Dependent                Chapter 4	  
	   245	  
Figure 12 
 
Figure 12.  Hydroxyl radical footprinting of 32P-labeled 2’-deoxyoligonucleotide duplex 
JJ to locate the site of cross-link attachment.  Lane 1 is a Maxam-Gilbert G-specific 
cleavage (sequencing) reaction of the 32P-labeled strand in duplex JJ.  Lane 2 is an A+G 
specific cleavage (sequencing) reaction of the 32P-labeled strand in duplex JJ.  Lane 3 is 
the hydroxyl radical footprinting reaction of the 32P-labeled strand in duplex JJ.  Lane 4 
is the hydroxyl radical footprinting reaction of the 32P-labeled slow-migrating cross-link 
band generated by incubation of duplex JJ in HEPES buffer (pH 7, 50 mM) and NaCl 
(100 mM) at 37 ˚C for 3 d.  32P-labeled 2’-deoxyoligonucleotides were resolved on a 
polyacrylamide gel visualized by phosphorimager analysis (Panel A) and used to develop 
densitometry traces (Panels B-D).  Panel B is the trace of lane 1.  Panel C is the trace of 
lane 2.  Panel D is the trace of lane 4. 
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 We performed hydroxyl radical footprinting on the duplex for entry jj in Table 1 
(duplex JJ, Figure 12) to determine the site of attachment.  We concluded that duplex JJ 
yielded a cross-link between the deoxycytidine residue and the Ap-site.  As shown by the 
break in the ladder (lane 4), the band does not match with a dG or dA residue (lanes 1 and 
2).  Presumably the distorted structure resulting from the A-C mismatch 3`-from the Ap-
site resulted in a favorable interaction between the deoxycytidine (dC) residue and the 
Ap-site.  This is the first direct evidence we have obtained for a linkage between an Ap-
site and a dC residue.   
 
4.5  Native dA-Ap and Reduced dG-Ap Cross-Links Stalls Polymerase Φ29 
 With such a large assortment of cross-linking sequences, the potential biological 
significance of these Ap-site derived cross-links appears to be substantial.  It is therefore 
important to understand how these DNA lesions behave during DNA transcription and 
replication.1, 11 We already discussed in Chapter 3 that DNA interstrand cross-links 
prevent strand separation, blocking DNA and RNA polymerases from performing their 
function.12 
 We used a simple model where Phi29 polymerase (Φ29) is utilized to assess the 
capabilities of these cross-links to block primer extension reactions.13-14 Φ29 polymerase 
is an enzyme isolated from the Bacteriophage Φ29.  The protein exhibits effective 
polymerase activity, with strand displacement properties as well.13-14 This allows us to 
model DNA replication using double stranded DNA without the need for a helicase 
protein.  We tested for polymerase stalling by each the native dA-Ap cross-link (structure 
3, Figure 6) and reduced dG-Ap cross-link (structure 2, Figure 6) by incubating DNA 
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duplexes resembling duplex I and B with Φ29.  We incubated unlabeled Ap-containing 
duplexes (PA and PG, Figure 13) containing the central base pair sequences seen in 
duplexes I and B under neutral (pH 7) or reductive amination (pH 5.2, NaCNBH3) 
conditions previously described.  The resulting cross-links generated were purified by 
denaturing PAGE, eluted from the gel, desalted, and annealed with a 5`-32P-labeled 15-
mer primer (Figure 13, PA-3 and PG-3).  Control duplexes missing the cross-link (PA-2 
and PG-2) or the uracil-containing strand (PA-1 and PG-1) but still containing the 5`-32P-
labeled 15-mer primer were prepared as well.  Figure 14 display the results of Φ29 
extension for the dA-Ap cross-link and reduced dG-cross-link. 
Figure 13 
 
Figure 13.  Sequences used for primer extension reactions containing either the native 
dA-Ap cross-link (PA) or the reduced dG-Ap cross-link (PG).  Three duplexes each were 
extended with Φ29: 1-primer hybridized to the template strand, 2- primer hybridized to 
the template strand annealed to the uracil containing strand, and 3- primer hybridized to 
the cross-linked template. 
 
 
 
5`-ATAGATGAATApAAGACATATA
3`-CTACTGTCACTCATGTTATCTTATCTACTTG A TTCTGTATAT
5`-ATAGATGAATApTAGACATATA
3`-CTACTGTCACTCATGTTATCTTATCTACTTG A ATCTGTATAT
5`-32P-GATGACAGTGAGTAC
5`-32P-GATGACAGTGAGTAC
PA-3
PG-3
5`-ATAGATGAATUAAGACATATA
3`-CTACTGTCACTCATGTTATCTTATCTACTTGATTCTGTATAT
5`-ATAGATGAATUTAGACATATA
3`-CTACTGTCACTCATGTTATCTTATCTACTTGAATCTGTATAT
5`-32P-GATGACAGTGAGTAC
5`-32P-GATGACAGTGAGTAC
PA-2
PG-2
3`-CTACTGTCACTCATGTTATCTTATCTACTTGATTCTGTATAT
3`-CTACTGTCACTCATGTTATCTTATCTACTTGAATCTGTATAT
5`-32P-GATGACAGTGAGTAC
5`-32P-GATGACAGTGAGTAC
PA-1
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Figure 14 
 
Figure 14.  Phi29 primer extension of duplexes PA (Panel A) and PG (Panel B) using 
templates 1, 2, and 3.  The lower bands corresponds to non-extended primer (15-mer) and 
the upper bands  corresponds to fully extended primer (42-mer) as marked by 32P-labled 
standards.  Lanes marked as 1, 2, or 3 contain primer extension reactions incubated in 
NEB buffer (1X) with primer annealed template (0.4 ρmol/µL final conc.), DNTPs (200 
µM), BSA (200 µg/mL) and Φ29 (400 U/mL) absent of the uracil containing strand (lane 
1), annealed to the uracil-containing strand (lane 2), or cross-linked to the Ap-containing 
strand (lane 3) at 37 °C for the indicated time.  Reactions were quenched with EDTA (10 
mM, pH 7) and ethanol precipitated before being separated on a sequencing gel. 
 
 Incubation of primer annealed duplexes with Φ29 in the presence of a mixture of 
deoxyribonucleotide triphosphates (dNTPs, 200 mM) at 37 °C yielded extended 32P-
labeled products.  After the reactions were quenched and analyzed by PAGE, lanes 2 and 
30min 60min 30min 60min
5`-CApT
3`-G A A
1
2
3
Extension
32P-5`
32P-5`
32P-5`
1 2 3 1 2 3 1 2 3 1 2 3
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5`-CApA
3`-G A T
site 1 site 1
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3 left a light ladder of uncompleted extended primers, primarily in the range of where 
annealed DNA duplexes begin (site 1, Figure 14).  Here we see the start of bands forming 
that correspond to initial stalling at the beginning of strand displacement.  Primer 
extension of cross-linked duplexes PA-3 and PG-3 results in a dark band where the 
cross-linking site would be just short of the fully extended products (lane 3, site 2, Figure 
14).  This indicates significant stalling of the primer extension reaction occurred.  As 
expected, the cross-link inhibited the primer extension reaction from finishing.  This 
provided first evidence that Ap-derived cross-links could block strand separation by 
helicase enzymes, required for DNA transcription and replication to occur.12  
 We see quantifiable amounts of fully extended product for cross-link containing 
reactions.  This is not surprising as the dA-Ap cross-link (Figure 13, duplex PA-3) was 
already characterized as reversible, meaning there most likely was a small amount of 
reversed cross-link at the start of the primer extension reaction resulting in fully extended 
primer product.  And although PA would produce a reversible cross-link, significant 
amounts of stalled extension product were still obtained (Figure 14, lane 3).  We were 
surprised to see a similar result, though not as significant, for the reduced dG-Ap cross-
link.  Theoretically an irreversible cross-link (Chapter 3) would completely prevent 
strand separation, thereby preventing completion of the primer extension reaction.  It is 
possible that the fully extended product could result from polymerase bypass,15 involving 
extension past the lesion.  To investigate, a sample of the prepared reduced dG-Ap cross-
link stock (duplex PG-3) was 5`-labeled and analyzed by PAGE.  Results indicated a 
portion (~5%) of the purified cross-link for PG-3 was contaminated with uncross-linked 
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single-strand DNA.  This can account for the small amount of fully extended primer seen 
in lane 3 for duplex PG. 
 
4.5 Chapter 4 Summary 
 In this chapter we characterized cross-link formation between an Ap-site and a 
deoxyadenine residue on the opposing strand of a DNA duplex.  We characterized these 
cross-links specifically as higher yielding reversible DNA adducts.  The results were 
consistent with cross-link generation via reversible imine formation, involving attack of 
the exocyclic amino group of adenine or guanine (or cytosine) on the aldehyde of an Ap-
site.  This likely proceeds via hemiaminal (2, Scheme 1) formation followed by 
dehydration (3, Scheme 1) and ring closure (4, Scheme 1), supported by mass 
spectrometry analysis.  It is also possible that the cross-link could exist partially as 
enamine 5, supplying some evidence as to why we do not observe stabilization by 
reduction with hydride.  Literature precedent supports hemiaminal structure 4 as being 
the predominant form.16-17 This is also supported by the significant stability of the cross-
link, allowing for isolation from a gel.  Combined with the results discussed in Chapter 3, 
we have identified that both dG and dA can adduct with Ap-sites to form two distinct 
cross-links.  Defining 5`-CAp/5`-AG and 5`-ApT/5`-AA core sequences as optimal 
locations for Ap-derived cross-links to form, where the underlined bases are involved in 
Ap-adduction.18 
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Scheme 1 
 
 We see a distinct preference for dA-Ap over dG-Ap crosslink formation.  We 
believe this results from the lower inherent nucelophilicity of dG. This is supported by 
substitution of dG for 2-aminopurine (P) in duplex M resulting in a second cross-link 
product, most likely with the 2-aminopurine residue.  We cannot rule out base positioning 
as having significant effect towards imine formation of the Ap-site, as seen by the varied 
yields in cross-link formation dependent on DNA sequence (Tables 1 and 2).  Observing 
cross-link formation for so many unique sequences further supports biological 
significance of the lesion.  And even though Ap-sites are only estimated to exist as an 
aldehyde at ~1% abundance, the human genome is ~3.2 x 109 base pairs in size,19 with 
estimated steady state levels of Ap-sites are approximately 1 lesion per 105 nucelotides.20  
Making the possibility of Ap-derived cross-links more prevalent, particularly for some of 
the higher yielding Ap-containing cross-link sequences.   
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 We know that DNA repair processes initiated by APE1 are efficient in processing 
Ap-sites, and that this would compete with cross-link formation.  Additionally Ap-sites 
spontaneously cleave if not repaired, resulting in single strand breaks.21 Therefore not all 
Ap-sites would engage in DNA cross-linking.  But given the chance, an Ap-derived DNA 
interstrand cross-link could present significant challenges to replication, transcriptions 
and repair.  Upon initial inspection, Ap-derived cross-links appear to inhibit Φ29 
polymerase activity.  We see distinct primer extension stalling (if not complete 
inhibition) at the cross-link site as shown in Figure 14, similar to other known DNA 
interstrand cross-links.15  
 In summary, Ap-derived DNA interstrand cross-links have potential significance, 
with observed native cross-link yields of anywhere between ~1-80%.  With a large 
variety of possible cross-linking sequences, these lesions could explain why complicated 
repair pathways such as NER are utilized in eukaryotic cells, repairing lesions formed 
endogenously on genomic DNA for cell survival.1-3 Finally, one example of literature 
providing evidence for the existence of Ap-derived interstrand cross-links was from 
examination of ancient DNA.  It has been theorized that difficulty in sequencing and 
amplification of ancient DNA is the result of cross-links, in addition to oxidative damage, 
Ap-sites, and strand breaks.22 Studies are still needed to provide hard evidence of Ap-
derived cross-links generated in cells utilizing LC-MS analysis of enzymatically digested 
DNA and small molecule synthetic standards, a project currently underway in the Gates 
research group. 
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4.7  Experimental 
Materials and Methods.  Oligonucleotides were purchased from Integrated DNA 
Technologies.  All enzymes were purchased from New England Biolabs (Ipswich, MA, 
USA).  [γ-32P]-ATP (6000 Ci/mmol) was purchased from Perkin Elmer.  C-18 sep-pak 
cartridges were from Waters.  BS Polyprep columns were purchased from BioRad.  
Quantification of radioactivity in polyacrylamide gels was carried out using a Personal 
Molecular Imager (BIORAD) with Quantity One software (v.4.6.5).  All other reagents 
were purchased from Sigma-Aldrich. 
 
Representative procedure for cross-link formation.  Single-stranded uracil containing 
2’-deoxyoligonucleotides were 5’-labeled using standard procedures.  Labeled DNA was 
annealed23 with its complimentary strand and treated with the enzyme UDG (50 
units/mL, final concentration) to generate Ap sites.  UDG enzyme was removed by 
phenol-chloroform extraction.23  Individual DNA duplexes were incubated in a buffer 
composed of HEPES (50 mM, pH 7) containing NaCl (100 mM) at 37 ˚C for 72 h.  The 
DNA was ethanol precipitated,23 resuspended in formamide loading buffer,23 loaded onto 
a 20% denaturing polyacrylamide gel, and the gel electrophoresed for 4 h at 1000 V.  
Direct loading of cross-linking reactions (without ethanol precipitation) showed that 
ethanol precipitation does not alter the yield of the slow-migrating, cross-link band.  The 
amount of radiolabeled DNA in each band on the gel was measured by phosphorimager 
analysis.  The time course for the formation of the Ap site cross-link was carried out by 
incubating a solution containing labeled DNA (approximately 300,000 cpm), in  HEPES 
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(50 mM, pH 7) and NaCl (100 mM) at 37 ˚C.  At specified time points, aliquots (10 µL) 
were removed and frozen at –20 ˚C, after all time points were collected samples were 
loaded directly on the gel and analyzed as described above. 
 
Hydroxyl radical footprinting of cross-linked duplexes.  Standard literature protocols 
were used in the footprinting of the cross-linked duplexes.24-25  In these experiments, the 
strand opposing the uracil-containing oligonucleotide was 5’-labeled using standard 
procedures.23  Labeled DNA was annealed with the uracil-containing complement and 
treated with UDG to generate the abasic site as described above.  The Ap-containing 
double-stranded DNA (~500,000 cpm) was incubated in HEPES (50 mM, pH 7) and 
NaCl (100 mM) at 37 ˚C for 120 h.  The DNA was ethanol precipitated, suspended in 
formamide loading buffer, and the 2’-deoxyoligonucleotides resolved on a 0.4 mm thick 
20% denaturing polyacrylamide gel.  The slow-migrating cross-linked duplex band was 
visualized using X-ray film, the band cut out of the gel, the gel slice crushed, and the gel 
pieces vortexed in elution buffer (NaCl 200 mM; EDTA, 1 mM) at room temperature for 
at least 1 h.  The mixture was filtered through a poly-prep column to remove gel 
fragments and the filtrate desalted using a C18 Sep-pak (100 mg size).  The resulting 
solution was evaporated using a Speed-Vac concentrator, the residue redissolved in water 
(24 µL), split evenly into three microcentrifuge tubes, and diluted with 2x oxidation 
buffer (10 µL of a solution composed of sodium phosphate, 20 mM, pH 7.2; NaCl, 20 
mM; sodium ascorbate, 2 mM; H2O2, 1 mM).  To this mixture was added a solution of 
iron-EDTA (2 µL, EDTA, 70 mM; Fe(NH4)2(SO4)2•6H2O, 70 mM) to start the reaction, 
the mixture vortexed briefly, and incubated at room temperature for 1, 2, and 3 min 
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before addition of thiourea stop solution (10 µL of a 100 mM solution in water).  
Hydroxyl radical footprinting reactions, Maxam-Gilbert G, and Maxam-Gilbert A+G 
reactions were performed on the labeled single-strand to generate marker lanes.26  The 
resulting DNA fragments were analyzed using gel electrophoresis as described above. 
 
Static Nanospray QTOF MS.  The oligonucleotide sample was analyzed in a 40 mM 
dimethylbutylammonium acetate (pH 7.1) buffer.  Negative ion MS spectra was taken for 
mass range of 280-3200 Da on an Agilent6520A QTOF MS with Chip Cube source 
(G4240A).  Monoisotopic neutral masses were calculated from the multiply charged ion 
spectrum present in the 500-2000 Da mass range.  Sample introduction was done with 
New Objective Econo12 N uncoated borosilicate glass emitters.  Negative ion spectrum 
was acquired at a capillary potential sufficient to initiate spray of the sample.  The 
nitrogen gas was heated to 290°C and introduced at a flow rate of 4L/min. The 
Fragmentor, Skimmer, and Octapole1 RF Vpp potentials were set to 200 V, 65 V, and 
750 V, respectively.  External Calibration was done with the Agilent ESI-Low calibration 
tuning mixture (cat. no. G1969-85000) and data analysis was performed with Agilent 
Mass Hunter Workstation Qualitative Analysis software v B.02.00, Build 2.0.197.0 with 
Bioconfirm Software (2008).  Peptide isotope model was assumed and peak set height 
threshold for extraction was set to ≥ 500 counts.  Deconvolution was done with a 0.1 Da 
step size with a result of 20 iterations of the algorithm calculation 
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Chapter 5.  DNA Interstrand Cross-Links Derived From 
Single Strand Breaks in the DNA Duplex. 
 
 
5.1 Introduction 
 As discussed in Chapter 3, Ap sites (1, Scheme 1) resulting from hydrolysis of the 
glycosidic bond are among the most common form of DNA damage.1 C4`-Oxidized Ap-
sites have also been shown to be generated by radiation or bleomycin (C4-AP, Scheme 2) 
via C4`-hydrogen abstraction from the deoxyribose sugar, followed by oxidation.2 
Additionally, several other oxidized Ap-sites have been identified.3 The C4`-oxidized Ap 
sites have been shown to cross-link with lysine and deoxyadenine residues (structures 10 
and 11, Scheme 3).4  
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Scheme 1 
 
 One common reaction of C4`-oxidized Ap sites is α,β-cleavage to give structure 9 
by elimination of the 3`-phosphate group.5 The elimination product 9 exists as an 
equilibrium mixture of ring closed (9cyc) form and ring opened α,β-unsaturated aldehydes 
(9open).  In general, α,β-unsaturated aldehydes are reactive electrophiles, readily reacting 
with various nucleophiles at the β-carbon via conjugate addition reactions (Scheme 3).  
For example, acrolein, a simple α,β-unsaturated aldehyde, has been studied for its 
toxicological effects as it is a common environmental pollutant from many sources 
(cooking, smoking, plastics).6-7 Acrolein has been shown to readily form adducts with 
both enzymes and DNA bases,8-10 and can cause DNA-DNA inter- and intrastrand cross-
links between two deoxyguanosine residues in a 5`-CG sequence (Chapter 3, Scheme 2).9 
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Scheme 2 
 
 
Scheme 3 
 
 Similarly, the α,β-unsaturated oxidized Ap-site 9 has been shown to be highly 
reactive in DNA,3-4 forming cross-link adducts with an opposing deoxyadenine (12) or 
deoxycytosine (13) residue in the DNA duplex through conjugate addition and imine 
formation (Scheme 3).2, 4 DNA cross-links of this type are especially deleterious to cells, 
as failed repair by NER can result in double-strand breaks.4  
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 While cross-links generated from the C4-oxidized α,β-unsaturated Ap site (9) 
have been well characterized,2-4 cross-links have yet to be indentified from native α,β-
unsaturated Ap sites (2).  It is known that the α,β-elimination of the 3`-phosphate from 
the Ap-site occurs readily.11  This process is assisted by heat and Schiff-Base formation 
via lysines or secondary amines (Scheme 1).3,5,12 Some repair enzymes like UV 
endonuclease V, 8-oxoguanine glycosylase, and endonuclease III contain lyase activity 
that generates 2.13-18 With several sources of these lesions and substantial literature 
precedent suggesting their high degree of reactivity, 2 could potentially be a severe threat 
to the function of cellular DNA.   
 We were interested in studying the formation of what we will term "low 
molecular weight" (LMW) cross-links, derived from reaction of 2 with a nucleobase on 
the opposing strand of a DNA duplex.  This chapter will describe two different methods 
for generating 2 in 32P-5`-labeled oligonucleotides and characterization of the cross-
linked products.  Initially we utilized endonuclease III (Scheme 4), an enzyme reported to 
selectively cleave Ap-sites via β-elimination (2).19-20 Interestingly we found that Endo III 
is an inefficient reagent for generating α,β-unsaturated Ap-sites (2) as it also catalyzes 
hydration of the α,β-unsaturated Ap-site to yield a 3`-deoxyribose phosphate (4), 
resulting in a mixture of single-strand break products in our experiments (approximately 
40:60 ratio for 2 and 4).18 This led us to use spermine (14) as a Schiff-Base catalyst to 
generated 2.  We use a combination of PAGE and mass spectrometry experiments to 
analyze products formed upon incubating 2 and 4 in a DNA duplex under biologically 
relevant conditions.  Additionally we used thiols 15 (thioglycolate), 16 (glutathione), and 
17 (β-mercaptoethanol) to assist in structure determination.   
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Scheme 4 
 
 
5.2 Generating Low Molecular Weight Cross-Links with Endonuclease III 
 We initially employed endonuclease III to generate 2.  This enzyme has been used 
previously for the conversion of the C4-Ap to 9.21 We treated deoxyuridine containing 
32P-5`-labeled DNA duplexes with UDG (Scheme 4) to generate an Ap-site (1).  We used 
sequences that mimic duplexes described in earlier chapters (Duplex I, Chapter 4) 
designed to place a dA-residue with the N6-amino group in close proximity of the α,β-
eliminated abasic site.  Elimination of the 3`-phosphate was catalyzed by incubation of 
UDG treated duplex N (1) with Endo III in HEPES buffer (50 mM, pH 8) and NaCl (100 
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mM) at 37 °C for 30 minutes to give predominantly 4 with small amounts of 2.  Control 
cross-linking reactions (Chapters 3 and 4) were done by incubating Ap-containing (1) 
duplex N in HEPES buffer (50 mM, pH 7) and NaCl (100 mM) at 37 °C for 5 d.  LMW 
cross-link formation was done by incubating α,β-eliminated Ap-containing duplex N 
containing under matching conditions.  The reaction mixtures were analyzed by 20% 
denaturing PAGE to give a mixture of slow moving bands relative to un-reacted single-
stranded DNA (Figure 1).  The bands with slowest mobility was identified as the 
previously described Ap-dA cross-link (~71% yield) via gel mobility (Figure 1, lane 5) 
formed after incubation of 1 (Chapters 3 and 4).22 The slightly faster moving band, 
suggestive of a LMW cross-link (~35%), was mainly present in the reaction mixture 
incubated at 37 °C at pH 7 after pretreatment with EndoIII (lane 6).  This reaction 
resulted in significantly lower yields of the dA-AP cross-link (Chapter 4), as EndoIII 
processed the majority of the abasic DNA.  Low yields of this LMW cross-link were also 
seen in lanes 4 and 5 (~5%) from DNA not treated with EndoIII.  Most likely this 
occurred from spontaneous α,β-elimination of 1 (without EndoIII treatment).   
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Figure 1 
 
Figure 1.  Interstrand cross-link formation in 32P-labeled 2’-deoxyoligonucleotide duplex 
N.  Lanes 1 is the uracil-containing duplex.  Lane 2 is the UDG-treated (1) duplex 
without further incubation.  Lane 3 is the UDG-treated duplex subjected to piperidine 
work-up (1 M, 95 ˚C, 25 min) to cleave the Ap site.  Lane 4 is the UDG/EndoIII-treated 
duplex (2) without further incubation.  Lane 5 is the cross-linking reactions involving 
incubation of the Ap-containing duplexes (1) in HEPES buffer (50 mM, pH 7) containing 
NaCl (100 mM) at 37 ˚C.  Lane 6 is the cross-linking reactions involving incubation of 2 
in HEPES buffer (50 mM, pH 7) containing NaCl (100 mM) at 37 ˚C.  The 32P-labeled 
2’-deoxyoligonucleotides were resolved by electrophoresis on a 20% denaturing 
polyacrylamide gel and the radioactivity in each band quantitatively measured by 
phosphorimager analysis. 
 
 To avoid uncatalyzed cleavage of 1, we utilized longer duplexes to ensure neither 
the labeled nor α,β-cleaved fragment would melt off after β-elimination of Ap-containing 
DNA (1, Duplex O).  Duplex O was treated with UDG and EndoIII as before and further 
incubated in HEPES (50 mM, pH 7) and NaCl (100 mM) at 37 °C for 1 d before being 
analyzed by 20% denaturing PAGE.  The results are presented in Figure 2.  Incubation 
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after treatment with only UDG selectively provided the dA-Ap cross-link (~44%, Lane 
2).  While incubation after treatment with both UDG and EndoIII provided the LMW 
cross-link (~20%, Lane 4).  Additionally, cross-link formed in the presence of thiol 
(~17%, lane 5), but was blocked in the presence of methoxyamine (lane 6). 
Figure 2 
 
Figure 2.  Interstrand cross-link formation in 32P-labeled 2’-deoxyoligonucleotide duplex 
O.  Lane 1 is the UDG-treated duplex (1) without further incubation.  Lane 2 contains the 
cross-linking reactions involving incubation of 1 in HEPES buffer (50 mM, pH 7) 
containing NaCl (100 mM) at 37 ˚C.  Lane 3 contains the UDG and EndoIII-treated 
duplex (2) without further incubation.  Lane 4 contains the cross-linking reactions 
involving incubation of 2 in HEPES buffer (50 mM, pH 7) containing NaCl (100 mM) at 
37 ˚C.  Lane 5 is the same with thioglycolate (15, 1 mM) at 37 ˚C.  Lane 6 is the same 
with methoxyamine (2 mM) at 37 ˚C.  The 32P-labeled 2’-deoxyoligonucleotides were 
resolved by electrophoresis on a 20% denaturing polyacrylamide gel and the radioactivity 
in each band quantitatively measured by phosphorimager analysis. 
1 2 3 4 5 6
3`-TAC GTA CGA TAT TAT GAC GTA GAA TCT GTA TAC GTA CGA TAT
Duplex O
dA-Ap cross-link
LMW cross-link
(5 and 6)
Uracil DNA and 1
2, 3, and 4
5`32P-ATG CAT GCT ATA ATA CTG CAT CUT AGA CAT ATG CAT GCT ATA
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 These LMW cross-links were all obtained in relatively high equilibrium yields 
(~25-30%) within 1 day incubation at 37 °C in NaCl (100 mM) and HEPES (50 mM, pH 
7) (Figure 3A).  This is much faster rate of formation than the dA-Ap derived cross-links 
described in Chapter 4, which typically required incubations of 2-5 days to reach 
equilibrium yield.22-23 Intuitively this makes sense, as the newly formed α,β-cleaved Ap-
sites should have superior flexibility when not tethered by the 3`-phosphate (2 and 4, 
Scheme 1) and thus would react faster with opposing bases.  Additionally, the purified 
LMW cross-links dissociated much quicker as well, returning to equilibrium yields in 
less than 24 hours at 37 °C in NaCl (100 mM) and HEPES (50 mM, pH 7) buffer (Figure 
3B).  The incomplete yield and reversibility of these products suggest that imine 
formation is involved in the attachment, as imines are reversible in aqueous solutions.24-26 
Although we cannot rule out that purification involves denaturing conditions, causing 
inefficient re-hybridization and decreased stabilization.  
Figure 3 
 
Figure 3.  Time course showing formation (Panel A) and Decomposition (Panel B) of 
LMW cross-link of duplex O in HEPES buffer (50 mM, pH 7) and NaCl (100 mM) at 37 
˚C. 
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 To expand the scope of this cross-linking reaction, we examined which 
nucleobases were capable of forming LMW cross-links.  We prepared duplexes P-S 
(below), each possessing only a specific nucleobase directly opposing and flanking in the 
5`- and 3`- direction of the α,β-eliminated Ap-site (2 and 4).  This was to ensure that any 
cross-link seen from reaction of the Ap-site, resulted from reaction of that specific base 
(dA, dT, dG, or dC).  32P-labeled uracil containing DNA was treated with UDG and 
EndoIII as before and allowed to incubate further in HEPES buffer (pH 7).  After 24 
hours, the reaction products were analyzed with PAGE and the results shown in Table 1.  
Only duplexes P, R and S generated LMW cross-links. Duplex P gave the highest yield 
(~11%) of the three while duplexes R and S produced only modest yields (~3-4%).  
Additionally, no cross-link was seen for duplex Q as expected since deoxythymine 
residues do not contain exocyclic amines for cross-link formation.  While no structural 
characteristics can be confirmed, these results show that most bases have the potential to 
form LMW cross-links but suggest dA is superior.  We discuss in a later section the 
effect of LMW cross-link formation using spermine instead. 
 
 
 
5`-ATG CAT GCT ATA ATA CTG CAT TUT AGA CAT ATG CAT GCT ATA
3`-TAC GTA CGA TAT TAT GAC GTA AAA TCT GTA TAC GTA CGA TAT
5`-ATG CAT GCT ATA ATA CTG CAT CUC AGA CAT ATG CAT GCT ATA
3`-TAC GTA CGA TAT TAT GAC GTA GGG TCT GTA TAC GTA CGA TAT
5`-ATG CAT GCT ATA ATA CTG CAT GUG AGA CAT ATG CAT GCT ATA
3`-TAC GTA CGA TAT TAT GAC GTA CCC TCT GTA TAC GTA CGA TAT
P
Q
R
S
5`-ATG CAT GCT ATA ATA CTG CAT AUA AGA CAT ATG CAT GCT ATA
3`-TAC GTA CGA TAT TAT GAC GTA TTT TCT GTA TAC GTA CGA TAT
Duplex
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TABLE 1.  Sequence Dependent Formation of LMW 
Cross-Links From α,β-Unsaturated Ap-Sites 
 
 
5.3 Structure Elucidation of the Endonuclease III-Generated Cross-Links by 
Hydroxyl Radical Footprinting and Gel Shift Assay 
 Observation of cross-link bands with faster mobility than dA-Ap cross-links 
(dependent upon EndoIII treatment) is consistent with formation of LMW cross-links.  
We next set out to better characterize the structure and location of this LMW cross-link.  
It was important to locate the site of attachment, so we performed hydroxyl radical 
footprinting reactions as described in Chapter 3 for sequence O.  After analysis with 
PAGE, results show that the site of attachment is at A9 (Figure 4).  This cross-link site of 
attachment resembles that of the dA-Ap cross-links discussed in Chapter 4 from which 
the duplex O sequence was based.   
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Figure 4 
 
Figure 4. Hydroxyl radical footprinting of duplex O to locate the site of attachment for 
Endo III generated LMW cross-link (Panel A).  Panel A: Lane 1 is a Maxam-Gilbert G-
specific cleavage (sequencing) reaction of the labeled strand.  Lane 2 is an A+G specific 
cleavage (sequencing) reaction of the labeled strand.  Lane 3 is the hydroxyl radical 
footprinting reaction of the single stranded non-uracil containing oligonucleotide.  Lane 4 
is the hydroxyl radical footprinting reaction of the PAGE purified cross-link generated by 
incubation of UDG and EndoIII treated duplex O in HEPES buffer (50 mM, pH 7) 
containing NaCl (100 mM) at 37 ˚C.  32P-labeled 2’-deoxyoligonucleotides were resolved 
on a polyacrylamide gel visualized by phosphorimager analysis (Panel A) and used to 
develop densitometry traces (Panels B-D).  Panel B is the trace of lane 1.  Panel C is the 
trace of lane 2.  Panel D is the trace of lane 3. 
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 To determine approximately the amount at which Ap-containing DNA (1) were 
converted to 2 and 4, we performed the LMW cross-link reactions in the presence of 
thiols to capture the α,β-unsaturated aldehydes (2) present to form 7 (Scheme 1).  It is 
known that thiols react quickly with α,β-unsaturated aldehydes.27 If the major site of 
cross-link formation was at the β-carbon, then thiols were expected to diminish or quench 
cross-link formation.  Furthermore, a gel shift assay was used to "visualize" conjugate 
additions of thiols to the α,β-unsaturated Ap-sites (2).28 DNA fragments adducted by 
thioglycolate (15) can produce significant changes to their gel mobility.28 Consequently, 
all thiol adducted α,β-unsaturated aldehydes (7) or LMW cross-linked (8) would be 
observed as a gel shifted (faster moving) band relative to the non-thiol-adducted DNA 
because of the additional negative charge. 
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Figure 5 
 
Figure 5.  Thiol induced gel shift assay of LMW cross-link generated from UDG and 
EndoIII treated duplex N.  α,β-Eliminated DNA from treatment with EndoIII was 
incubated in HEPES buffer (50 mM, pH 8) containing NaCl (100 mM) at 37 ˚C for 24 h 
in the presence (or absence) or glutathione (16, 1 mM).  Lane 1 is enzyme treated DNA 
(no inc), Lane 2 is enzyme treated DNA with incubation, Lane 3 is a mixture of reactions 
co-loaded with samples included in Lanes 2 and 4, and Lane 4 is enzyme treated DNA 
incubated in the presence of thiol 16.   
 
 For this assay, we first followed a procedure described by Bailly and Verly.28 We 
incubated α,β-eliminated Ap-DNA with thioglycolate (15) in HEPES buffer (50 mM, pH 
8) and NaCl (100 mM).  After analysis by PAGE, no observable gel shift was seen.  
Examining Verly's work more closely revealed their gel shifted DNA involved 8-mer 2-
deoxyoligonucleotides (~3 kDa) with a terminal α,β-unsaturated Ap-site (2).  
Oligonucleotides of this length are much smaller in size and mass than the duplexes 
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employed in this study (>16 kDa), therefore a single negative charge produced by 
thioglycolate would have less of an effect on gel mobility than in Verly's work.28 
 So instead we decided to use a much larger thiol, utilizing its size to slow the 
mobility of any α,β-eliminated Ap-DNA.  Glutathione (GSH, 16, Scheme 4) is a large 
thiol present in high abundance in cells, with a molecular mass of 307.32 g/mol.  While 
GSH contains two negatively charged carboxyl groups, it is much larger than any single 
nucleoside within DNA and should produce a noticeable gel shift from its additional 
mass and inherent bulkiness.  This was actually observed in experiments described in 
Chapters 3 and 4 when Ap-derived cross-link formation was tested in the presence of 
various additives.  α,β-eliminated Ap-DNA that formed during incubation produced gel-
shifted bands in the presence of GSH (slowed mobility). 
 EndoIII-treated, Ap-containing duplex N incubated in the presence of GSH (16, 1 
mM) produced a gel shift for the LMW cross-link (8) as well as the uncross-linked 
cleaved DNA (7) (Figure 5, lanes 3 and 4).  Only a fraction of each band resulted in a gel 
shift, indicating only partial adduction by thiol.  Quantification of the bands in Figure 5 
tells us that a mixture of 2 and 4 was obtained after EndoIII treatment of 1.  About 40-
50% of the EndoIII treated Ap-DNA was gel shifted when incubated in the presence of 
GSH.  Furthermore, a similar portion of the LMW cross-link was also gel shifted from 
the presence of GSH (~30%).  This result is consistent with a mixture of cleaved AP-
containing DNA (2 and 4).  Any α,β-unsaturated Ap-sites (2) would be adducted by thiol 
giving a gel-shifted band corresponding to a 3`-GSH adduct of the Ap-site (7, Scheme 1).  
The 3`-thiol adducted Ap-site (7) was able to cross-link; presumably by imine formation 
resulting in a GSH adducted LMW cross-link (8).  Formation of this product was not 
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dependent on whether thiol was present during or after treatment with EndoIII (data not 
shown).  Finally, any 3`-deoxyribose phosphate (4) DNA present would not be adducted 
by thiol as the α,β-unsaturation was hydrated.  For this reason we would not observe a gel 
shifted band for both the 3`-deoxyribose phosphate (4) and 3`-deoxyribose phosphate 
LMW cross-link (5).   
 
5.4 Mass Spectrometric Analysis of Low Molecular Weight Cross-link Generated by 
Endonuclease III 
 We were curious why we did not see a complete gel shift in the DNA upon thiol 
treatment.  So we used mass spectrometry to get the molecular mass of the EndoIII-
generated, cross-linked product, with and without thiol.  LMW cross-links were prepared 
as before using duplex N-2 (Figure 6).  Purification was done by preparative PAGE and 
analysis by Nanospray-QTOF MS provided the spectra in Figure 6.  We observed a 
neutral mass of 16115.53 Da for the non thiol-adducted cross-link of duplex N-2 (Figure 
6).  This mass is 18 mass units (+H2O) higher than the mass expected for structure 18 
(calc'd 16097.42 Da) that would form through an imine intermediate from 2.  Initially this 
would suggest that conjugate addition was the preferred method of cross-link formation 
(Scheme 5, structure 19, calc'd 16115.44 Da).  But as suggested before a mixture of 
LMW cross-links most likely was obtained providing the isobaric structure 22 (calc'd 
16115.44 Da).   
 We also observed smaller masses identified as each of the single strand DNA 
dissociated from the LMW cross-link isolated with neutral masses of 9244.04 Da and 
6889.54 Da.  These masses correspond to the full-length complimentary bottom strand 
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(Figure 6, calc'd 9244.00 Da) and the 3`-deoxyribose-containing top strand (4, calc'd 
6889.46 Da).  These results are consistent with dissociation of LMW cross-link with 
structure 22, formed by the reaction between the aldehyde of structure 4 and the 
exocyclic -NH2 of deoxyadenine on the opposing strand.   
 
Scheme 5 
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Figure 6 
 
Figure 6.  Nanospray QTOF MS of LMW cross-link generated by treating duplex N2 
with UDG and Endo III and isolated from a 20% denaturing polyacrylamide gel. 
 
Figure 7 
 
Figure 7.  Nanospray QTOF MS of LMW cross-link (formed in the presence of β-
mercaptoethanol, 17) generated by treating duplex N with UDG and Endo III and isolated 
from a 20% denaturing polyacrylamide gel. 
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 We derivatized the LMW cross-links by thiol adduction to provide additional 
evidence that EndoIII treated AP DNA generated a mixture of products (2 and 4, Scheme 
1).  We used β-mercaptoethanol (17) for this experiment as it is a much smaller thiol and 
less bulky, therefore more nucleophilic for conjugate addition.  LMW cross-links were 
prepared as before using UDG and EndoIII treated duplex N incubated in the presence of 
17 (1 mM) (Duplex N differs in only 1 base pair, changing the masses of each single-
stranded DNA, but is isobaric with duplex N-2).  LMW cross-link was isolated from a 
preparative polyacrylamide gel and was analyzed by Nanospray-QTOF MS to provide 
Figure 7.  We observed a neutral mass of 16115.63 Da corresponding to the non thiol-
adducted LMW cross-link of duplex N (22, Scheme 5) (calc'd 16115.44 Da).   
 Again we observed smaller masses identified as each of the single strand DNA 
dissociated from the LMW cross-link isolated with neutral masses of 9204.11 Da and 
6929.56 Da.  These correspond to the full-length complimentary bottom strand (Figure 6, 
calc'd 9203.97 Da) and the Ap-containing top strand (calc'd 6929.48 Da).  This is again 
consistent with the structure 4 (Scheme 5).  Upon closer inspection of the spectrum, we 
see minor peaks at m/z 16175.48 Da and 6989.23 Da corresponding to thiol (17) 
adducted cross-link of duplex N (14, calc'd 16175.55 Da) and the dissociated β-ME 
adducted Ap-cleaved top strand (13, calc'd 6989.60 Da).  These less abundant but heavier 
masses would result from removal of H2O (18 Da) from the 16115.63 and 6929.56 Da 
masses and addition of 17 (78.13 Da).  These results are consistent with Endo III 
generated LMW cross-link primarily results from structure 4.  Only small amounts of 20 
and 21 were observed, consistent with only small amounts of 2 present during the cross-
link reaction after enzyme treatment.  EndoIII cleaved DNA containing a 3`-OH cap (4) 
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would only react with an opposing dA by imine formation and prevent conjugate addition 
from occuring.  The thiol adducted products would arise from small amounts of 2 
released from the enzyme before hydration occurred at the α,β-unsaturation. 
 As mentioned before, recent publications report that EndoIII primarily generates 
3`-deoxyribose phosphate products (4, Scheme 1).18 It is also possible that the α,β-
unsaturated Ap-sites (2) hydrate after cross-link formation, as Schiff Bases can assist in 
reactions involving α,β-unsaturated aldehydes.29 But it is more likely it that Endo III 
lyase activity is the primary source of 4.30 Additionally, the amount of thiol adduction 
determined by gel shift was independent of whether GSH (1 mM) was present during the 
EndoIII treatment or after.  Combined these results suggest that a mixture of 
predominantly 3`-OH capped Ap-sites (4) with lower amounts of α,β-unsaturated Ap-
sites (2) were obtained after EndoIII treatment.   
 
5.5 Generating Low Molecular Weight Cross-Links with Spermine 
 While catalyzing α,β-cleavage of Ap-sites is an efficient process enzymatically, 
significant hydration product is clearly obtained in the process.18 For this reason we 
decided to generate the α,β-unsaturated Ap-sites (2) by a chemical method instead.  
Spermine (Scheme 4, 14) has been shown to efficiently and selectively catalyze the β-
elimination of Ap-sites (1) to yield α,β-unsaturated products with little γ,ζ-cleavage and 
no significant hydration at the 3`-carbon (4, Scheme 5).31-32 Uracil containing 5`-32P-
labeled duplex N was treated with UDG in the presence of spermine (1-10 mM) in 
HEPES buffer (50 mM, pH 8) and NaCl (100 mM) to generate the α,β-unsaturated Ap 
sites (2).  After enzyme removal and ethanol precipitation, further incubation in HEPES 
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(50 mM, pH 8) and NaCl (100 mM) at 37 °C produced high yields (~63%) of LMW 
cross-link product within 24 hours (lane 4, Figure 8A) and the presence of thiols 
significantly reduce LMW cross-link yields (Lanes 5 and 6).  Similar incubations under 
pH 7 conditions instead provided yields of ~30%.  Performing the same incubation on 
duplex O at pH 8 provided slightly lower yields (~35-40%, lane 3, Figure 8B) with no 
significant difference when incubating at pH 7 (~35%).  The substantial change in yield 
for two duplexes with an identical core is most likely due to changes in flexibility after 
α,β-cleavage.  Remember, duplex N was designed so the β-eliminated strand would melt 
off the duplex after elimination of the 3`-phosphate, whereas duplex O would remain 
hybridized as a double helix (Scheme 6).   
Scheme 6 
 
 We noticed that cross-link yield seems to be pH dependent, as we generally see 
higher yields obtained when using slightly basic pH 8 buffer, rather than neutral pH 7 
buffer (Table 2) after spermine treatment.  The higher LMW cross-link yield resulting 
from slightly basic buffer pH is only observed for α,β-unsaturated Ap-sites generated 
with spermine (2).  These results are consistent with a conjugate addition mechanism in 
aqueous media, as basic conditions would increase the rate of addition.  Additionally, 
LMW cross-link yields were not as sensitive to pH when treating Ap-containing DNA 
with EndoIII.  We have shown EndoIII primarily generates 4, which would only form 
imine-type cross-links (Scheme 4).  Finally, significant thiol adduction onto cleaved Ap-
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DNA was observed, indicated by changes in gel mobility (Figure 8, lanes 5 and 6).  Thiol 
also significantly decreased the LMW cross-link yield.  Thiol adduction (7, Scheme 1) 
would inhibit cross-link formation by conjugate addition, leaving only imine formation to 
occur (8, Scheme 1). 
 
Table 2  pH Dependent Formation of LMW Cross-Links 
From α,β-Unsaturated Ap-Sites 
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Figure 8 
 
Figure 8.  Interstrand cross-link formation from 32P-labeled duplexes N and duplex O 
resolved by electrophoresis on 20% denaturing polyacrylamide gels.  Panel A Duplex N 
incubated in HEPES buffer (50 mM, pH 8) containing NaCl (100 mM) at 37 ˚C for 24 h 
with the indicated reagent: Lane 1 is duplex N alone.  Lane is 2 duplex N with UDG.  
Lane 3 is duplex N with spermine (1 mM).  Lane 4 is duplex N with UDG and spermine 
(1 mM).  Lane 5 is duplex N with UDG and spermine (1 mM) in the presence of GSH (1 
mM).  Lane 6 is duplex N with UDG and spermine (1 mM) in the presence of sodium 
thioglycolate (1 mM).  Panel B Duplex O incubated in HEPES buffer (50 mM, pH 7) 
containing NaCl (100 mM) at 37 ˚C for 24 h AFTER the indicated treatment: Lane 1 is 
duplex O with no treatment.  Lane is 2 duplex O pretreated with UDG.  Lane 3 is duplex 
O pretreated with UDG and spermine (1 mM). 
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 Ap-containing duplexes P-S incubated in HEPES (50 mM, pH 7) and NaCl (100 
mM) at 37 °C for 3 d after being treated with spermine (1 mM) produced different results 
than when treated with EndoIII.  α,β-Unsaturated Ap-containing (2) duplex P 
significantly decreased in cross-link yield while duplexes Q and S gave no additional 
cross-link or none at all for the spermine treated duplexes when compared to the EndoIII 
treated duplexes (Table 1).  Surprisingly, we observed a substantial increase in LMW 
cross-link yield for duplex R (~40%) following spermine treatment when compared to 
Endo III treatment (~2%).  These results lead us to believe dG residues are excellent 
candidates for conjugate addition of α,β-unsaturated Ap-sites (2).  Deoxyguanosine 
residues are previously reported to adduct and cross-link with α,β-unsaturated aldehydes 
(Chapter 3, Scheme 2).10 We show in the next section evidence that these new high 
yielding LMW cross-link are formed by conjugate addition of both adenine (duplex N) 
and guanine (Duplex R) residues on the α,β-unsaturated Ap-site (structure 6, Scheme 1). 
 
5.6 Site of Attachment for Cross-Links Generated by Spermine Treated Ap-DNA 
 Hydroxyl radical footprinting was performed for duplex O (Figure 9) and R 
(Figure 10) after UDG and spermine treatment as described in the previous section.  
Footprinting of duplex O produced a break in the ladder (lane 4) at A9, meaning this is 
the major site of attachment, with no cross-link indicated at the dG residue.  A minor 
band is observable at A8, indicating a small amount of cross-link at the adenine directly 
opposing the α,β-unsaturated Ap-site (2).  DNA footprinting of duplex R did not provide 
a single site of attachment (Figure 9).  The histogram plotting 32P-intensity over distance 
traveled by DNA fragments does not show a clean break for lane 4 (Figure 10, Panel D).  
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As seen in the gel, the increasing signal intensities for G 5-7 indicates that multiple cross-
links were formed. This means that duplex R generated a mixture of dG cross-links at 
G5, G6, and G7, each with similar mobility in denaturing PAGE, as they were isolated 
from the same band in the gel used to purify the LMW cross-links. 
Figure 9 
 
Figure 9.  Hydroxyl radical footprinting of duplex O to locate the site of attachment for 
spermine generated LMW cross-link.  Lane 1 is a Maxam-Gilbert G-specific cleavage 
(sequencing) reaction of the labeled strand.  Lane 2 is an A+G specific cleavage 
(sequencing) reaction of the labeled strand.  Lane 3 is the hydroxyl radical footprinting 
reaction of the single stranded non-uracil containing oligonucleotide.  Lane 4 is the 
hydroxyl radical footprinting reaction of the PAGE purified cross-link generated by 
incubation of UDG and spermine with duplex O in HEPES buffer (50 mM, pH 8) 
containing NaCl (100 mM) at 37 ˚C.  32P-labeled 2’-deoxyoligonucleotides were resolved 
on a polyacrylamide gel visualized by phosphorimager analysis (Panel A) and used to 
develop densitometry traces (Panels B-D).  Panel B is the trace of lane 1.  Panel C is the 
trace of lane 2.  Panel D is the trace of lane 3. 
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Figure 10 
 
Figure 10.  Hydroxyl radical footprinting of duplex R to locate the site of attachment for 
spermine generated LMW cross-link.  Lane 1 is a Maxam-Gilbert G-specific cleavage 
(sequencing) reaction of the labeled strand.  Lane 2 is an A+G specific cleavage 
(sequencing) reaction of the labeled strand.  Lane 3 is the hydroxyl radical footprinting 
reaction of the single stranded non-uracil containing oligonucleotide.  Lane 4 is the 
hydroxyl radical footprinting reaction of the PAGE purified cross-link generated by 
incubation of UDG and spermine with duplex R in HEPES buffer (50 mM, pH 8) 
containing NaCl (100 mM) at 37 ˚C.  32P-labeled 2’-deoxyoligonucleotides were resolved 
on a polyacrylamide gel visualized by phosphorimager analysis (Panel A) and used to 
develop densitometry traces (Panels B-D).  Panel B is the trace of lane 1.  Panel C is the 
trace of lane 2.  Panel D is the trace of lane 3. 
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5.7  Mass Spectrometric Analysis of Low Molecular Weight Cross-link Generated 
by Spermine  
 We used mass spectrometry to analyze LMW cross-link prepared by incubating 
uracil containing duplex N with UDG in the presence of spermine (10 mM).  The LMW 
cross-link was separated from uncross-linked DNA on a 20% denaturing polyacrylamide 
gel, excised from the gel, and analyzed by Nanospray QTOF MS.  We obtained a single 
peak with a neutral mass of 16115.73 Da, consistent with a conjugate addition of the 
opposing dA onto the α,β-unsaturated abasic site (Figure 11, structure 19, calc'd 16115.44 
Da).  Moreover, no significant dissociation peaks were observed.   
Figure 11 
 
Figure 11.  Nanospray QTOF MS of LMW cross-link generated by treating duplex N 
with UDG and Endo III isolated from a 20% denaturing polyacrylamide gel. 
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 We also incubated duplex N under the same conditions in the presence of β-
mercaptoethanol (1 mM).  While no cross-link was obtained in this reaction, the single 
stranded cleaved DNA recovered from this reaction produced a single neutral mass of 
6989.21 Da.  This matches the mass of a 3`-β-mercaptoethanol adducted Ap-containing 
top strand of duplex N (structure 20, calc'd 6989.60 Da).  From this we can conclude full 
thiol adduction at the 3`-carbon was observed, preventing cross-link formation. 
Additionally no evidence of hydration at the α,β-unsaturation was observed.  
 Overall our results provide evidence supporting our hypothesis that these LMW 
cross-links form via conjugate addition of an opposing base with the α,β-unsaturated Ap-
site.  We saw earlier that incubation of the uracil-containing duplex N with UDG and 
spermine in the presence of GSH or thioglycolate resulted in significant decrease of the 
LMW cross-link yield (Figure 8, lanes 5 and 6).  Thiols inhibited cross-link formation.  
Consistent with a conjugate addition mechanism, this suggests that the 3`-opposing dA 
residue A9 (Figure 9) and thiol competed for addition onto 2 (Scheme 1).  This 
competition is supported by literature reported on inhibition of cross-link formation of 
C4`-oxidized Ap-sites with DNA bases by dithiothreitol (DTT).4 It was suggested that 
conjugate addition of DTT prevented addition by the DNA bases required for cross-link 
formation.4 It is unclear why we do not see a mixture of cross-linked products with 
differing gel mobility after treatment with GSH, as seen before for the EndoIII treated 
duplex (Figure 5).  It is possible spermine competed for Schiff-Base formation, resulting 
in no interstrand cross-links by imine attachment after thiol addition at the 3`-carbon. 
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5.8 Chapter 5 Summary 
 We have described interstrand cross-links resulting from the reaction of a cleaved 
Ap-site resulting from a single strand break at the 3`-carbon with an opposing base in 
DNA duplexes.  Two known methods for generating α,β-unsaturated Ap-sites (to varying 
degrees) were utilized in this study.  Treating Ap-containing DNA (1) with either EndoIII 
or spermine catalyzes the elimination of the 3`-phosphate of an Ap-site.  Using 
modifications of literature methods,22-23,33 we generated Ap-sites with UDG and further 
treated them with either cleaving agent.  Yields of cross-link varied greatly depending on 
the reagent used, resulting from differences in chemical structure of the cleaved Ap-site 
products.  We have provided evidence for Ap-site structures with gel mobility and mass 
spectrometry experiments.  It has been determined that cross-links formed by reaction of 
an Ap-site treated with EndoIII generating primarily 4 will occur via imine formation (5) 
with smaller amounts of conjugate addition product (6) resulting from the release of 2 
(Scheme 1).  We have supplied evidence that spermine cleaved Ap-sites primarily gave 
conjugate addition products (6).  Additionally the presence of thiol inhibits formation of 
LMW cross-links by conjugated addition (7, Scheme 1), but does not completely prevent 
it (Figure 8).   
 Hydroxyl radical footprinting allowed us to identify that α,β-unsaturated Ap-sites 
(via spermine cleavage) cross-link with both deoxyadenine as well as deoxyguanine.  
Duplex R yielded a mixture of attachments with the various opposing dG residues from 
the α,β-unsaturated Ap-site (Figure 10.  And while duplex O contains a guanine residue 
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near the α,β-unsaturated Ap-site, only a single major attachment with dA residue A9 
(Figure 9) was observed.   
 Mass spectrometry experiments for the spermine generated LMW cross-link 
(Figure 11) provided a neutral mass consistent with structure 19 (Scheme 5, calc'd 
16115.44 Da).  Incubation of the 32-P-labeled α,β-unsaturated Ap-containing (2) DNA 
provided a single observable cross-link band on the gel (Figure 8), indicating a single 
cross-linked product.  It is possible that the isolated LMW cross-link actually exists as 
cyclized structures 23 or 24  (Scheme 7).  These attachments would have been forged by 
subsequent conjugate addition and hemiaminal formation of the exocyclic N6-nitrogen 
and endocyclic N1-nitrogen of adenine.  We could not discern between them using mass 
spectrometry as they are isobaric.  Structures like these have been previously proposed 
for the C4-oxidized cross-links.4 Only a single product cross-linkband was observed 
throughout our experiments, indicating a single major product was obtained.  Though the 
gel mobilities of each structure may be too similar to separate them effectively on a 20% 
denaturing polyacrylamide gel.  Further characterization is needed. Overall we have 
presented evidence for the formation of a previously uncharacterized cross-link resulting 
from α,β-unsaturated Ap-sites in duplex DNA. 
Scheme 7 
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5.9 Experimental 
Materials and Methods.  Oligonucleotides were purchased from Integrated DNA 
Technologies.  All enzymes were purchased from New England Biolabs (Ipswich, MA, 
USA).  [γ-32P]-ATP (6000 Ci/mmol) was purchased from Perkin Elmer.  C-18 sep-pak 
cartridges were from Waters.  BS Polyprep columns were purchased from BioRad.  Zeba 
Spin Desalting Columns (7K MWCO, 0.5 mL) were purchased from Thermo Scientific.  
Quantification of radioactivity in polyacrylamide gels was carried out using a Personal 
Molecular Imager (BIORAD) with Quantity One software (v.4.6.5).  All other reagents 
were purchased from Sigma-Aldrich. 
Representative procedure for cross-link formation using Endonucelase III.  Single-
stranded uracil containing 2’-deoxyoligonucleotides were 5’-labeled using standard 
procedures.34  Labeled DNA was annealed with its complimentary strand and added to an 
enzyme cocktail containing Uracil DNA Glycosylase (200 units/mL, final concentration), 
Endonuclease III (Nth) (200 units/mL), and BSA (1X) to generate α,β-Unsaturated Ap-
Sites.  NOTE: Buffer exchange of enzymes must be done prior to DNA treatment to 
remove DTT included in storage buffer.  Enzymes were passed through a Zeba spin 
column exchanged with HEPES buffer (50 mM, pH 8) and NaCl (100 mM).  After 
addition of DNA to enzyme, the mixture was incubated at 37 ˚C for 30 min.  Enzymes 
were removed by phenol-chloroform extraction and then the aqueous layer was ethanol 
precipitated.34  DNA duplexes were then incubated further in HEPES buffer (50 mM, pH 
7 or 8) containing NaCl (100 mM) at 37 ˚C for 24 h.  The DNA was ethanol 
precipitated,34 resuspended in formamide loading buffer,34 loaded onto a 20% denaturing 
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polyacrylamide gel, and the gel electrophoresed for 4 h at 1000 V.  The amount of 
radiolabeled DNA in each band on the gel was measured by phosphorimager analysis.  
The time course for the formation of the Ap site cross-link was carried out by incubating 
a solution containing labeled DNA (approximately 300,000 cpm), in  HEPES (50 mM, 
pH 7) and NaCl (100 mM) at 37 ˚C.  At specified time points, aliquots (1 µL) were 
removed and frozen at –20 ˚C, after all time points were collected samples were loaded 
directly on the gel and analyzed as described above. 
 
Representative procedure for cross-link formation using Spermine.  Single-stranded 
uracil containing 2’-deoxyoligonucleotides were 5’-labeled using standard procedures.34  
Labeled DNA was annealed with its complimentary strand and added Uracil DNA 
Glycosylase (200 units/mL, final concentration) and spermine (1 mM) and the mixture 
was incubated at 37 ˚C for 30 min to generate α,β-Unsaturated Ap-Sites.  Enzyme was 
removed by phenol-chloroform extraction and then the aqueous layer was ethanol 
precipitated.34  DNA duplexes were then incubated like above and analyzed by 20% 
denaturing polyacrylamide gel. 
 
Hydroxyl Radical Footprinting.  DNA footprinting reactions were done as in Chapter 3 
and 4, preparing the cross-link using the conditions  above. 
 
Static Nanospray QTOF MS.  The oligonucleotide sample was analyzed in a 40 mM 
dimethylbutylammonium acetate (pH 7.1) buffer by static nanospray QTOF MS 
(negative ion detection) on an Agilent 6520A mass spectrometer equipped with a Chip 
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Cube source (G4240A).  Spectra were calibrated internally using the ion at m/z 
1279.99666473 which was the [M-H]- for the acetate adduct with the reference standard 
Hexakis (1H, 1H, 4H-hexafluorobutyloxy)phosphazine (C24H18O6N3P3F36, 1221.990637 
Da), introduced into the instrument source separately from the samples.  An 
oligodeoxynucleotide standard (IDT, Neutral Average mass: 12379.12 Da) was also 
analyzed as a check on the calibration.  Samples were introduced into the instrument with 
New Objective Econo12 N uncoated emitters.  Negative ion MS spectra were acquired in 
the extended dynamic range (2-GHz) mode over the range of 100-3200 Da at a rate of 1.5 
seconds per spectrum  Monoisotopic neutral masses were calculated from the multiply 
charged ion spectrum present in the 500-2000 Da mass range.  Sample introduction was 
done with New Objective Econo12 N uncoated borosilicate glass emitters.  Negative ion 
spectrum was acquired at a capillary potential sufficient to initiate spray of the sample.  
The nitrogen gas was heated to 290°C and introduced at a flow rate of 4L/min. The 
Fragmentor, Skimmer, and Octapole1 RF Vpp potentials were set to 200 V, 65 V, and 
750 V, respectively.  External Calibration was done with the Agilent ESI-Low calibration 
tuning mixture (cat. no. G1969-85000) and data analysis was performed with Agilent 
Mass Hunter Workstation Qualitative Analysis software v B.02.00, Build 2.0.197.0 with 
Bioconfirm Software (2008).  Peptide isotope model was assumed and peak set height 
threshold for extraction was set to ≥ 500 counts.  Deconvolution was done with a 0.1 Da 
step size with a result of 20 iterations of the algorithm calculation 	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Thesis Summary 
 In summary, this thesis presents research completed towards designing new uses 
for the 3-amino-1,2,4-benzotriazine 1,4-dioxide (Tirapazamine, 1) core in regards to 
hypoxia selective probes and DNA alkylating drug candidates.  The well-described di-N-
oxide system shows promise for generating many structurally diverse compounds with 
tuneable reactivity and function.  Several scaffolds and synthetic methods have been 
developed for generation of numerous benzotriazine-containing compounds potentially 
useful for development of fluorescent probes for cellular hypoxia or drugs for anti-cancer 
chemotherapy.  We also presented work important for understanding processes involving 
cross-links that could form from the biologically important abasic site in duplex DNA.  
Showing that the abasic site aldehyde while in low abundance can react with DNA bases 
to form significant amounts of DNA interstrand cross-links.  We have provided evidence 
that while common anti-cancer drugs and alkylating agents commonly produce Ap-sites 
through depurination, they indirectly are capable of causing Ap-site derived cross-links as 
well.  Cross-links resulting from generation of native Ap-sites and α,β-unsaturated Ap-
site can have profound biological consequences and are important targets for study. 
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